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ABSTRACT 
INFLUENCES OF MATERNAL OBESITY ON INDUCTION OF LABOR 
REQUIRING CERVICAL RIPENING  
by 
JESSICA ANN ELLIS 
Statement of the Problem 
Although obese women are less likely to initiate spontaneous labor than normal 
weight women, have longer labors, and higher rates of cesarean birth, evidence suggests 
little is known about the most effective methods for labor induction requiring cervical 
ripening in women with obesity. Using a population-based sample we evaluated the 
relationships between maternal obesity and methods for induction of labor requiring 
cervical ripening.  
Methods 
This retrospective cohort study used data from 41,359 women in the nationally 
representative Consortium of Safe Labor (CSL) dataset, collected from 2006 to 2012. 
Women with a low risk pregnancy (cephalic, singleton, and term gestation), undergoing 
induction of labor were included. The primary outcome of this study was cesarean birth 
after the use of cervical ripening methods. The secondary outcome was the time to birth 
with the use of cervical ripening methods. Binomial regression models and a survival 
analysis were adjusted for age, parity, race, insurance, and hospital type. 
Results 
Of the 41,359 cases included in the study, 6,035 women received one or more 
cervical ripening methods for induction of labor. The odds for cesarean birth in the 
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highest obesity category (obese cat 3) were lower after using misoprostol [aOR 3.44; CI 
1.95-6.07] than using other prostaglandins [aOR 7.03; CI 3.98-12.43], and lower using 
mechanical means [aOR 3.69; CI 2.04-6.68} then using either prostaglandin [aOR 3.94; 
CI 2.67-2.54] compared to normal weight women. The time to birth in the highest obesity 
category (Obese Cat 3) had higher hazard after using other prostaglandins [aHR 1.62; CI 
1.20-2.11] and lower hazard after using mechanical means [aHR .91; CI .65-1.28] when 
compared to the use of misoprostol. 
Conclusions 
These data suggest women with obesity have more cesarean births with the use of 
other prostaglandins for cervical ripening than with the use of mechanical means when 
misoprostol is the comparison group. Women with obesity also require a longer time to 
birth after using other prostaglandins and a shorter time to birth after using mechanical 
means when compared to using misoprostol. Clinicians can better support women with 
obesity requiring cervical ripening for induction of labor with careful consideration of 
cervical ripening method choice and effective counseling on length of labor induction, 
and risk for cesarean birth.  
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CHAPTER I 
INTRODUCTION 
In the past three decades, the incidence of obesity in the United States (U.S.) has 
tripled (Flegal, Kruszon-Moran, Carroll, Fryar, & Ogden, 2016). Current birth certificate 
data in the U.S. indicates over 50% of women who gave birth had a body mass index 
(BMI) that is either overweight (25.6%) or obese (24.8%) (Branum, Kirmeyer, & 
Gregory, 2016). Prevalence of maternal obesity is even higher across racial and ethnic 
minority groups, with nearly half of Hispanic women (45.75%) and over half of non-
Hispanic Black women (56.9%) being obese during childbearing years (Hales, Carroll, 
Fryar, & Ogden, 2017). Intrapartum complications associated with maternal obesity 
include increased rates of post-partum hemorrhage, sepsis, a prolonged hospital 
admission, increased fetal birth weight, and increased risk of fetal distress (Mission, 
Marshall, & Caughey, 2013). 
Use of labor induction for all women in the United States has increased 
significantly, rising from 9.9% in 1990 to 23.1% in 2008, and remains at this level today 
(Martin et al., 2007; Osterman & Martin, 2014) Among women with obesity, use of labor 
induction is much more common with rates over 30% (Wolfe et al., 2011). Not only are 
women with obesity more likely to undergo induction of labor, often the induction 
process is unsuccessful leading to an increased rates of cesarean births (Kabiru & Denise 
Raynor, 2004).  
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Among all types of labor onset (spontaneous and induced) an increased rate of 
cesarean births are seen with each stepwise increase in BMI category (Berendzen & 
Howard, 2013). A similar relationship between BMI and cesarean birth has been 
observed among women with induced labors (Zhao, Zhang, & Zhou, 2017). Slow labor 
progression, known as labor dystocia, can lead to the use of cesarean birth among women 
with obesity (Neal, Lowe, et al., 2015; Neal, Ryan, et al., 2015; Wu, Chen, & Chien, 
2013). In addition, women with obesity are less likely to initiate spontaneous labor than 
normal weight women (Bogaerts, Witters, Van den Bergh, Jans, & Devlieger, 2013; 
Stirrat et al., 2014). Some postulate that these obesity-associated changes in labor onset 
and progression are caused by hormone signaling that is altered in women with a high 
BMI (Bogaerts et al., 2013; Carlson, Hernandez, & Hurt, 2015). With increased obesity 
rates among women it is important for researchers and clinicians to understand the best 
method for induction of labor to optimize maternal and fetal processes and outcomes in 
this population.   
To explore this problem, we plan to examine outcomes associated with different 
labor induction methods among women stratified by their BMI category. To ensure 
sufficient sample size in each BMI category, we will conduct this analysis using a large, 
multi-site, dataset.  Specifically, we plan to compare outcomes in women undergoing 
induction of labor using prostaglandins vs. mechanical devices. Our proposed model is 
supported by early evidence that mechanical devices work better in women with obesity 
than prostaglandins for induction of labor (Suidan, Rondon, Apuzzio, & Williams, 2015). 
Our improved understanding of the process and outcomes of induction methods will 
allow for better care of childbearing women, with a goal of reducing primary cesarean 
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sections due to a failed induction of labor.  
Body Mass Index 
Body mass index (BMI) is a value derived from the mass and height of an 
individual (Institute of Medicine, 2009; World Health Organization, n.d.). This score is 
an attempt to quantify the amount of tissue mass, fat and bone density of an individual. 
BMI is calculated by dividing a person’s weight in kilograms by the square of the height 
in meters. BMI is commonly interpreted in categories from underweight to obese (See 
Figure 1). This study will use the following standard weight status categories (Institute of 
Medicine, 2009). 
Categories BMI (kg/m2) 
Underweight  18.5 
Normal Weight 18.5 - 24.9 
Overweight 25 - 29.9 
Obesity (Class 1)  30 - 34.9 
Obesity (Class 2)  35 - 39.9 
Obesity (Class 3)   40  
Figure 1. Body Mass Index Categories 
Labor Induction 
Induction of labor has been defined by World Health Organization (WHO) as “the 
process of artificially stimulating the uterus to start labor” (WHO, 2011, p. 6).  The goal 
of labor induction is to stimulate uterine contractions that will eventually result in a 
vaginal birth (ACOG, 2009). The following section explores the interplay of cervical 
readiness and parity, the number of times a woman has given birth, on induction of labor.  
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Both cervical readiness and parity impact induction of labor (Melamed, Ben-Haroush, 
Kremer, Hod, & Yogev, 2010). Additionally, the indications, contraindications, risks and 
benefits of induction of labor are outlined.  
Cervical Assessment 
Cervical readiness is an important component in labor induction. To prepare for 
birth the cervix, which is the lower segment of the uterus that sits at the top of the vagina, 
begins to soften (ripen), thin out (efface), and open (dilate). The cervical remodeling 
process begins weeks before labor starts (ACOG, 2009). When a woman’s cervix is ready 
for induction it is said to be ripe. Cervical ripening as defined by the American Congress 
of Obstetricians and Gynecologists (ACOG) as the process where the cervix softens and 
thins out in preparation for labor; medications or devices maybe used to help facilitate 
this process (ACOG, 2009). A recent randomized trial of nulliparous women, compared 
women being induced to women with expectant management, finding 63.5% of the 
women randomized to the induction of labor group required cervical ripening (W. 
Grobman, 2018).  
Bishop score. Developed in 1964, the Bishop score is a cervical scoring system 
which is commonly used for assessing cervical readiness for labor (Bishop, 1964; 
Penfield & Wing, 2017). This score accounts for the position, consistency, effacement, 
and dilation of the cervix, as well as the fetal station (location) of the presenting fetal part 
relative to the ischial spines (see Figure 2).  A modified Bishop score has been developed 
which replaces effacement with cervical length.  Scoring for these systems includes 
assigning a numeric score of 0-3 to each category, which is summed for a possible 
maximum score of 13. A modified Bishop score of less than 6 generally means the cervix 
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would benefit from cervical ripening (Penfield & Wing, 2017). In other research a Bishop 
score of less than 5 was used as a cut off point for cervical ripening (W. Grobman, 2018; 
Lassiter et al., 2016) and a Bishop score 5 or greater in nulliparous women was found to 
be predictive of successful induction of labor at term (Zelig, Nichols, Dolinsky, Hecht, & 
Napolitano, 2013).  
Factor 
Score 
Dilation 
(cm) 
Effacement 
(%) 
Station * 
Cervical 
consistency 
Position of 
the cervix 
0 closed 0-30 -3 Firm  Posterior 
1 1-2  40-50 -2 Medium  Central  
2 3-4 60-70 -1, 0 Soft  Anterior  
3 5-6 80 + 1, +2 - - 
Figure 2. Modified Bishop Scoring System *Station reflects a -3 to +3 scale. Modified 
from Bishop, 1964 
 
Assessing the Influence of Parity 
Parity is the number of times a woman has given birth (Medical Dictionary Farlex 
and Partners, 2009). A nulliparous woman has never given birth, whereas a multiparous 
woman has given birth more than one time to a fetus over 20 weeks’ gestation (Levine, 
Hirshberg, & Srinivas, 2014). Understanding the influences of parity on the likelihood of 
cesarean birth is important when inducing an individual. In a woman who is nulliparous, 
it is unknown if the pelvis can adequately accommodate the passage of the fetus or if the 
uterus will contract with sufficient strength to achieve vaginal birth.  In a recent study on 
term labor induction and risk of cesarean (n = 863) researchers found that of women 
requiring induction of labor, nulliparous women were more likely to have a cesarean birth 
than multiparous women (27% vs 13%) (Levine et al., 2014). 
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Indications and Contraindications 
Labor induction among all women most commonly occurs for indicated or 
medical reasons. Women with obesity have higher rates of medical complications in 
pregnancy making them more likely to require induction of labor than normal weight 
women. A medical induction is indicated when the health of the mother or the fetus is at 
risk. Reasons for medical induction include maternal medical conditions (e.g,. gestational 
diabetes, renal disease, chronic pulmonary disease) gestational or chronic hypertension, 
preeclampsia, eclampsia, pre-labor rupture of membranes, chorio-amnionitis, a post term 
pregnancy, fetal demise, fetal compromise (i.e. severe fetal growth restriction, iso-
immunization, oligohydramnios) and fetal macrosomia (ACOG, 2009; WHO, 2011). 
Elective inductions occur in special situations when a person is induced for non-medical 
reasons such as living far from the hospital. According to professional guidelines 
published by ACOG, elective inductions are not to be performed prior to 39 weeks of 
pregnancy (ACOG, 2009).  
Contraindications to labor induction include all contraindications to a vaginal 
birth (ACOG, 2009). Some contraindications are absolute such as transverse fetal lie or a 
severe degree of placenta previa, where the placenta is completely covering the cervix 
(ACOG, 2009). Other contraindications are relative, including active genital herpes 
(HSV) infection, untreated human immunodeficiency virus (HIV) infection, a high 
floating fetal head, or a previous myomectomy entering the uterine cavity (ACOG, 2009).  
Benefits and Risks  
When the benefits of expeditious delivery outweigh the risks of remaining 
pregnant, inducing labor can be justified as a therapeutic intervention. When used 
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appropriately, induction of labor can improve health of mothers and babies. Risks 
associated with induction of labor have been reported as uterine hyperstimulation and 
uterine rupture, increased risk of cesarean birth, fetal distress, fetal death, and increased 
risk of infection for the mother and fetus (ACOG, 2009). Uterine hyper-stimulation, also 
known as uterine tachysytole, can cause changes in the fetal heart rate, including variable 
decelerations. The following definition for uterine tachysytole is given by the Association 
of Women’s Health, Obstetric and Neonatal Nurses (AWOHNN) (Kunz, Loftus, & 
Nichols, 2013): 
1. “More than five contractions in 10 minutes averaged over a 30-minute window; 
2. A series of single contractions lasting 2 minutes or more; 
3. Contractions of normal duration occurring within one minute of each other” 
(ACOG, 2003, p. 1446; Simpson & Creehan, 2008, p. 397). 
4. “Insufficient return of uterine resting tone between contractions via palpation or 
intra-amniotic pressure above 25 mm Hg between contractions via intrauterine 
pressure catheter [IUPC]” (Simpson & Creehan, 2008, p. 397). 
Expectant Management  
Currently research regarding induction of labor compares women undergoing 
induction of labor to similar women with expectant management. Expectant management 
is a medical management strategy where a person’s condition is closely monitored, but 
treatment is not given unless the condition changes or symptoms appear (Medical 
Dictionary, 2009 Farlex and Partners). For example, a woman either receives an 
induction of labor or a woman is closely monitored for changing health conditions and/or 
early labor symptoms before receiving any medical interventions. This is a newer way of 
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thinking about induction of labor, as much of the previous research was based on 
induction of labor outcomes being compared to spontaneous labor outcomes. We must 
now compare the risks of inducing labor to the risks of remaining pregnant.  
Labor Induction Methods 
This section will outline and define different methods of labor induction (ACOG, 
2009; Mozurkewich et al., 2011; WHO, 2011). Prostaglandins and mechanical devices 
are used for induction of labor when women need cervical ripening. Oxytocin Other 
methods used for labor induction of labor fall into two broad categories: those used in the 
hospital for a medical induction of labor (oxytocin and AROM) and methods that are 
often used informally to induce labor outside of the hospital setting, (stripping 
membranes, nipple stimulation, sexual intercourse, castor oil, and acupuncture), these 
methods will be referred to as non-medical methods for inducing labor. 
Prostaglandins 
Endogenous prostaglandins are chemicals that are made by the body that have 
many effects, including causing the cervix to ripen and the uterine muscles to contract.  
Synthetic prostaglandins are drugs that are given to ripen the cervix and induce labor. 
Synthetic prostaglandins mimic compounds found naturally in the body. Prostaglandins 
can be administered by many routes including buccal, oral, vaginal or rectal routes 
(ACOG, 2009). When compared to placebo, prostaglandins increase the likelihood the 
birth will occur within 24 hours, but also increase the risk of uterine tachysystole.  
There are two main types of prostaglandins used for induction of labor 
misoprostol and dinoprostone. Misoprostol is a synthetic prostaglandin analogue E1 
(PGE1) that can be used for both cervical ripening and induction of labor. The 
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medication was originally approved by the Food and Drug Administration (FDA) for the 
treatment of peptic ulcers. In 2002, the FDA added a labeled use for labor induction and 
cervical ripening, but misoprostol is not FDA approved for labor induction (U.S. Food 
and Drug Administration- Misoprostol, n.d.). Common PGE1 dosing for induction of 
labor is 25-50 micrograms (mcg) administered either vaginally or sublingually. 
Dinoprostone, a prostaglandin analogue E2 (PGE2) is also commonly used for induction 
of labor. Currently, there are two PGE2 preparations that are commercially available for 
use in the United States (ACOG, 2009). One is a vaginal gel and the other is a vaginal 
insert. Both are used for cervical ripening in women who are at or near-term gestation.   
Mechanical Devices  
Mechanical devices for cervical ripening exert a local pressure that stimulates the 
release of prostaglandins (Tenore, 2003). Mechanical methods include the use of Foley 
catheters, double balloon devices, extra amniotic saline infusion, and occasionally 
hydroscopic dilators, laminaria or dilapan (Mozurkewich et al., 2011). Mechanical 
devices are most commonly used in inpatient settings but are being investigated for use in 
outpatient settings, outside of the hospital (Policiano, Pimenta, Martins, & Clode, 2017). 
Mechanical devices mechanically dilate the cervix. A transcervical catheter has a small 
tube with a balloon at the end, the tube is inserted in the opening of the cervix and the 
balloon places mechanical pressure directly on the cervix as the balloon is inflated with 
saline (ACOG, 2009; Tenore, 2003). Several types of transcervial catheters are used 
including single balloon catheters such as the Foley Bulb catheter and double balloon 
catheters such as the Cook’s Catheter (Mozurkewich et al., 2011). Often the Foley is 
tethered or taped to the leg, creating additional pressure (Tenore, 2003). Hydroscopic 
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dilators are placed in the cervical opening, then absorb both endocervical and local tissue 
fluids causing expansion, providing a controlled mechanical pressure on the cervix 
(Tenore, 2003). Side effects are bleeding, membrane rupture, and placental disruption. A 
recent retrospective study of nulliparous women using hydroscopic dilators verses 
balloon catheters found the vaginal birth rate with hydroscopic dilators was equivalent to 
using a balloon catheter and safe when comparing maternal and fetal outcomes (Ryosuke 
Shindo, 2017).  
Oxytocin and Amniotomy 
Oxytocin, a hormone that causes contractions of the uterus, was first isolated in 
1948 for synthetic production (ACOG, 2009). Synthetic oxytocin is commonly used to 
both initiate (induce) or augment (speed up) labor, and is used postpartum to prevent 
hemorrhage (den Hertog, de Groot, & van Dongen, 2001). Today, oxytocin is one of the 
most widely used drugs in the United States, approximately 50% of women reported 
oxytocin use during their labor (Declercq, Sakala, Corry, Applebaum, & Herrlich, 2014). 
Amniotomy, also known as artificial rupture of membranes (AROM), is a procedure 
where the amniotic sac is deliberately ruptured to induce or accelerate labor (Busowski & 
Parsons, 1995). The procedure has been used for the past two centuries with varying 
popularity. If used alone for labor induction, AROM may result in unpredictable intervals 
to the onset of labor (Bricker & Luckas, 2000). AROM is most effective for labor 
induction when used in combination with oxytocin once the cervix is favorable (Penfield 
& Wing, 2017).  
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Other Common Methods 
There are many other methods recognized for their ability to induce labor in 
women who require cervical ripening. Five additional methods are detailed here 
including stripping membranes, breast or nipple stimulation, sexual intercourse, castor oil 
and acupuncture.  
Stripping or sweeping membranes to induce labor is a practice that dates back to 
antiquity (Heilman & Sushereba, 2015). In modern times, membrane sweeping is 
accomplished with sweeps, from a gloved hand, over the membranes that connect the 
amniotic sac to the wall of the uterus. This action causes the body to release 
prostaglandins which soften and ripen the cervix. Membrane sweeping is commonly used 
to avoid a formal induction of labor (WHO and HRP, 2015).  
Breast or nipple stimulation has been used as a natural and inexpensive means of 
labor induction. Nipple stimulation releases endogenous oxytocin. Nipple stimulation is 
achieved by either manual stimulation of the nipple or use of a breast pump.  
Sexual intercourse is also thought to stimulate labor through three different 
mechanisms 1) physical stimulation of the lower uterine segment 2) endogenous release 
of oxytocin from orgasm or 3)  direct action of prostaglandins found in semen 
(Kavanagh, Kelly, & Thomas, 2001).  
Castor oil (Ricinus communis) is classified by the FDA as a laxative, it also 
seems effective at labor induction. Researchers are finding that castor oil increases 
cervical ripening and enhanced uterine contractions (Knoche, Selzer, & Smolley, 2008). 
The mechanism of action seems to be the activation of a metabolite, ricinoleic acid, 
which acts on prostaglandin EP3 receptors in the smooth muscles of the uterus and 
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intestines (DeMaria et al., 2017; Tunaru, Althoff, Nusing, Diener, & Offermanns, 2012).  
Acupuncture is a form of Chinese medicine where thin needles are inserted into 
the body.  Overall acupuncture showed some benefit in improving cervical status for 
induction of labor, but no clear benefit on reduction of cesarean birth (Smith, Armour, & 
Dahlen, 2017). However, more research is needed on the use of acupuncture for labor 
induction, including well designed trials.  
While there are many different methods available for inducing labor that also 
requires cervical ripening. The reminder of the dissertation will focus on prostaglandins 
(misoprostol and dinoprostone), mechanical methods.  These methods are used for 
cervical ripening and are present in contemporary medical records. Oxytocin and 
amiotomy will as be explored as they are also commonly used methods for medical 
induction of labor. Clinicians should consider each method, weighing availability and 
feasibility for use. Each induction should start with a thorough patient assessment, prior 
to choosing the appropriate agent to induce labor as the outcome of induction of labor 
may be affected by method choice. Clinicians must make informed decisions when 
choosing the best method for induction of labor, as there are many factors affecting labor 
induction that must be considered. 
Outcomes of Induction of Labor 
 This section focuses on outcomes of induction labor, namely unsuccessful 
induction, also known as a failed induction and cesarean birth. An induction of labor may 
be declared a failed induction once set time parameters have been exceeded. Other 
outcomes include the success or failure of cervical ripening and the time to birth, which is 
often defined as the time from hospital admission to the time of birth.  
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Failed Induction 
Sometimes labor induction does not work and the induction is declared a ‘failed’ 
induction of labor. While the definition for failed labor induction of labor continues to 
evolve, current thoughts are that a failed induction occurs when a woman remains in the 
latent phase of labor for an extended period of time, such as 12 hours or more after being 
induced (Spong, Berghella, Wenstrom, Mercer, & Saade, 2012). The definition of a failed 
induction should also account for cervical dilation with the timeframe starting at the 
initiation of oxytocin and AROM. For example, if cervical dilation of 4 cm and 90% 
effacement, or 5 cm of dilation regardless of effacement is not achieved within 12 hours 
of time and the woman is still in the latent phase of labor after induction, a failed 
induction of labor is diagnosed (Rouse, Owen, & Hauth, 2000). Recently, the timeframe 
for latent phase during induction was suggested to be increased to 15 hours based on 
findings that a longer duration did not cause additional maternal or fetal distress (W. A. 
Grobman et al., 2018). The decision to continue labor beyond this should be 
individualized. A failed induction can lead to use of a different method or to cesarean 
birth. 
Cesarean Birth 
Cesarean birth is the delivery of the infant through incisions in the abdominal wall 
and uterus (ACOG - Cesarean birth, 2015). The international healthcare community 
estimates that an ideal cesarean section rate is 10-15% (Betran et al., 2015; WHO and 
HRP, 2015). This rate is suggested as optimal for achieving the best health outcomes for 
mothers and neonates, accounting for medically necessary cesarean births.  The U.S. 
cesarean birth rate is 30%-32% (Martin, Hamilton, & Osterman, 2016) which is double 
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the suggested medically necessary rate (WHO, 2015). While cesarean births are 
becoming increasingly common in developed and developing countries, the overall health 
of women and infants does not seem to increase with a cesarean birth rate greater than 
15% (Betran et al., 2015). Cesarean births are associated with short and long-term risks 
that may extend many years beyond the surgery and pose risks to the mother, her children 
and to future pregnancies (Catalano & Shankar, 2017; Keag, Norman, & Stock, 2018). 
Women with obesity have a higher risk for poor maternal and neonatal outcomes 
following cesarean birth than women at normal weight (Mission et al., 2013). 
Purpose of Study  
The purpose of the proposed study is to examine the choice, and effectiveness of 
methods used for induction of labor in women with obesity. With several recent meta-
analyses and clinical trials reporting decreased risk of cesarean birth among induced 
women compared to those managed expectantly, rates of labor induction are likely to rise 
in the future due to changes in clinical practice (Gibbs Pickens et al., 2018; Gibson, 
Waters, & Bailit, 2016; Lee et al., 2016).  However, the labor induction methods that are 
most effective and safe for obese women are not currently known (Carlson et al., 2015). 
Until clinicians have better information on how to optimally implement labor induction in 
women with obesity, this vulnerable population could see continued increases in the rate 
of cesarean birth due to failed labor induction.  
Significance of the Study for Nursing 
This study is significant to nursing in several ways. The study focuses on 
precision healthcare for a select group of individuals. The results of the study will add to 
the existing body of knowledge regarding individualized care for women with obesity. In 
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addition, this study will hopefully create new knowledge that can help nurses and other 
healthcare providers understand the use and limitations of induction methods/medications 
for optimal health outcomes. 
This study also is significant to the field of advanced-practice nursing, as 
Certified Nurse Midwives manage the labors and inductions of many women with 
obesity. Increased understanding of induction of the labor is needed to guide their 
practice, including normal variations in the induction processes, the actions of cervical 
ripening and how each of these things differs among women with obesity.  
This study has the potential to influence the practice of hospital nurses, hospital 
staffing, and allocation of health care resources. By increasing the knowledge base 
regarding effectiveness of labor induction interventions, this study could potentially assist 
hospital nurses to decrease length of hospital stay for women with obesity who are 
induced.  This change would impact staffing of nurses on Labor and Delivery units across 
the United States (CMQCC, 2018).  
Research Aims 
Aim 1. Interventions: Compare the effectiveness of labor induction methods (PGE1, 
PGE2, and Mechanical methods) in women undergoing labor induction requiring cervical 
ripening by BMI category.    
  Hypothesis 1: the odds of requiring intervention to initiate labor will be higher in 
obese women by BMI category when compared with normal weight women.   
Aim 2.  Time to birth: Compare the effectiveness of labor induction methods 
(misoprostol, dinoprostone and mechanical methods) by the time to birth with results 
stratified by BMI category.   
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 Hypothesis 1: Women induced using misoprostol for cervical ripening will have a 
shorter time to birth as compared to women induced using dinoprostone, and this 
time differential will be more pronounced with each successive BMI category. 
 Hypothesis 2: The time to birth will be shorter with mechanical methods than the 
use of either prostaglandin (PGE1 or PGE2). 
Aim 3: Cesarean birth: Examine the risk of cesarean birth after labor induction among 
women by BMI category.  
 Hypothesis 1: Compared to women with normal range body mass index, the odds 
of cesarean birth following labor induction will be higher with each increase in 
body mass index category.  
 Hypothesis 2: The odds of cesarean birth in women induced with misoprostol will 
be lower compared to the odds in similar women induced using dinoprostone. 
 Hypothesis 3: Women with obesity (in any obesity category) who are induced 
using mechanical means will have lower odds of cesarean birth than women with 
obesity (in any obesity category) induced with prostaglandins (misoprostol or 
dinoprostone).  
Assumptions 
 The data in the electronic record are accurately recorded  
 A rate of 10%-15% adequately represents medically necessary cesarean deliveries 
in the U.S. population 
Conceptual Framework 
The Quality Health Outcomes Model (QHOM) will guide the selection and analysis 
of the variables for the proposed study (Mitchell, Ferketich, & Jennings, 1998; Mitchell 
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& Lang, 2004). The QHOM has been used to guide the development of outcomes-based 
databases, interventions, and research (Mitchell et al., 1998). Two functions of the model 
are to (1) identify variables in clinical research, and (2) provide a framework for 
outcomes research and management that compares treatment options as well as 
organizational or systems-level interventions. The QHOM has been used to measure 
outcomes in a variety of patient settings including skilled nursing facilities, ambulatory 
care settings, surgical units, and for inpatient hospitalization (Altares Sarik & Kutney-
Lee, 2016; Cohen, Dick, & Stone, 2016; Gerolamo, 2004, 2006).  
In previous obstetrics research the QHOM was used to examine the relationships 
between labor induction and cesarean birth (Mayberry & Gennaro, 2001; Wilson, Effken, 
& Butler, 2010). In a secondary analysis (n = 62,816) the model was used to determine 
what variation in cesarean birth rates was due to differences in hospitals, providers, and 
patients (Wilson et al., 2010). Wilson et al. (2010) found the occurrence of cesarean birth 
in nulliparous women was related to maternal age, race, education level, the number of 
prenatal visits, and place of childbirth. Cesarean birth and epidural analgesia, were 
associated with significant differences in quality health outcomes for women (Mayberry 
& Gennaro, 2001).  Thus, the QHOM is appropriate as a framework to examine the 
clinical interventions of labor induction processes and outcomes in search of better 
clinical outcomes for women undergoing induction of labor.  
Concepts in the Quality Health Outcomes Model 
The QHOM illustrates integration and interaction of four concepts; system 
characteristics, individual characteristics, interventions, and outcomes (Mitchell et al., 
1998). The relationships in the model are circular in nature. With both system 
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characteristics and individual characteristics acting on the interventions and outcomes in 
the model. The original model has equal input from both system and individual 
characteristics as demonstrated with a bidirectional arrow between the two influences, as 
well as curved arrows towards the interventions and outcomes.  
  In the proposed study, the adapted QHOM provides guidance in the selection of 
variables that may influence the type of birth. The systems characteristics, (hospital size, 
location and type and provider type), individual characteristics (BMI, age, parity, and 
cervical status), interventions (the method used for cervical ripening or labor induction) 
and the outcomes (type of birth) and secondary outcomes (success or failure of the 
cervical ripening method and the time to birth) as well as maternal and neonatal adverse 
events (See Figure 2).  
System characteristics. The system characteristics as defined by the original 
theorists are traditional structure and process elements (Mitchell et al., 1998). System 
characteristics are the characteristics of a structured system, such as a hospital system, or 
provider network. The hospital size, location, ownership, individual demographics, 
provider training and skill mix, and technology are among many of the structural 
elements included in the system characteristics.  The system characteristics included in 
the adapted model for this study are the hospital type, and size.   
Individual characteristics. Outcomes in the model may be affected by the 
characteristics of the individuals who are receiving the interventions (Mitchell et al., 
1998). Outcomes research has raised awareness on the important need to adjust 
interventions based on individual characteristics, such as general health, demographics, 
and disease risk factors.   
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In the proposed study, individual characteristics will be conceptualized as 
maternal characteristics before cervical ripening. Maternal characteristics of interest 
include body mass index (BMI), age, parity, and cervical status on admission. The 
proposed study will examine women undergoing induction of labor who have carried the 
pregnancy to term (gestational age greater than 37 weeks), have a cephalic presentation 
(head first presentation), and a singleton pregnancy (one fetus).  
Interventions.  Clinical interventions are the actions that are altered with the 
intent of changing other constructs in the model (Mitchell et al., 1998). Interventions are 
directly or indirectly influenced by system and individual characteristics. The 
intervention of interest is induction of labor using either prostaglandins, or mechanical 
means for cervical ripening.  
Outcomes. Outcomes of treatment interventions from general research have been 
widely based on the Five D’s: death, disability, dissatisfaction, disease, and discomfort 
before use of this model (Mitchell et al., 1998). The QHOM allows for measurement and 
analysis of outcomes related to increased health status, increased functionality, and an 
increase in the quality of life. The primary outcomes of interest are the success or failure 
of labor induction, which will be measured by the time to birth and type of birth.  
Secondary outcomes in the model are the maternal and neonatal adverse events as 
complications associated with maternal obesity included post-partum hemorrhage, sepsis, 
prolonged hospital admission, increased fetal birth weight and fetal distress (Mission et 
al., 2013).  
20 
 
 
 
Figure 3. Quality Health Outcomes Model 
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CHAPTER II  
LITERATURE REVIEW 
This chapter provides an overview of the current literature on induction of labor 
in women with obesity. The chapter will first describe current thoughts, theories and 
evidence of the physiology of cervical ripening and labor initiation, and the differences in 
cervical ripening and labor initiation for women with obesity. Then, the remainder of the 
chapter is guided by the QHOM, the conceptual framework of this dissertation. Literature 
will be reviewed related to each of the four concepts in the model; system characteristics, 
individual characteristics, interventions and outcomes.   
Brief Review of the Physiology of Labor Initiation 
This section describes current theories on normal physiology of cervical ripening 
and labor initiation in women with a normal weight, as well as proposed theories 
regarding the pathophysiology of cervical ripening and labor initiation in women with 
obesity. Some current literature is included to support biological based theories on the 
physiology and pathophysiology of cervical ripening and labor initiation. This section 
adds insight on the reasons labor is induced more frequently in women with obesity.  
Physiology of Cervical Remodeling 
Towards the end of pregnancy, the cervix begins to soften in preparation for birth. 
This softening is due to cervical remodeling at the cellular level. According to Yellon 
(2017), cervical remodeling occurs in three phases (Yellon, 2017).  Phase 1- softening of 
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the cervix, due to the breakdown of collagen and extracellular remodeling. Phase 2- 
cervical ripening, there is a continued breakdown of the collagen structure resulting in 
further ripening.  Structures that were previously present such glands and smooth muscle 
tissue are broken down during this period of tissue remodeling. Phase 3- cervical dilation, 
when the cervix effaces into the uterus allowing labor to result in birth.   
Biochemical changes occur during the process of cervical remodeling. In general, 
the cervical remodeling process is much like the inflammatory process (Yellon, 2017). 
There is an increased presence of immune cells and macrophages in the lower uterine 
segment. During the transition from Phase 1 to Phase 2 going from a soft to a ripe cervix, 
there is a noted increase in vascular permeability and elevated concentrations of pro-
inflammatory mediators. Also, there is significant degradation of extracellular linked 
collagen. Additionally, increased numbers of macrophages are noted. Therefore, 
macrophages may play a significant role in cervical remodeling. The presence of 
macrophages in other tissues has been known to restructure the extracellular matrix 
(Yellon, 2017).  
Physiologic Differences in Women with Obesity  
Women with obesity have difficulty initiating labor at term when compared to 
normal weight women (Harper et al., 2012; Hermesch, Allshouse, & Heyborne, 2016; 
Stirrat et al., 2014). These changes in labor initiation are thought to be caused by 
endocrine and inflammatory alterations present in women with obesity (Carlson, 
Hernandez, & Hurt, 2015). The following pathophysiologic conditions are associated 
with obesity; increased blood cholesterol levels, increased leptin levels, which seem to 
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disrupt normal labor progression (Bogaerts, Witters, Van den Bergh, Jans, & Devlieger, 
2013; Hajagos-Tóth, 2017; Wendremaire et al., 2013).  
First, increased blood cholesterol levels lead to changes in cell membrane 
permeability ultimately decreasing myometrial (uterine) activity (Hajagos-Tóth, 2017). 
Cellular level changes associated with obesity seem to promote cervical collagen 
synthesis in late gestation delaying the onset of labor. Increased leptin levels are noted, 
which appear to increase placental PGE2 release leading to inflammation (Wendremaire 
et al., 2013). Additionally, maternal obesity is associated with increased circulating leptin 
levels, which may affect the cellular remodeling of the myometrial extracellular matrix 
that occurs before the onset of labor (Wendremaire et al., 2013). The changes noted in the 
remodeling of the cervical collagen matrix may play a role in the increased need for 
cervical ripening in women with obesity (Wendremaire et al., 2013).  
The Quality Health Outcomes Model 
The Quality Health Outcomes Model as the conceptual framework for the study 
will now be discussed. The model is made up of four components 1) system 
characteristics, 2) individual characteristics, 3) interventions and 4) outcomes. The 
system characteristics and the individual characteristics collectively influence the 
intervention and the outcomes within the model. The literature review will present 
relevant studies to support the chosen variables that make up the individual 
characteristics (age, parity, cervical status and BMI) and the system characteristics 
(hospital size, type, and location). Literature will also be presented related to induction of 
labor in women with obesity, interventions or methods such as prostaglandins, 
mechanical devices, and other methods. The outcomes are time to birth and cesarean 
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birth. All literature has been retrieved by online proxy using either the Georgia State 
University or the Emory University online library. 
System Characteristics 
System characteristics are the influences that system-level factors have on 
interventions and outcomes. Current literature suggests that hospital type, size, and 
geographic location influence the labor induction methods, time to birth, and cesarean 
birth rates among all women. 
Hospital Type, Size, and Geographic Location 
The location and type of hospital are system variables that may affect both the 
intervention and the outcomes within the health quality outcomes model. Literature 
related to system characteristics and the methods for induction, and time to birth is 
lacking so cesarean birth rates will be explored in this section.  
Location of a hospital in a rural or urban setting has been shown to impact 
cesarean birth rates among all women. Smaller community hospitals in rural locations 
tend to have a higher variation in the cesarean birth rate than larger hospitals 
(Kozhimannil, Law, & Virnig, 2013). Rural and urban differences in care may be 
explained by the demographics of the populations, health disparities, and access to care 
(ACOG, 2014; Kent, McClure, Zaitchik, & Gohlke, 2013; Kozhimannil, Casey, Hung, 
Prasad, & Moscovice, 2016). Rural minority populations are also more likely to be obese 
and less likely to have access to high-level care. Additionally, teaching hospitals show 
less variability in cesarean birth rates than other types of a hospital such as community 
hospitals (Kozhimannil et al., 2013) 
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The type and location of the hospital have been shown to affect labor induction 
for all women by way of the relationship between induction and cesarean birth rates 
(Kozhimannil et al., 2013; Wilson, Effken, & Butler, 2010). Hospital cesarean birth rates 
have been shown to vary widely in nationwide data from 593 U.S. hospitals 
(Kozhimannil et al., 2013). The cesarean birth rates reportedly varied ten-fold across 
hospitals, ranging from 7.1 percent to 69.9 percent. The cesarean birth rates for low-risk 
women varied fifteen-fold between hospitals, ranging from 2.4 percent to 36.5 percent 
(Kozhimannil et al., 2013). By including only low-risk women and effectively controlling 
for high-risk complications, one would expect to see less variation in the cesarean birth 
rate among low-risk women. However, this was not the case, which indicates other 
factors also affect cesarean birth rates. For example, hospitals may have varied practice 
patterns among providers.  
Primary cesarean births are a contributing factor to the increase in the overall 
cesarean birth rate seen over the past two decades (Caughey, 2015).  Primary cesarean 
birth is defined as a cesarean birth that is performed when a woman, who has not 
previously had a vaginal birth, has a cesarean section with a singleton fetus, a cephalic 
presentation, and term gestation. Primary cesareans rates have been shown to vary three-
fold across hospitals in the U.S. and cannot always be attributed to patient mix or patient 
caseload (Sebastiao et al., 2016). In a retrospective cohort study (n= 412,192), Sebastiao 
(2016) examined individual and hospital level factors that contributed to the primary 
cesarean rate in Florida (Sebastiao et al., 2016). The overall primary cesarean rate among 
nulliparous, low-risk women in this sample was 23 percent, with hospital-specific 
estimates that ranged from 12.8 percent to 47.3 percent depending on hospital location. 
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Hospital geographic location was found to contribute to hospital variation in the primary 
cesarean birth rate among low-risk women in Florida (Sebastiao et al., 2016).  
Literature describing the influences of system characteristics for women with 
obesity being induced was non-existent related to the methods of inducing labor, and the 
time to birth.  System characteristics have been shown to influence the primary outcome 
of cesarean birth, which varied widely in both national data and statewide data from 
Florida. Cesarean birth among all women was influenced by system level characteristics. 
While the system level factors influencing maternal obesity among women undergoing 
induction of labor seem to affect the outcomes, other factors such as individual factors 
also play a role.  
Individual Characteristics 
Individual characteristics of women have been shown to affect labor induction 
methods and outcomes. A woman’s age, parity, cervical status, and BMI will be explored 
in this section. These characteristics have been shown to be independent factors affecting 
the success of labor induction with cervical ripening among women (Frederiks, 2012).  
Maternal Age 
Maternal age is an individual characteristic that is associated with higher rates of 
birth complications and a higher rate of cesarean birth. A nationally representative cohort 
(n = 4,109,297) was examined for associations between maternal age and labor and birth 
complications (Cavazos-Rehg et al., 2015). The study found higher odds of having 
complications with childbearing at the extremes of the childbearing age range. Maternal 
age was found to be an independent risk factor for having a failed induction of labor 
among nulliparous women (Frederiks, 2012). A study (n = 537), examining the 
27 
 
influences of maternal age compared elderly nulliparous women, over the age of 35 to 
non-elderly nulliparous women (Hadar et al., 2017) found that elderly nulliparous women 
had a higher rate of cesarean birth (36.2% versus 21.4%, p = 0.009). This difference was 
not significant after adjustment for maternal BMI, indication for birth, birth weight and 
gestational age at birth (Hadar et al., 2017). 
Parity 
A woman’s parity or the number of previous births over 20 weeks' gestation plays 
a significant role in both cervical ripening success, and the need for emergent cesarean 
birth after induction of labor (Gauthier et al., 2012; Isono et al., 2011). Gauthier 2012  
(n = 285), found that lower parity was significantly and independently associated with 
prostaglandin ripening failure [parity < 2 births (OR, 2.50; CI, 1.20–5.26], meaning 
higher parity is associated with cervical ripening success. In a different study, the need 
for emergent cesarean birth after induction of labor (n = 1,029) found multiparous 
women had a significantly lower cesarean birth rate as compared to nulliparous women 
(2% vs. 17.6%) (Isono et al., 2011). Additionally, there is evidence that regardless of a 
woman's parity, the rate for primary cesarean has been shown to increase with increasing 
BMI (Kunzier, Park, Cioffi, Calixte, & Vintzileos, 2016; Vahratian, Siega-Riz, Savitz, & 
Zhang, 2005). 
Cervical Status 
A woman’s cervical status measured by Bishop score or cervical dilation before 
induction of labor impacts both the choice of cervical ripening method and the associated 
outcomes (Gauthier et al., 2012). Gauthier (2012) reported that a lower Bishop score was 
significantly and independently associated with prostaglandin ripening failure (Bishop 
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score less than 3 (OR, 2.62; CI, 1.45 – 4.72) compared to Bishop score greater than 3). 
Additionally, the absence of cervical dilation was found to be an independent risk factor 
for failed induction of labor among nulliparous women (Frederiks, 2012).  
Body Mass Index 
BMI is an important predictor of the need for induction of labor as well as 
induction of labor success. This section will focus inconsistencies in the classification of 
body mass index used in different studies. The BMI categories differed between studies, 
and the timing of BMI collection occurs at different intervals.   
Body Mass Index Classification. This section will discuss how BMI has been 
categorized. Most commonly, studies used the World Health Organizations (WHO) BMI 
classification categories, which consist of the categories of underweight (BMI < 18.5 
kg/m2), normal weight (BMI 18.5 - 24.99 kg/m2), overweight (BMI 25 - 29.99 kg/m2), 
and obese (BMI > 30 kg/m2) (World Health Organization, n.d.). Within the obese 
category, there are three BMI categories, Obese Class I (BMI 30 - 34.99 kg/m2), Obese 
Class II (BMI 35 - 39.99 kg/m2), and Obese Class III (BMI > 40 kg/m2) (World Health 
Organization, n.d.).  
BMI categories are not always used consistently. Most commonly, women with a 
BMI over 30 kg/m2 were considered obese. One study used a BMI over 29 kg/m2 as the 
cut off for women with obesity (Vahratian, Zhang, Troendle, Savitz, & Siega-Riz, 2004); 
whereas in another study, women with a BMI of less than 28 kg/m2 were considered lean 
(Hill, Reed, & Cohen, 2015). Often times, studies lacked the sample size needed for 
analysis, so the BMI categories were collapsed into fewer categories for analysis, most 
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commonly lean and obese (Anabusi, Mei-Dan, Hallak, & Walfisch, 2016; Lassiter et al., 
2016; Melamed, Ben-Haroush, Kremer, Hod, & Yogev, 2010).  
The timing of measurement for the collection of the maternal BMI measurement 
in relation to pregnancy varies (Table 1). A pre-pregnancy BMI was recorded at either 
the first prenatal visit or by self-report of the last known weight before pregnancy 
(Gauthier et al., 2012; Melamed et al., 2010; O'Dwyer et al., 2013). A study reported 
using a self-reported pre-pregnancy BMI but collected the information up to 25 weeks of 
pregnancy, which is well beyond the first trimester (Vinturache, Moledina, McDonald, 
Slater, & Tough, 2014). The hospital admission BMI was another timing for BMI 
collection (Anabusi et al., 2016; Lassiter et al., 2016; Pevzner, Powers, Rayburn, 
Rumney, & Wing, 2009; Roloff, Peng, Sanchez-Ramos, & Valenzuela, 2015; Suidan, 
Rondon, Apuzzio, & Williams, 2015). Finally, a study collected, reported, and stratified 
study outcomes using both the pre-pregnancy BMI and the hospital admission BMI 
(Beckwith, Magner, Kritzer, & Warshak, 2016). Thus, BMI at time of hospital admission 
is the most common timing for collection of BMI in women undergoing induction of 
labor.  
Body mass index and labor induction. 
Women with obesity are more likely than women of normal weight to undergo 
labor induction due in large part to their higher risks for antepartum complications and 
post-term pregnancy (Caughey, Snegovskikh, & Norwitz, 2008; Ruhstaller, 2015). Once 
they are induced, women with obesity are more likely to have a failed labor induction as 
compared to normal weight women (Wolfe, Rossi, & Warshak, 2011). Higher maternal 
BMI has been associated with higher failed induction of labor. In a cohort study (n = 279, 
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521) the rate of failed induction increased with an increase in maternal BMI categories 
(Wolfe et al., 2011).  
Interventions 
Compared to expectant management, induction of labor has been shown to result 
in better outcomes with fewer cesarean births and better neonatal outcomes. In a large 
study (n = 362,154) women undergoing induction of labor had decreased odds of 
cesarean birth at 37 weeks’ gestation (OR, 0.44; CI, 0.34 - 0.57), 38 weeks’ gestation 
(OR, 0.43; CI, 0.38 - 0.50), 39 weeks’ gestation (OR, 0.46; CI, 0.41 - 0.52), and 40 
weeks’ gestation (OR, 0.57;  CI, 0.50 - 0.65) (Darney et al., 2013). Another study  
(n = 74,725) examining perinatal outcomes of women with obesity found the odds of 
cesarean birth were lower for both nulliparous and multiparous women with term elective 
induction as compared with expectant management (Lee et al., 2016).  The odds of 
cesarean birth were lower among nulliparous women with elective induction of labor 
compared to expectant management at 37 weeks (OR, 0.55; CI, 0.34 - 0.90) and 39 
weeks’ gestation (OR, 0.77; CI 0.63 - 0.95) compared to expectant management. Among 
multiparous women with a prior vaginal birth, elective induction was associated with 
lower odds of cesarean at 37 weeks’ gestation (OR, 0.39; CI, 0.24 - 0.64), 38 weeks’ 
gestation (OR, 0.65; CI, 0.51 - 0.82), and 39 weeks’ gestation (OR, 0.67; CI, 0.56 - 0.81). 
Additionally, elective induction at 38 weeks’ gestation, 39 weeks’ gestation, and 40 
weeks’ gestation was associated with lower odds of macrosomia (Lee et al., 2016). There 
was no difference noted in other perinatal outcomes for induction compared to expectant 
management.  
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Induction of labor requiring cervical ripening for women with obesity tends to 
take longer, require higher doses of cervical ripening methods, may have higher failure 
rates, and may lead to a higher rate of cesarean births (Lassiter et al., 2016). This section 
will examine studies where prostaglandins and mechanical methods have been used for 
induction of labor with cervical ripening among women with obesity. There will also be a 
brief review of other induction of labor methods and the influences of maternal obesity 
on the use of oxytocin and amniotomy.  
Induction of Labor Requiring Cervical Ripening  
While labor can be induced by many methods, the main focus of this study will be 
the induction of labor requiring cervical ripening stratified by BMI categories (see Table 
1). The main methods for cervical ripening are the two prostaglandins misoprostol and 
dinoprostone and mechanical methods mainly transcervical catheters.  
Prostaglandins for Induction of Labor. 
Using prostaglandins as a method for induction of labor usually suggests the 
women have an unfavorable cervix needing cervical ripening. Prostaglandin cervical 
ripening methods commonly include the use of misoprostol (PGE1) or dinoprostone 
(PGE2) (see Table 1).  
Misoprostol (PGE1). A study (n = 329) using misoprostol alone for cervical 
ripening with outcomes stratified by BMI categories found a significant increase in the 
time to birth with increasing BMI (Lassiter et al., 2016). Women with a high BMI 
required more doses of misoprostol and had a higher rate of cesarean birth as compared 
to normal weight women. The Lassiter study also reported among women with obesity, 
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higher doses of cervical ripening methods were needed to achieve successful cervical 
ripening.  
Dinoprostone (PGE2). A study (n  = 488) using dinoprostone for cervical 
ripening reports findings of significantly higher cervical ripening failure rates in women 
with each increase in BMI category (Melamed et al., 2010). Overweight women with a 
BMI of  26 - 30 kg/m2 were 5.75 times more likely to experience cervical ripening failure 
and women with a BMI > 30 kg/m2 were 6.22 times more likely to experience cervical 
ripening failure as compared with normal weight women (Melamed et al., 2010). In a 
different study, cervical ripening failure after using dinoprostone (n = 285) was 53.7% for 
women with obesity (BMI < 30 kg/m2) as compared to 34.2% for normal weight women 
(Gauthier et al., 2012). Additionally, the odds of having a first ripening attempt failure 
were significantly increased 2.22 times in women with obesity as compared to normal 
weight women. These two small studies with similar research designs suggest 
dinoprostone has higher cervical ripening failure rates among women with obesity as 
compared with normal weight women.  
A study (n = 1, 927) using dinoprostone alone or with the use of oxytocin  
(O'Dwyer et al., 2013) reports an emergency cesarean birth rate of (19.5 %) among 
normal weight nulliparous women; (27.4%) among overweight nulliparous women and 
(34.6%) among nulliparous women with obesity. For multiparous women, the cesarean 
birth rates were (2.2%) for normal weight women, (0.6%) for overweight women, and 
(3.4%) for women with obesity. Nulliparous women with obesity were found to have the 
highest cesarean birth rates among this sample (O'Dwyer et al., 2013).    
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Comparisons of differing types of prostaglandins. Eleven studies compared the 
use of the types of prostaglandins (see Table 1). A study compared prostaglandin use for 
induction of labor (n = 564) among a sample of women with obesity misoprostol 
(52.7%), and dinoprostone (47.3%) (Suidan et al., 2015). Finding the misoprostol group 
had a higher successful cervical ripening rate (78.1% vs. 66.7%) (OR, 1.79; CI, 1.23 – 
2.60) and a lower cesarean birth rate (39.1% vs. 51.3%) (OR, 0.61; CI, 0.44 – 0.85] when 
compared to the dinoprostone group (Suidan et al., 2015). In a study comparing 
prostaglandin dosing and type (misoprostol vs. dinoprostone) (n = 331), the misoprostol 
group had a significantly shorter time to active labor (median 8 hours versus 12 hours), a 
decreased overall time to birth [median; 11 hours versus 17 hours] and a decreased stay 
on the labor and delivery unit [median; 16 hours versus 24 hours] (Kunzier et al., 2016). 
The results of the Kunzier study remained significant after being adjusted for BMI. These 
results indicate that dinoprostone may not be as effective as misoprostol for cervical 
ripening in women with obesity.  
In a secondary analysis of data from a randomized controlled trial (n = 1,273) the 
dosing and safety of three prostaglandin vaginal inserts were compared; dinoprostone 10 
milligrams (mg), misoprostol 50 micrograms (mcg) and misoprostol 100 micrograms 
(mcg) (Pevzner et al., 2009). The researchers found that cesarean birth occurred in 21.3% 
of lean women (BMI less than 30 kg/m2), 29.8% of women with obesity (BMI 30 -39 
kg/m2), and 36.5% of women with a BMI of 40 kg/m2 or higher. Data from the secondary 
analysis were used rather than the original study as the outcomes had been stratified by 
BMI category. Data from the original study were not stratified by BMI category and 
showed similar cesarean birth rates for all three prostaglandin vaginal insert preparations; 
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dinoprostone 10 mg (72.9%), misoprostol 50 mcg (71.1%), and misoprostol 100 mcg 
(71.7%) (Wing, 2008).  
Mechanical methods for induction of labor.  
Mechanical methods include the use of transcervical catheters. A look at a 
Cochrane review (2012) on the use of mechanical methods for induction of labor at term 
which included 71 trials (n = 9,722) (Jozwiak et al., 2012) giving insight to the efficacy 
of the use of mechanical method for labor induction among all women. The results 
indicate mechanical methods had similar cesarean birth rates to women using vaginal 
PGE2 (eight studies; 1,203 women; RR, 0.16; CI 0.06 - 0.39) and misoprostol (3% versus 
9%) (nine studies; n = 1,615; RR, 0.37; CI 0.25 - 0.54) (Jozwiak et al., 2012). When 
compared to oxytocin, mechanical methods were shown to reduce the risk of cesarean 
birth (five studies; n = 398; RR 0.62; CI 0.42 - 0.90) (Jozwiak et al., 2012). The 
following section reports the use mechanical methods for induction of labor among 
women with obesity.  
Transcervical catheters. Transcervical catheters are commonly used for induction 
of labor. There are different types of catheters such as single balloon catheters, for 
example, a Foley balloon catheter, or double balloon catheters like the Cook’s catheter. 
These transcervical catheters are used to dilate the cervix in preparation for labor (See 
Table 1).  
The Anabusi study (n = 181) compared outcomes between two types of 
mechanical devices, the Foley catheter, and the Cooks catheter. The results of this study 
found no statistically significant differences in outcome based on catheter type and 
maternal BMI category (Anabusi et al., 2016). The Beckwith study (n = 709), compared 
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cervical ripening with a Foley bulb and the use of misoprostol. Women with obesity had 
a higher cesarean birth rate than non-obese women with the use of misoprostol (35% 
versus 26% respectively) but not with mechanical ripening (31% versus 29% 
respectively, p = .69). The results of the limited data in this study suggest that mechanical 
methods are not affected by BMI (Beckwith et al., 2016).  
Other mechanical methods. Hydroscopic dilators, either synthetic like Dilapan or 
laminaria can be used for mechanical dilation of the cervix at term, but these other 
methods seemed to be used in different ways than transcervical catheters for mechanical 
cervical ripening. Commonly, hydroscopic dilators were used for mechanical cervical 
dilation in cases of missed abortion early pregnancy (Khooshideh, Yarmohammadi, 
Shahriari, & Sheikh, 2017), as part of cervical management for surgical abortion 
(Firouzabadi, Sekhavat, Tabatabaii, & Hamadani, 2012; Kapp, Lohr, Ngo, & Hayes, 
2010), or with induction of labor for second-trimester fetal demise (Drey et al., 2014). A 
study used laminaria was for term induction (n = 782) after premature rupture of 
membranes (PROM) (Kurasawa et al., 2014). The researchers reported the Bishop score 
increased from 2.5 cm to 6.1 cm with laminaria use. Because the results of this study 
were not stratified by BMI category, it is unknown if women with obesity would respond 
the same as the normal weight women. No literature was located where laminaria or other 
any other mechanical methods were used in term pregnancy induction of labor requiring 
cervical ripening with outcomes stratified by BMI category.  
Other Methods for Induction of Labor 
Oxytocin and amniotomy will be reviewed in this section as other methods for 
induction of labor. While the use of the prostaglandins and mechanical means for cervical 
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ripening are the main focus for this study, the use of oxytocin and amniotomy for 
induction of labor should not be overlooked. Oxytocin may be used alone for induction of 
labor but is often used in conjunction with other methods. 
Oxytocin. 
Oxytocin use for labor induction is well studied among all women and is growing 
in use for women with a higher BMI. Oxytocin can be used in conjunction with other 
methods for induction of labor. A study previously reviewed for  the use of 
prostaglandins also reported the findings from oxytocin use by BMI category as the time 
oxytocin was used in hours [BMI < 30 kg/m2, 7.17 hours; BMI 30 - 40 kg/m2; 8.54 hours; 
BMI > 40 kg/m2: 10.39 hours] (Lassiter et al., 2016). In a separate study where 
prostaglandins were used for cervical ripening, reported outcomes of oxytocin use and 
duration of use (n = 1,273) found increasing use of oxytocin with each increase in BMI 
category. The reported dose and duration was as follows: a) the lean group (2.6 units and 
6.5 hours); b) the obese group (3.5 units and 7.7 hours) and c) the extremely obese group 
(5.0 units and 8.5 hours) (Pevzner et al., 2009). Many studies indicate that women with 
obesity undergoing labor induction with oxytocin required a longer time in labor, and 
higher doses of oxytocin (Hill et al., 2015; Maeder et al., 2017; O'Dwyer et al., 2013; 
Pevzner et al., 2009; Roloff et al., 2015; Vinturache et al., 2014).  
Amniotomy.  
Amniotomy, the artificial rupture of the amniotic membranes (AROM), can be 
used to induce labor for women with a term gestation and a favorable cervix (Bishop 
score of > 7) ("ACOG Practice Bulletin No. 107: Induction of labor," 2009). Amniotomy 
is often paired with the use of oxytocin, as there is evidence that the use of amniotomy 
37 
 
with low dose oxytocin had a faster induction to birth time when compared to amniotomy 
alone (Bricker & Luckas, 2000). The use of amniotomy among women with obesity did 
not show an increase in uterine activation following amniotomy, while for women with 
normal weight did (Hiersch et al., 2015). Amniotomy alone may not induce labor in 
women with obesity.   
Outcomes 
 The outcomes are the product of the intervention and are affected by the system 
and individual characteristics. Common outcomes reported after induction of labor 
among women with obesity are the success or failure of cervical ripening, time to birth, 
and type of birth. These outcomes will be explored in this section. 
Time to Birth 
The time to birth is a commonly reported labor outcome among women 
undergoing induction of labor. Time to birth was found to be either a primary or 
secondary outcome in several studies regarding induction of labor with cervical ripening 
stratified by BMI category (Anabusi et al., 2016; Hill et al., 2015; Lassiter et al., 2016; 
Pevzner et al., 2009).  The Anabusi study (n = 181) defined the time to birth as the time 
from device insertion for mechanical ripening to birth. The median time to birth (in hours 
and minutes) was 16 hours for normal weight women and 16 hours and 57 minutes for 
women with obesity (Anabusi et al., 2016). Lassiter (2016) used the time to birth as the 
primary outcome, defining the time to birth as the time from the start of labor induction 
to birth (Lassiter et al., 2016). The Lassiter study found women with a higher BMI had a 
significantly longer time to birth than normal weight women. The Pevzner study  
(n = 1,273), reported the time to birth in hours, as the time from insertion of the induction 
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method to the time of birth. A statistically significant relationship (p < .001) was reported 
between a prolonged duration of labor and higher BMI categories (Pevzner et al., 2009). 
Prolonged time to birth was seen with increasing BMI category (Anabusi et al., 2016; 
Lassiter et al., 2016; Pevzner et al., 2009). The time to birth has been reported in both 
hours and minutes and is calculated as the time from the start of an induction method to 
birth. 
Type of Birth 
The type of birth is a commonly reported labor outcome among women undergoing 
induction of labor. Types of birth include vaginal birth, assisted vaginal birth or operative 
vaginal birth, and cesarean birth. Cesarean birth is the primary outcome of this study. 
Vaginal birth. Vaginal birth is the birth of a neonate through the vagina and is 
regarded as the preferred method of birth, if possible. A vaginal birth may be either 
spontaneous or induced. After induction of labor requiring cervical ripening, the rate of 
spontaneous vaginal births decreases as BMI increases (Callaway, Prins, Chang, & 
McIntyre, 2006; Smith, Shah, Pell, Crossley, & Dobbie, 2007).  
Assisted vaginal birth. Assisted vaginal birth is a vaginal birth where forceps or 
vacuum assistance is needed to assist in the birth of the neonate. Assisted vaginal birth is 
sometimes called operative birth. The use of assisted vaginal birth is declining, with 
reported use down from 9.01% in 1990 to 3.21% in 2014 among all women in the United 
States (Hamilton, Martin, & Osterman, 2015). The use of assisted vaginal birth among 
women with obesity is unclear due to the low incidence of the intervention (Carlson  
et al., 2015).  
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Cesarean birth. Cesarean birth is the primary outcome of the proposed study. The use 
of cesarean birth after induction of labor has been linked to failed induction of labor. 
Common indications for cesarean birth after induction of labor among women with a 
high BMI were the failure of labor progression (failure to progress), cephalopelvic 
disproportion (CPD), or non-reassuring fetal heart rate (Kawakita et al., 2016). The 
cesarean birth rate was also found to be higher by BMI category after induction of labor 
(n  =329) [BMI < 30 kg/m2, 17.48%; BMI 30- 40 kg/m2, 37.09%; BMI > 40 kg/m2, 40%] 
(Lassiter et al., 2016).  
Maternal and Fetal Adverse Outcomes  
Maternal adverse outcomes. Maternal adverse outcomes are a way of measuring the 
effects of an intervention such as induction of labor. Having a higher BMI places a 
woman at a higher risk for adverse outcomes including postpartum hemorrhage, sepsis, 
prolonged hospital stay, and other complications (P. Agrawal, 2015; Mission, Marshall, 
& Caughey, 2013). Postpartum hemorrhage has been defined clinically as an estimated 
blood loss of 500 milliliters (ml) or more for a vaginal birth and 1,000 ml or more for 
cesarean birth (Grobman, 2012; Sentilhes et al., 2016). Maternal sepsis is a maternal 
infection which is measured by a fever of 101 degrees Fahrenheit or higher or the use of 
antibiotics in the postpartum period (Le Gouez, Benachi, & Mercier, 2016). The average 
hospital stay is one to two nights for a vaginal birth and three to four nights after having a 
cesarean birth. Therefore, a prolonged hospital stay after birth can be a signal that 
maternal complications are present (Glantz, 2005; Grobman, 2012). Assessing adverse 
maternal outcomes is an important part of ensuring induction of labor methods are both 
safe and effective. 
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Fetal adverse outcomes. The incidence of adverse fetal outcomes is also 
increased among women with obesity (S. Agrawal & Singh, 2016; Mission et al., 2013; 
O'Reilly & Reynolds, 2013). Common fetal adverse outcomes among women with 
obesity are congenital anomalies, intrauterine fetal demise (IUFD), fetal macrosomia, and 
fetal distress in labor (S. Agrawal & Singh, 2016; Mission et al., 2013; O'Reilly & 
Reynolds, 2013). There is a two-fold increase in the incidence of IUFD in women with 
obesity (Mission et al., 2013). Additionally, babies born to women with obesity tend to 
have fetal macrosomia, defined as a fetal weight over 4,000 grams (gm) (Mission et al., 
2013). Fetal macrosomia places an infant at an increased lifetime risk for diabetes, heart 
disease, and obesity (Agrawal & Singh, 2016; O'Reilly & Reynolds, 2013). Assessing 
adverse fetal outcome for labor induction methods is as important as assessing adverse 
maternal outcomes for ensuring safe and effective methods for labor induction. 
Gaps in the Literature 
The use of cervical ripening with induction of labor for women with a high BMI 
has not been studied extensively.  Previous studies of labor induction indicate there is a 
complex process affected by population health, hospital type and location, provider 
difference or training, and the regional availability of health care. By gaining a well-
informed understanding of the phenomena of successful cervical ripening, providers will 
be better prepared to make clinical decisions.  Women will have the benefit of better 
physiologic preparation for labor induction and have a better chance at achieving vaginal 
birth. Understanding outcomes based on BMI stratification could reduce the risk of 
medical intervention and reduce the overall cost of care.  
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Initial evidence indicates that misoprostol may be a better choice for 
prostaglandin cervical ripening than dinoprostone in women with a high BMI and that 
mechanical cervical ripening may work better than pharmacological cervical ripening. 
The time to birth was longer for women who were induced and women who had a higher 
BMI, but there is little literature regarding the time to birth in women with a high BMI. 
What is known about labor induction with cervical ripening among women with a high 
BMI has been largely based on the retrospective analysis of cohort studies. While there 
are a few studies with large sample sizes, these existing studies do not appropriately 
control for parity, which plays a significant role in labor induction outcomes regardless of 
obesity category. A multiparous woman with a previous vaginal birth has a higher chance 
at a subsequent vaginal birth than a nulliparous woman who has not yet had a vaginal 
birth. Little is known regarding whether a woman’s BMI affects labor induction 
outcomes based on the type of cervical ripening method used for induction of labor. It is 
unknown if either pharmacological or mechanical means of cervical ripening will result 
in a different cesarean birth rate among nulliparous women with a high BMI. Finally, the 
best practices of inducing women with a high BMI in a manner that achieves optimal 
outcomes are yet to be defined. The proposed study will be a beginning step to examine 
whether different cervical ripening methods result in different outcomes for women who 
are overweight and women with obesity as compared to normal weight women 
undergoing induction of labor.  
In summary, there is a need for the proposed study, as it will add to the growing 
body of knowledge about women who are overweight and obese and labor induction 
outcomes. The large sample size of the proposed study will address the limitation of 
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small sample sizes previously reported in the literature. Understanding the optimal 
timing, and dosing of labor induction methods in women who are overweight and women 
with obesity can guide practice by influencing clinical decisions, clinical guidelines, and 
future policy regarding induction of labor.  
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Table 1 
 
Study Characteristics- Prostaglandin and Mechanical Methods for Labor Induction 
 
Study, Country, 
Years of  
Included Births 
 
Sample Methodology 
Inclusion 
Criteria 
Primary 
and 
Secondary 
Aims 
Timing of 
BMI 
collection and 
BMI 
categories 
used (kg/m2) 
Induction Method Used 
and Dosing Schedule 
Outcomes 
Anabusi, 2016 
Israel, 2007-
2011 
 
181 Cohort study  Singleton 
pregnancy, 
cephalic 
presentation, 
intact 
membranes at 
term, planning 
induction, and 
unfavorable 
cervix 
 Mixed parity  
Primary  
Time to 
birth 
Successful 
ripening 
Cesarean 
birth rates  
Maternal 
and 
neonatal 
adverse 
events 
 
Hospital 
admission 
 
Non-obese < 
30 
Obese > 30 
 Cook or Foley catheter  
 Prostaglandins PV (In 
cases of first attempt 
failure) 
 
Cesarean birth 
rate was 17.6% 
vs. 25.3% for 
normal weight 
and women with 
obesity, 
respectively 
Beckwith, 2016 
USA 2008-2011 
 
709 Retrospective 
cohort 
 
Singleton, live 
born, non-
anomalous infant  
Induced labor 
 
 Mixed parity 
Primary  
Failure to 
achieve 
active labor 
Secondary  
Cesarean 
birth rate  
Doses of 
misoprostol 
use 
Need for 
protocol 
deviation 
 
Pre-pregnancy 
and hospital 
admission 
 
Non-obese < 
30 
Obese > 30 
 
 Misoprostol 25 mcg PV 
       Foley bulb inflated to 30 
       ml and tethered;  
       accompanied by  
       Oxytocin a 
Women with 
obesity had a 
higher cesarean 
birth rate with 
misoprostol 
(35% versus 
26%, 
p.0.03) but not 
with mechanical 
ripening (31% 
versus 29%, 
p.0.69) 
 
(Table 1 Continues) 
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(Table 1 Continued) 
 
Study, Country, 
Years of  
Included Births 
 
Sample Methodology 
Inclusion 
Criteria 
Primary 
and 
Secondary 
Aims 
Timing of 
BMI 
collection and 
BMI 
categories 
used (kg/m2) 
Induction Method Used 
and Dosing Schedule 
Outcomes 
Gauthier, 2012 
France, 2008-
2009 
285 Retrospective 
cohort with 
case 
matching 
BMI between 
20- 25 kg/m2 
and > 30 
kg/m2, 
singleton, live 
birth, term 
gestation, one 
previous 
cesarean, 
cephalic, no 
contraindications 
to vaginal birth, 
Bishop score < 
6, and over 18 
years of age 
 
 Mixed parity 
 
Primary  
First 
cervical 
ripening 
attempt 
failure 
First prenatal 
visit 
 
Normal 20-25 
Obesity 
Moderate 30-
35 
Severe 35-40 
Morbid > 40 
 Dinoprostone 10 mg for 
12 hours if Bishop score 
< 3, or 1 mg if Bishop 
score 4-6 
 
Cervical 
ripening failure 
was higher 
among women 
with obesity 
(53.7%) as 
compared to 
women with a 
normal weight 
(34.2%).  
 
Kunzier, 2016 
USA 
2012-2014 
331 Retrospective 
cohort 
Term IOL 
Bishop score < 4 
 
Primary 
Length of 
hospital stay  
Cost 
comparisons 
Results 
adjusted for 
BMI 
 Misoprostol 50 mcg PV 
       Dinoprostone 10 mg PV 
Misoprostol had 
a shorter length 
of labor reduced 
cost without 
increase adverse 
fetal effects 
 
 
(Table 1 Continues) 
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(Table 1 Continued) 
 
Study, Country, 
Years of  
Included Births 
 
Sample Methodology 
Inclusion 
Criteria 
Primary 
and 
Secondary 
Aims 
Timing of 
BMI 
collection and 
BMI 
categories 
used (kg/m2) 
Induction Method Used 
and Dosing Schedule 
Outcomes 
Lassiter, 2016 
USA, 2012-2013 
 
329 Retrospective 
cohort 
All women 
undergoing 
induction at the 
research site, 
gestational age 
37 weeks, and 
Bishop score < 5 
 
Mixed parity 
Primary 
Time to 
birth 
Secondary 
Number of 
doses of 
misoprostol 
Duration of 
oxytocin 
Cesarean 
birth 
Hospital 
admission 
 
Group 1 < 30 
Group 2 30-40 
Group 3 > 40 
 
 Misoprostol 25 mcg PV  
 Oxytocin 1 mU/min 
increased 1-2 mU every 
30 min  
Time to birth 
was increased 
with BMI 
Increased risk of 
cesarean birth 
Melamed, 2010 
Israel, 2000-
2007 
 
488 Retrospective 
cohort 
Case 
comparison 
3:1 ratio 
All women 
admitted who 
failed to respond 
to PGE2 cervical 
ripening 
compared to 
women with 
successful 
cervical 
ripening. 
Singleton, 
cephalic, one 
previous 
cesarean, and no 
contraindication 
for vaginal birth 
 
 Mixed parity 
 
Primary  
Failure of 
cervical 
ripening 
with PGE2 
First prenatal 
visit 
 
Normal 21-25 
Overweight 
26-30 
Obese > 30 
 Dinoprostone 3 mg PV  
 Oxytocin 2.5 mU/min, 
increased by 2.5 mU/min 
every 20 min 
Predictors of 
cervical ripening 
failure are 
maternal age 
above 30 years, 
pre-pregnancy 
BMI above 25 
kg/m2, cervical 
dilation, cervical 
effacement and 
gestational age 
less than 37 
weeks  
 
(Table 1 Continues) 
46 
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Study, Country, 
Years of  
Included Births 
 
Sample Methodology 
Inclusion 
Criteria 
Primary 
and 
Secondary 
Aims 
Timing of 
BMI 
collection and 
BMI 
categories 
used (kg/m2) 
Induction Method Used 
and Dosing Schedule 
Outcomes 
O’Dwyer, 2013 
Ireland 2008-
2010 
1,927 
 
Prospective 
cohort 
Singleton in the 
first trimester, 
Northern 
European race, 
older than 18 
years, able to 
give consent and 
no gestational 
diabetes mellitus 
 
 Mixed parity 
Primary  
Mode of 
birth  
Obstetric 
outcomes  
On enrollment 
(in the first 
trimester) 
 
Underweight  
< 18 
Normal 20 -29 
Obese > 30 
 Prostaglandin PVc 
 Oxytocin 
  
Labor induction 
on nulliparous 
women is 
associated with 
increased rates 
of emergency 
cesarean birth 
and increased 
use of 
interventions 
such as epidural 
and fetal blood 
sampling 
Pevzner, 2009 
USA, 2006-2007 
 
1,273 
 
Cohort study  18 years or 
older, low parity 
(3 or less 
previous births), 
singleton, and  
36 weeks’ 
gestation 
Mixed parity 
Primary  
Reached 
active labor 
Secondary  
Total 
oxytocin 
for 
induction 
Less than 
24 hours to 
birth 
Type of 
birth 
 
Hospital 
admission 
 
Lean < 30 
Obese 30-39 
Extremely 
obese > 40 
 Misoprostol 100 mcg PV 
 Misoprostol 50 mcg PV 
 Dinoprostone 10 mg PV   
 
Increased 
incidence of 
cesarean birth 
with increasing 
BMI, higher 
doses of 
oxytocin use and 
a longer time to 
birth 
 
(Table 1 Continues) 
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(Table 1 Continued) 
 
Study, Country, 
Years of  
Included Births 
 
Sample Methodology 
Inclusion 
Criteria 
Primary 
and 
Secondary 
Aims 
Timing of 
BMI 
collection and 
BMI 
categories 
used (kg/m2) 
Induction Method Used 
and Dosing Schedule 
Outcomes 
Roloff, 
2014(Roloff et 
al., 2015) 
USA 2012 
413 
 
Retrospective 
cohort  
Viable singleton 
pregnancies at 
term (37-42 
weeks’ 
gestation), and 
cephalic 
presentation 
Primary 
Cumulative 
oxytocin 
needed for 
vaginal 
birth 
 
Hospital 
admission 
 
Non-obese  
< 30 
Obese >30 
 
 Misoprostol 25-50 mcg 
PO or PV 
 Foley Bulb ripening [n = 
2] 
 Oxytocin at 1-2 mU per 
min and increased by 1-2 
mU every 20-30 min  
All women were 
induced. 
More oxytocin  
Similar labor 
length for obese 
and normal 
weight women. 
Sudain, 2015 
USA 
2008-2013 
564 Retrospective 
cohort  
Cephalic, 
singleton 
gestational age 
>24 weeks, 
Bishop score < 
6, BMI > 30 
kg/m2 
 
 Mixed parity 
Primary  
Successful 
cervical 
ripening 
Cesarean 
birth rates 
Hospital 
admission 
 
> 30 
 Misoprostol 50 mcg PV 
 Misoprostol 25 mcg PO 
Dinoprostone 10 mg PV 
Use of 
misoprostol 
leads to lower 
cesarean birth 
rate as 
compared with 
dinoprostone 
Similar rates of 
maternal and 
fetal 
complications  
Vinturache 
2014(Vinturache 
et al., 2014) 
Canada, 2008-
2010 
1996 Retrospective 
cohort 
Term singleton 
pregnancies, 
participation in 
All Our Babies 
cohort study 
Primary  
Type of 
birth  
Secondary  
Obstetric 
outcomes 
On enrollment 
(before 25 
weeks’ 
gestation) 
 
Normal 18.5-
24.9 
Overweight 
25-29.9 
Obese >30 
 Oxytocin c  
Prostaglandins c 
Obese women 
were more 
likely to be 
induced and 
have cesarean 
birth compared 
to normal 
weight women 
Table Notes. BMI, Body mass index; kg, kilogram; m2 meter; PO, by mouth; PV, per vagina; IOL, Induction of Labor; min, minute; max, maximum; 
cm, centimeters; ml milliliters; mu; mcg.  
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CHAPTER III 
METHODS 
This chapter describes the methods for the proposed study including the research 
design, the sampling design, and the plan for analysis. A retrospective cohort study 
design will be used to perform a secondary analysis of the Consortium of Safe Labor 
(CSL) database. The CSL database is a large nationally representative database 
containing over 228,000 labor and delivery records that are electronically linked with 
neonatal outcomes (Zhang et al., 2010).  
Proposed Research Study Design 
This proposed study will use a retrospective cohort study design. In a cohort 
study, an investigator selects a group of exposed and non-exposed individuals and makes 
comparisons in the incidence of disease (Gordis, 2014). According to Gordis, there are 
two important reasons for conducting cohort studies. First, cohort studies allow 
researchers to determine whether there is an association between a characteristic and the 
development of a disease, by studying the characteristics of individuals and/or groups. 
Second, it is possible to derive inferences regarding possible causal relationships that 
have been found.  
The retrospective cohort design uses the same design as the cohort study 
described above; it uses data that is already obtained to help shorten the timeframe 
needed to complete the research (Gordis, 2014). There are certain biases to be aware of 
when designing and conducting a retrospective cohort study. The two main biases 
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associated with cohort studies are selection bias and information bias (Gordis, 2014). 
Selection bias addresses individuals who are lost to follow-up (Gordis, 2014), this type of 
bias is minimized in the proposed study as the data were collected at a single point in 
time. There is a chance for selection bias by individuals who began care at a CSL site but 
changed sites prior to delivery, there is nothing in particular that can be done to reduce 
this potential bias except for being aware that the bias may exist.  Information bias is the 
bias that arises from measurement or reporting error. The proposed study may be prone to 
information bias from using secondary analysis for existing data. Having different data 
quality for the exposed and non-exposed groups will be minimized as the whole sample is 
taken from one dataset. Information bias may exist form differences in reporting between 
the sites. For example, some centers did a better job of collecting data on women with 
normal weight, while other centers did a better job of collecting data on women who were 
obese. The investigator or others may also unintentionally introduce information bias 
during the analysis of the data and the interpretation of the findings. 
Sampling Design 
The proposed study is a secondary analysis of data from the Consortium on Safe 
Labor (CSL) database. This database is an existing National Institutes of Health (NIH) 
database which is publicly available for use with permission (National Institute of Health, 
n.d.). Permission for data use has been obtained by the researcher and Georgia State 
University. The sample will include women who are present in CSL database, underwent 
an induction of labor, who had with a singleton fetus with cephalic presentation, a term 
gestation  37 weeks, and a plan for a vaginal delivery. Exclusion criteria are women 
with documented placenta previa, placenta accrete, active herpes or untreated HIV, 
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antepartum stillbirth, eclampsia, prior uterine scar, or congenital/chromosomal anomalies 
of the neonate. These factors were excluded because all are either contraindications for 
vaginal birth, or conditions that would be expected to significantly alter the labor course, 
thus confounding our analysis of BMI influences on labor induction processes/outcomes. 
Additional exclusions are missing data in CSL to calculate BMI (height and weight at 
labor admission), missing data in CSL on inclusion or exclusion criteria, and missing data 
in CSL on important demographic variables (race/ethnicity, maternal age). Table 2 
presents an example of variables that can be used for sample selection within the CSL 
database.  
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Table 2 
Example of Variable to use for Sample Selection within the CSL Database 
 
Variable 
Variable name in 
CSL dataset 
CSL 
Number 
Variable label in 
CSL dataset 
Inclusion     
 Singleton fetus  Numfetus 29 Number of Fetuses 
  CS-mult   
  TTTwin 69 Twin to twin 
transfusion 
 Cephalic 
presentation 
Admpresent 
CSbreech 
PesentDel 
Delfetalpos 
Breech9 
79 
106 
Presentation 
CSbreech 
PesentDel 
Delfetalpos 
Breech9 
 Term  37 
weeks 
BESTGA 75 Best estimate GA 
(week) 
 Induction of 
labor 
Induction 126  Labor induction 
  Induction_new 585  
Exclusion      
 Complete 
placenta Previa 
Anteprevia 55 Placenta previa 
 Active herpes Activeherpes 42 Active genital herpes 
 HIV infection HIV 27 HIV 
  CS_HIV 116  
 Congenital 
anomaly in 
fetus  
CS_Fetanom 
Ind_anomaly 
Conanomaly9_1 
 
114 
129 
 
 Chromosomal 
anomaly in 
fetus 
nanomalies9_new3 661 NEW neonatal ICD-
9 collection: 
chromosomal 
anomaly (ICD-9 
code 758) 
 Eclampsia Eclampsia 49 Prenatal history: 
eclampsia  
 Prior uterine 
scar 
uscar 581 Derived variable: 
previous uterine scar 
 Antepartum 
stillbirth 
Outcome1 516 Newborn 
Information: Birth 
outcome 
Notes. CSL, consortium of safe labor. HIV, Human immunodeficiency virus. ICD, 
international classification of diseases
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Consortium of Safe Labor Dataset Description 
The Consortium on Safe Labor (CSL) database was a prospectively collected 
cohort study of all the women delivering at 23 weeks’ gestation or greater between 2002 
and 2008 in 12 clinical centers with 19 hospitals across nine American College of 
Obstetricians and Gynecologists (ACOG) districts (Zhang et al., 2010). The CSL includes 
a total of 228,668 deliveries with linked data for 233,844 newborns. Many women had 
more than one child during the data collection period so the data from the first birth from 
each subject in the study will be selected to avoid intra-person correlation, leaving 
206,969 births for analysis (Zhang et al., 2010).  
The CSL database contains detailed information from the electronic medical 
records on maternal demographic characteristics, medical history, reproductive and 
prenatal history, labor and delivery, as well as postpartum and newborn information. 
Information from the neonatal intensive care unit (NICU) is linked to the newborn 
records. Information on hospital type is also included in the database (Zhang et al., 2010).  
Data are included from eight university-affiliated teaching hospitals, nine teaching 
community hospitals, and two non-teaching community hospitals. These hospitals were 
chosen because of the availability of the electronic medical records at each institution and 
their geographic distribution. 
Projected Sample Size  
A power analysis (a priori) was performed to determine the sample size needed to 
ensure statistical significance (Polit, 2010). For multinomial logistic regression the power 
level was set at 0.8. The alpha level is 0.05. The data are assumed to have two tails, a 
normal distribution, and an odds ratio of 1.5. The power analysis was performed using G 
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Power 3.1 ("G Power," 2017). The output from the analysis shows a critical z value of 
1.95. The estimate of the required sample size is 503 participants. The sample size should 
result in sufficient power to detect a moderate effect size (Faul, 2009).  
A power analysis for a linear regression with three predictor variables was also 
conducted. The power level was set at 0.8. The alpha level is 0.05. The data are assumed 
to have two tails, a normal distribution The power analysis was performed using G Power 
3.1 ("G Power," 2017). The output from the analysis shows a lower critical r2 of .004 and 
an upper critical r2 of 0.16. The estimate of the required sample size is 58 participants. 
The sample size should result in sufficient power to detect a moderate effect size. The 
actual power is estimated at .95 (Faul, 2009).  
Data Collection and Instruments 
Retrospective cohort studies commonly collect data for comparison between two 
groups, exposed and non-exposed (Gordis, 2014). The groups to be compared will be 
based on the type of labor induction method (prostaglandins, or mechanical) in women 
undergoing induction of labor. The groups will be stratified by BMI category. Primary 
comparisons will be made on the type of birth. Secondary outcomes will be other labor 
outcomes (time to birth, and maternal and fetal adverse outcomes). The hospital type may 
influence induction of labor outcomes in women with obesity. The influences of 
individual and system characteristics will be summarized using multivariate statistics. 
Selected adverse maternal and fetal outcomes will be analyzed and reported. Table 3 is an 
overview of the study variables with examples of operational definitions from the CSL 
database.  
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Table 3  
 
Overview of Study Variables 
 
Framework 
concept 
Conceptual 
variable 
Operational 
definition 
CSL 
number 
Variable name 
in CSL dataset 
Variable label in CSL 
dataset 
Individual 
characteristics 
     
 Maternal age Age, in years, of 
the mother at 
hospital admission 
  
6 momage Maternal age 
 Maternal race Race or ethnicity  
 
541 Momrace new Maternal race 
 Parity  Number of times a 
woman has given 
birth over 20 
weeks gestational 
age 
 
7 Parity Reproductive history: parity 
 BMI Pre-pregnancy 
BMI 
 
16 PrBMI BMI (mg/kg2) 
  Maternal height 542 Height_new Height (m), some missing data 
replaced with data from repeat 
pregnancies 
 
  Delivery 
admission weight 
71 Admweight Admission to L&D: weight in 
gm 
 
 
(Table 3 Continues) 
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(Table 3 Continued) 
 
Framework 
concept 
Conceptual 
variable 
Operational 
definition 
CSL 
number 
Variable name 
in CSL dataset 
Variable label in CSL 
dataset 
 Cervical status  Bishop score at 
admission 
83 AdmBishop Labor and delivery: admission 
bishop score 
 
  Cervical dilation 89 Dilat_1st Repeated measures: dilation 
at 1st exam 
 
System 
characteristics 
     
 Hospital Type Academic or 
community 
 
216 Hostype Type of hospital 
 Hospital Level Obstetric care 
level 
217 HosLevel Hospital level for obstetric 
care 
 
  NICU level 226 HosNICUlevel Highest level of neonatal care  
 
Intervention      
 Induction of labor Induction of labor  126 Induction  Labor and delivery summary: 
labor induction 
 
 misoprostol Misoprostol 143 MthInd_miso Method of Induction: 
Cytotec/misoprostol/PGE1 
 
 dinoprostone Dinoprostone 145 MthInd_PGE2 Method of Induction: Other 
prostaglandins 
 
 
(Table 3 Continues) 
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(Table 3 Continues) 
 
Framework 
concept 
Conceptual 
variable 
Operational 
definition 
CSL 
number 
Variable name 
in CSL dataset 
Variable label in CSL 
dataset 
 Transcervical 
catheter 
Transcervical 
catheter 
144 MthInd_Mec Method of Induction: 
Mechanical 
 
 Oxytocin  Oxytocin 146 MthInd_Oxy Method of induction: 
Oxytocin/ Pitocin 
 
 AROM AROM 142 MthInd_AROM Method of Induction: AROM 
 
Outcomes      
 Type of birth Cesarean Birth 252 Delmode_B1 Labor and delivery summary: 
Mode of delivery 
 
   256 Operative_B1 Labor and delivery summary: 
Mode of delivery 
 
 Time to birth Time to birth  772 Inducttime Derived: Minutes from 
Induction to delivery 
 
  Cervical ripening 
time 
773 Ripentime Derived: Minutes from 
cervical ripening to delivery 
 
 Maternal adverse 
outcomes 
 
    
 
(Table 3 Continues)  
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(Table 3 Continued) 
 
Framework 
concept 
Conceptual 
variable 
Operational 
definition 
CSL 
number 
Variable name 
in CSL dataset 
Variable label in CSL 
dataset 
  3rd and 4th-degree 
perineal laceration 
201 Lac_majperi Lacerations major Perineal (3rd 
and 4th degree) 
 
  Postpartum 
hemorrhage  
190 Postbleed Maternal Postpartum: 
Hemorrhage 
 
  Maternal fever  192 Postfever Maternal Postpartum: Fever 
 
  Transfer to ICU 
during 
hospitalization 
199 MomICU Maternal Postpartum: ICU 
admission 
 
  Blood transfusion 153 Bloodproduct Labor and Delivery summary: 
Blood products 
 
  Shoulder dystocia 175 Shoulder Labor and Delivery summary: 
Shoulder dystocia 
 
  Maternal death  200 Momdeath Maternal Postpartum: Maternal 
death 
 
 Neonatal adverse 
outcomes 
 
    
  APGAR <7 at 5 
min 
296 APGAR5_1 Newborn Information: 5 min 
Apgar 
 
 
(Table 3 Continues) 
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(Table 3 Continued) 
 
Framework 
concept 
Conceptual 
variable 
Operational 
definition 
CSL 
number 
Variable name 
in CSL dataset 
Variable label in CSL 
dataset 
  NICU admission 280 NICUadmit1 Newborn Information: NICU 
admission 
 
 
  Neonatal sepsis 344 Nsepsis1 NICU Outcomes: Sepsis 
 
  Birth-related 
injury 
288 Bthinjury9_1 Newborn information: Birth 
injury (ICD-9codes: 767) 
 
  Neonatal death 432 Ndeath1 NICU Outcomes: Death 
 
    Outcome 1  
 
Notes. Consortium of safe labor (CSL). Body mass index (BMI). Neonatal intensive care unit, (NICU). Intensive care unit, 
(ICU). Minutes (min) International classification of diseases (ICD). Artificial Rupture of Membranes (AROM).  
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Operational Definitions of Variables  
Exposure variable definitions. 
Labor induction. The variable for labor induction is labeled as induction and 
described as induction of labor. Labor induction is recorded as No/yes/unknown in the 
dataset. Mechanical means. The dataset contains a variable named MthInd_Mec, which is 
described as Method of Induction: mechanical. Recorded as no/yes/missing. The pre-
defined category was mechanical method, which likely was mainly transcervical 
catheters, but other mechanical methods may be included in this category (personal email 
with Katherine Laughon Grantz, PI CSL). Previous publications from the CSL database 
on induction of labor used method categories defined by the variables in the CSL 
database (Laughon et al., 2012). Misoprostol. The dataset contains a variable labeled 
MthInd_miso, which is described as Method of induction cyotec/misoprostol/PGE1. 
Prostaglandin E2. The dataset contains a variable for Prostaglandin E2 labeled 
MthInd_PGE2, which is described as other prostaglandins. The variable is recorded as 
no/yes/missing. Oxytocin. The variable for Oxytocin is MthInd_Oxy, which is described 
as Method of induction: Oxytocin/Pitocin. The variable for PGE2 is also recorded as 
no/yes/missing. Amniotomy. The variable for Amniotomy is MthInd: AROM, which is 
described as method of induction: Amniotomy/AROM. The variable is also recorded as 
no/yes/missing. Body mass index. The proposed study will use the BMI at the time of 
hospital admission created from the maternal height and admission weight gain recorded 
in the data set. The proposed study will use BMI as categorical variable, using the WHO 
BMI categories previously described as cut-off points.
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Outcome variable definitions. 
Time to birth. The time to birth is recorded as a continuous variable in minutes. 
The variable label is Inducttime, which is described as a Derived variable representing 
Minutes from Induction to delivery. The variable is recorded as a continuous variable in 
minutes. Cesarean birth. The outcome of cesarean birth will be used after induction of 
labor and a trial of labor. By using induction of labor and a trail of labor cases are 
selected were vaginal birth was the original plan. This outcome does not include planned 
or pre-labor cesarean births. There are several variables to be assessed for this outcome of 
cesarean birth. A variable in the dataset that represents cesarean birth Delmode_B1, is 
described as information from the labor and delivery summary, as mode of delivery. A 
second variable labeled Operative B_1, described as originating from the labor and 
delivery summary as mode of birth will also be used to check for additional cesarean 
births. The types of births for these variables are recorded as vaginal, vaginal assisted, 
VBAC, cesarean, cesarean repeat. 
Maternal and fetal adverse outcome variables. 
Maternal outcomes. 3rd and 4th degree perineal lacerations, postpartum 
hemorrhage (≥ 500 ml estimated blood loss for a vaginal birth or ≥ 1000 ml following a 
cesarean birth), maternal fever > 100.1° F, transfer to ICU during hospitalization, need 
for dilatation and cartage (D & C) in first 24 hours postpartum, unplanned return to 
surgery, need for transfusion of blood or blood products, shoulder dystocia, and maternal 
death. Neonatal outcomes. APGAR score < 7 at 5 minutes, NICU admissions, neonatal 
sepsis diagnosis, birth-related injury diagnosis and neonatal death 
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Plan for Analysis  
The data will be analyzed using IBM SPSS Statistics (Version 25). Initially, the 
data will be assessed for errors, missing data, and normality (Pallant, 2016). Errors or 
values that fall out of range will be assessed using frequencies, minimum, and maximum 
values. Missing data will be assessed by checking the number of valid and missing cases. 
Missing data will be dealt with by either deletion or imputation. Normality will be 
checked by using descriptive statistics then assessing for kurtosis or skewness.  
Sample Characteristics 
The sample characteristic data will include demographic data and other data to 
describe the sample. The following variables will be reported: Maternal age, race, marital 
status, education level, insurance type, parity, admission Bishop score (cervical dilation- 
if Bishop score not present), and delivery BMI category.  
Planned Analysis of Aims 
With statistical support from Research Assistant Professor of epidemiology and 
biostatistics, Brian Barger, PhD, Director of the center for leadership at the Georgia State 
University school of Public Health, the following data analysis plan was created. Each 
Aim contains the associated hypotheses and the plan for analysis.  
Aim 1 
Aim 1 states “Interventions: Compare the effectiveness of labor induction methods 
(PGE1, PGE2, and mechanical methods) in women undergoing labor induction requiring 
cervical ripening by BMI category”. Aim 1 Hypothesis 1: the odds of requiring 
intervention to initiate labor will be higher by each BMI category compared with normal 
weight women.   
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Planned analysis. Multinomial logistic regression with an alpha level of 0.05 will be 
used to determine the risk of cervical ripening with each increase in body mass index 
category. Logistic regression is “a multivariate statistical technique used for predicting a 
categorical dependent variable” p. 330 (Polit, 2010). This statistical test is used to analyze 
the relationship between multiple independent variables and a single dependent variable. 
Since logistic regression is based on estimation, the assumptions are less restrictive than a 
linear model. Multinomial logistic regression is used when there are multiple categories 
in the dependent variable (Polit, 2010). 
Aim 2   
Aim 2 states “Time to birth: Compare the effectiveness of labor induction 
methods (misoprostol, dinoprostone and mechanical methods) by the time to birth with 
results stratified by BMI category.”   
Hypotheses-Aim 2. A2H1: Women induced using misoprostol for cervical 
ripening will have a shorter time to birth as compared to women induced using 
dinoprostone, and this time differential will be more pronounced with each successive 
BMI category. A2H2: The time to birth will be shorter with mechanical methods than the 
use of either prostaglandin (PGE1 or PGE2). 
Planned analysis. Survival Analysis. A cox proportional hazard regression with 
an alpha level of 0.05 will be used to determine differences in cervical ripening methods 
and the time to birth (Meyers, Gamst, & Guarino, 2017).  
Aim 3  
Aim 3 states “Cesarean birth: Examine the risk of cesarean birth after labor 
induction among women by BMI category.”  
63 
 
 
Hypotheses-Aim 3. A3H1: Compared to women with normal range BMI, the odds of 
cesarean birth following labor induction will be higher with each increase in body mass 
index category. A3H2: The odds of cesarean birth in women induced with misoprostol 
will be lower compared to the odds in similar women induced using dinoprostone. A3H3: 
Women with obesity (in any obesity category) who are induced using mechanical means 
will have lower odds of cesarean birth than women with obesity (in any obesity category) 
induced with prostaglandins (misoprostol or dinoprostone).  
Planned analysis. The plan for analysis is a multinomial logistic regression. 
Multinomial logistic regression with an alpha level of 0.05 will be used to determine the 
risk of cesarean birth with each increase in body mass index category. 
Potential confounding variables.  
Maternal height: maternal height as documented in the CSL database 
(Kominiarek et al., 2010), Maternal educational level, Maternal race: as documented in 
the CSL database (white, Black, American Indian Asian Native Hawaiian, other), 
Maternal age: Age, in years, of the mother at hospital admission as documented in the 
CSL database, Birthweight: weight of the neonate in kilograms, as documented on the 
first full assessment after birth in the CSL database. Socioeconomic status (SES) by 
insurance type reported in the CSL dataset. 
Human Subject Consideration 
The application will be submitted to the Georgia State University Institutional 
Review Board (IRB) for non-human subject research. IRB approval may not be necessary 
to conduct the study since these data have been de-identified. The category for the 
proposed research study will be non-human subject research.  
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Confidentiality. Confidentiality will be maintained while accessing and storing 
the de-identified data. The de-identified data will be accessed by users after completion 
of a data use agreement. Only those involved in the analysis will have access to the data. 
The data will be downloaded from the NIH website and stored in a secure online storage 
system, which is a password protected.  
Inclusion of women, minorities, and children. Women, minorities, and children 
will be included in the proposed research. Since the focus of this study is labor induction 
with different types of cervical ripening methods, all participants will be women. All 
minorities that meet inclusion criteria will be included.  Because the database is a 
national database and has a large sample size of over 228,000, we expect an adequate 
representation of minorities. All children from the database meeting inclusion criteria will 
be included. The number of children included in the sample may be small but should 
reflect current trends in teen birth in the U.S.  
Summary 
Research on the outcomes of induction of labor requiring cervical ripening among 
women with obesity is limited. The existing studies had small sample sizes, some 
inconsistencies in BMI category and noted differences in labor induction protocols. The 
research design supports hypothesis formation and testing. Bivariate and multivariate 
statistics will be used for analysis. Strengths of the proposed the research design supports 
inferences regarding a possible causal relationship from the patterns of association.  A 
weakness of the retrospective cohort study design includes the potential for information 
bias due to the use of existing data that was collected for a different purpose.  
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CHAPTER IV 
RESULTS 
This chapter presents the results of this retrospective cohort study to determine the 
relationships among maternal BMI and the use of cervical ripening methods for inducing 
labor. Descriptive statistics are presented for both individual and system sample 
characteristics and for major study variables included in the interventions and outcomes. 
This study explored three aims. Aim 1 explored the use and effectiveness of induction 
methods used for cervical ripening by BMI category. Aim 2 explored the time from 
hospital admission to birth by the induction method used with results stratified by BMI 
category. Aim 3 explored the type of birth by induction method used with results 
stratified by BMI category.  The results of hypotheses testing are reported within each 
aim.  
Sample Selection 
A sample of women with a healthy, low risk pregnancy at term gestation was 
selected. This sample was selected from the Consortium of Safe Labor database, the 
inclusion and exclusion criteria details follow.  
Women with a singleton fetus, cephalic presentation, undergoing induction of 
labor were included in the sample. This cohort of women with healthy low risk 
pregnancies was chosen as the study to ensure study outcomes were comparable to other 
published literature using healthy low risk pregnancies.  
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The database was cleaned using two sets of exclusion criteria. The initial 
exclusions included women with a preterm gestational age of less than 37 weeks or a post 
term gestational age that was greater than or equal to 42 weeks. Women were excluded 
who had multiple gestations.  Women with a non -cephalic presentation were excluded by 
excluding fetal presentations that were coded as non- cephalic, vertex, or head down. 
Women with spontaneous labor were also excluded, by excluding women who had an 
admission cervical exam that was greater than or equal to 6 cm on admission.  The other 
exclusions included placenta previa or accrete, having a prior uterine scar, HIV, HSV, 
eclampsia, or fetal chromosomal anomaly. Women with antepartum stillbirth were 
excluded as the induction process is often clinically different for these women. Women 
who didn’t undergo a trial of labor, as evidenced by cases were only one vaginal exam 
was charted in the database, were excluded. Cases with missing data used to calculate 
BMI at time of hospital admission (height and weight at hospital admission) were 
excluded. The dataset was collected over several years so those who had a subsequent 
pregnancy within the dataset were excluded due to the need for independent observation. 
Figure 1 provides details about the sample selection.  
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Figure 4. Sample Selection Flowsheet. Notes. BMI, body mass index. HIV, human 
immunodeficiency virus. HSV, Herpes Simplex virus.  
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Sample Characteristics 
The sample characteristics for this study includes both individual characteristics 
and systems characteristics.  Descriptive statistics were calculated including median, and 
interquartile range.  Values are reported as number and percent (n (%)) for categorical 
variables, and median, interquartile range (IQR) for continuous variables, due to the 
distribution of the data. Data were analyzed using the Statistical Package for the Social 
Sciences (SPSS) version 25.0. 
Model predictors for individual characteristics were maternal age, BMI at time of 
hospital admission, parity and cervical status. Known theoretical predictors from the 
literature include maternal height, maternal race, maternal insurance status, gestational 
age and birth weight. These known predictors were included with the sample 
characteristics and as covariates for analysis. The model predictors for system 
characteristics were the hospital type, the level of obstetric care and the NICU level. 
Individual Characteristics  
The individual characteristics of maternal age, height, parity, race/ethnicity, BMI 
at time of admission, cervical dilation at time of admission, gestational age, and birth 
weight in grams, were included in the sample individual characteristics for this study. 
The maternal age and maternal height were reported as continuous variables in the 
dataset. Both were found to be non-normally distributed using statistics for skewness and 
kurtosis.  The median maternal age was 27 years at time of hospital admission. The 
median maternal height was 1.63 meters, which equal 5 feet 4 inches.  
The sample was almost evenly divided between nulliparous (49.8%), and 
multiparous (50.2%) women. For maternal race, the majority of the women in the sample 
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were non-Hispanic White (53.3%), with non-Hispanic Black (19.3%) and Hispanic 
(18.4%) being the second and third largest groups, respectively. The remaining 
racial/ethnicity categories were Asian/pacific islander (n = 1,523; 3.7%), multiracial (n = 
27; 0.1%), other (n = 972; 2.4%), and unknown (n = 1,163; 2.8%).  The insurance type 
for the majority of the women in the sample was private insurance (52.5%). The next 
largest group was public insurance (27.2%). Other insurance types within the sample 
were self-pay (n = 444; 0.1%) and other (n = 89; 0.2%), and unknown (n = 7,883; 
19.1%).   
The median maternal BMI on admission was 29.9 kg/m2. When the sample was 
stratified by BMI categories, the underweight women (n = 23; 0.01%) and normal weight 
women (n = 5,316; 12.9%) accounted for 13% of the sample. The overweight women 
were largest BMI group (n = 15,599; 37.7 %). The remaining half of the sample was in 
one of the three obese categories; obese cat 1 (n = 11,435; 27.6%), obese cat 2 (n = 
5,373; 13.0%), obese cat 3 (n = 3,613; 8.7%).   
Cervical dilation at time of hospital admission was transformed from a continuous 
variable and was reported as a categorical variable by each centimeter of cervical dilation 
as noted at time of admission. Approximately 70% of women within this sample had a 
reported cervical dilation of 1 - 3.99 cm on admission, meaning these women had a 
clinical indication for using cervical ripening methods for inducing labor.  Gestational 
age was also transformed from a continuous variable to a categorical variable for ease of 
describing the sample. The categorical variable is reported by week of gestational age at 
time of admission.  The sample was limited to term women 37- 41 weeks’ gestation.  The 
largest group of women in the sample was between 39 - 39.99 weeks’ gestation (37.7%), 
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which can be explained by the current standard that the mother must be 39 weeks for 
elective IOL.  
The birth weight was reported as a continuous variable that was found to be non-
normally distributed. The median birth weight was 3,366 grams, which is 7.42 pounds. 
Table 4 summarizes the descriptive statistics for the individual characteristics within this 
sample (n = 41,359) of women included in this study. 
Table 4 
Sample Individual Characteristics 
Individual Characteristics n (%) 
 
Median (IQR) 
 
Maternal age (years)  27(9) 
Height (meters)  1.63 (0.08) 
Parity   
  Nulliparous  20,583 (49.8)  
  Multiparous  20,776 (50.2)  
Maternal race/ethnicity    
  Non-Hispanic white  22.064 (53.3)  
  Non-Hispanic black 7,996 (19.3)  
  Hispanic  7,605 (18.4)  
  Asian or Pacific Islander 1,532 (3.7)  
  Multiracial  27 (0.1)  
  Others 972 (2.4)  
Insurance type   
  Private  21,693 (52.5)  
  Public 11,250 (27.2)  
  Self-pay 444 (1.1)  
  Other  89 (0.2)  
Insurance type   
  Private  21,693 (52.5)  
  Public 11,250 (27.2)  
  Self-pay 444 (1.1)  
  Other  89 (0.2)  
  Unknown 7,883 (19.1) 
 
 
 
(Table 4 Continues) 
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(Table 4 Continued) 
 
Individual Characteristics n (%) 
 
Median (IQR) 
 
BMI at hospital admission  29.9 (7.49) 
  Underweight <18.5 kg/m2 23 (0.1)  
  Normal weight 18.5-25 kg/m2 5,316 (12.9)  
  Overweight 25-29.9 kg/m2 15,599 (37.7)  
  Obese Cat 1 30 -34.9 kg/m2 11,435 (27.6)  
  Obese Cat 2 35-39.9 kg/m2 5,373 (13.0)  
  Obese Cat 3 > 40 kg/m2 3,613 (8.7)  
Cervical dilation admission (cm)   
  0.0 -0.99 3,609 (8.7)  
  1.00 -1.99 9,198 (22.2)  
  2.00 - 2.99 8,380 (20.3)  
  3.00 - 3.99 8,849 (21.4)  
  4.00 - 4.99 3,309 (8.0)  
  5.00 - 5.99 992 (2.4)  
  Missing data 7,022 (17.0)  
Gestational age   
  37.00 - 37.99 3,791 (9.2)  
  38.00 - 38.99 8,047 (19.5)  
  39.00 - 39.99 15,608 (37.7)  
  40.00 - 40.99 9,959 (24.1)  
  41.00 - 41.99 3,954 (9.6)  
Birth weight (grams)  3,366 
 
Notes. Abbreviations: centimeters (cm); Body mass index (BMI); interquartile range, 
(IQR); kilograms (kg); meter (m). 
 
Systems Characteristics  
 The majority of the women in the sample had labor induced in university teaching 
hospitals (51.5%), with an obstetric level of care designated as a tertiary care center 
(85.7%), and with a level 3 NICU (84.4%). The other hospital types were community 
teaching hospital (37.7%) and community non-teaching hospitals (10.8%). The NICU 
levels were NICU level 2 (11.7%) and No NICU (3.9%). Very few women in this sample 
were induced in community non-teaching hospitals or hospitals without a NICU. Table 5 
summarizes the descriptive statistics for the systems characteristics in this study.   
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Table 5 
Sample Systems Characteristics 
System Characteristic n (%) 
Hospital type   
  University, Teaching  21,311 (51.5) 
  Community, Teaching  15,578 (37.7) 
  Community, Non-teaching 4,470 (10.8) 
Hospital level for obstetric care   
  Secondary  5,927 (14.3) 
  Tertiary 35,432 (85.7) 
Highest level of neonatal care  
  No NICU 1,606 (3.9) 
  Level 2 (specialty) 4,827 (11.7) 
  Level 3 (subspecialty) 34,926 (84.4) 
Notes. Abbreviations. NICU, neonatal intensive care unit. 
Descriptive Statistics for Study Intervention and Outcome Variables  
This section includes descriptive statistics for study intervention and outcome 
variables. The study interventions were the method of cervical ripening used for 
induction of labor. The outcome variables include the method used for cervical ripening 
for induction of labor (misoprostol, PGE2, and mechanical means), the time from 
hospital admission to birth, and the type of birth (vaginal or cesarean).  
Interventions 
All of the women in the sample underwent induction of labor. Labor was induced 
with one or more of the following induction methods; misoprostol, PGE2, mechanical 
means, Pitocin or amniotomy. Since this study focuses on the cervical ripening methods 
used for induction of labor, cervical ripening methods used for induction of labor 
(misoprostol, PGE2, and mechanical means) are the main variables of interest. Of the 
cervical ripening methods used for induction of labor women in the sample were induced 
with misoprostol (8.8%) of the time, mechanical means (4.4%), and PGE2 (6.5%). The 
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missing data (10.2%) within this variable were mostly from one site, which did not 
collect or report the induction of labor method used. Cases with missing data for 
induction of labor were deleted prior to analysis. Table 3 summarizes the descriptive 
statistics for labor induction methods, used alone or in combination. The total in Table 6 
is greater than 100% due induction methods being used either alone or in combination. 
Table 6 
Descriptive Statistics for Methods of Induction of Labor, used alone or in Combination 
Induction Method n (%) 
Cervical ripening  6,035 (14.6) 
  Misoprostol  2,203 (36.5) 
  PGE2  2,100 (34.8) 
  Mechanical + Miso  908 (15.0) 
  Mechanical  504 (8.4) 
  Mechanical + PGE2  173 (2.9) 
  Miso+ PGE2  113 (1.9) 
  Mechanical + Miso + PGE2  34 (0.6) 
Oxytocin/Pitocin 26,209 (70.6) 
AROM 13,505 (36.4) 
Unknown 6,995 (16.9) 
Notes. Women may have been induced with one or more methods, totals for induction 
methods do not equal 100%. Abbreviations Prostaglandin analogue 2, PGE2; 
Misoprostol, Miso; Artificial rupture of membranes, AROM 
 
Outcomes 
 
The study outcome variables were the methods used for induction of labor 
requiring cervical ripening, the time from hospital admission to birth, and the type of 
birth. The methods used for induction of labor requiring cervical ripening are both 
exposure and outcome variables within this study. The median time to birth was 1,018 
minutes.  The type of birth for the majority of the women included in the sample was a 
vaginal birth (81.7%) with the remaining having a cesarean birth (18.3%).  
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The maternal adverse outcomes were rare in this sample of women but included 
either a third- or fourth-degree perineal laceration, postpartum hemorrhage, maternal 
fever, maternal transfer to ICU during hospitalization, transfusion of blood or blood 
products, shoulder dystocia and maternal death.  
The neonatal adverse outcomes were also rare in this sample. The neonatal 
adverse outcomes included APGAR < 7 at 5 min, NICU admission, neonatal sepsis, 
birth-related injury, and/or neonatal death. Table 7 summarizes the descriptive statistics 
for the major study outcome variables. 
Table 7 
Descriptive Statistics for Study Outcome Variables 
Outcome variables n (%) Median (IQR) 
Time to birth (min)   1,018 (638) 
  Missing  118 (0.0)  
Type of birth   
  Vaginal  33,802 (81.7)  
  Cesarean  7,557 (18.3)  
Maternal adverse outcomes   
  3r - 4th degree perineal 
laceration 
882 (2.1)  
  Postpartum Hemorrhage   517 (1.3)  
  Maternal fever  496 (1.2)  
  Transfer to ICU during 
hospitalization 
185 (0.4)  
  Transfusion of blood or 
blood products 
1,285 (3.1)  
  Shoulder dystocia  565 (1.4)  
  Maternal death  1 (0.0)  
Neonatal adverse outcomes   
  APGAR < 7 at 5 min 256 (0.01)  
  NICU admission 2,060 (5.0)  
  Neonatal sepsis 302 (0.7)  
  Birth-related injury 404 (1.0)  
  Neonatal death 9 (0.0)  
Notes. Inter quartile range, IQR; minutes, min; intensive care unit, ICU; neonatal 
intensive care unit, NICU 
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Bivariate Relationships among Individual and System  
Characteristics by BMI Category  
 Bivariate correlations were calculated between individual and system 
characteristics and BMI category. Categorical variables were analyzed with the Crosstabs 
function in SPSS using chi square analysis for significance. The continuous variables 
were analyzed using the Kruskal Wallis test for significance. Median values were 
reported due to the non-normal distribution (right skew) of the data.  
Three variables were collapsed for analysis due to small cell size. The maternal 
race/ethnicity, insurance status, and BMI at time of hospital admission variables had 
categories that were collapsed as outlined below. The maternal racial/ethnicity categories 
of Asian/Pacific Islander (n = 1,523; 3.7%), multiracial (n = 27; 0.1%), other (n = 972; 
2.4%) and unknown (n = 1,163; 2.8%) were collapsed into a group named other (20.3%). 
For insurance status the categories of self-pay (n = 444; 0.1%) and other (89; 0.2%) were 
collapsed into the unknown category (n = 7,883; 19.1%). This created a collapsed 
category named other/unknown (n = 8,416; 20.3%). Due to the low number of 
underweight women (n = 23), the BMI category of underweight was combined with the 
normal weight category for the analysis (n = 5,339; 12.9%).  
Bivariate correlations showed there was a statistically significant relationship 
between BMI and age, height, parity, race, insurance type, cervical dilation at time of 
admission, gestational age and birthweight. There was a statistically significant 
relationship between BMI and hospital type, obstetric level of care, and neonatal level of 
care. Tables 8 and 9 summarize descriptive statistics for individual characteristics, and 
systems characteristics by BMI category. Table 10 summarizes the type of birth by BMI 
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category. Categorical variables reported as n (%). Continuous variables are reported as 
median.   
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Table 8  
Bivariate Analysis of Individual Characteristics within BMI Category 
 
Individual 
Characteristics 
n (%) 
 
Normal weight 
(n = 5,339) 
 
Overweight 
(n = 15,599) 
 
Obese Cat 1 
(n = 11,435) 
 
Obese Cat 2 
(n = 5,373) 
 
Obese Cat 3 
(n = 3,613) 
P value 
Age (y) *  27 28 27 27 27 < .001 
Height (m) * 1.65 1.63 1.63 1.63 1.63 < .001 
Parity      < .001 
  Nulliparous  2,879 (53.9) 7,901 (50.7) 5,431 (47.5) 2,535 (47.2) 1,837 (50.8)  
  Multiparous  2,460 (46.1) 7,698 (49.3) 6,004 (52.8) 2,838 (52.8) 1,776 (50.2)  
Race/ethnicity      < .001 
  White  3,149 (59.0) 8,956 (57.4) 5,873 (51.4) 2,551 (47.5) 1,535 (42.5)  
  Black  776 (14.5) 2,213 (14.2) 2,312 (20.2) 1,435 (26.7) 1,260 (34.9)  
  Hispanic  817 (15.3) 2,805 (18.0) 2,332 (20.4) 1,054 (19.6) 597 (16.5)  
  
Other/unknown  
597 (11.2) 1,625 (10.4) 918 (8.0) 333 (6.2) 221 (6.1)  
Insurance type      < .001 
  Private  2,778 (52.0) 8,576 (55.0) 5,970 (52.2) 2640 (49.1) 1,729 (47.9)  
  Public 1,153 (21.6) 3,437 (22.0) 3,268 (28.6) 1,921 (35.8) 1,471 (40.7)  
  Unknown 1,408 (26.4) 3,586 (23.0) 2,197 (19.2) 812 (15.1) 413 (11.4)  
 
(Table 8 Continues) 
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Individual 
Characteristics 
n (%) 
 
Normal 
weight 
(n = 5,339) 
 
Overweight 
(n = 15,599) 
 
Obese Cat 1 
(n = 11,435) 
 
Obese Cat 2 
(n = 5,373) 
 
Obese Cat 3 
(n = 3,613) 
P value 
Cervical dilation      < .001 
   0.00-.99 419 (9.0) 1,234 (9.3) 972 (10.4) 545 (12.8) 439 (10.5)  
  1.00-1.99 1,162 (25.1) 3,418 (25.7) 2,590 (27.7) 1,189 (28) 839 (26.8)  
  2.00-2.99 1,177 (25.4) 3,391 (25.5) 2,220 (23.7) 962 (22.7) 630 (22.5)  
  3.00-3.99 1,324 (28.6) 3,545 (26.6) 2,410 (25.8) 999 (23.6) 571 (20.3)  
  4.00-4.99 420 (9.1) 1,338 (10.1) 864 (9.2) 420 (9.9) 267 (9.5)  
  5.00-5.99 128 (2.8) 385 (2.9) 292 (3.1) 127 (3.0) 60 (2.1)  
Gestational age      < .001 
  37.00-37.99 608 (11.4) 1,204 (7.7) 1,017 (8.9) 537 (10.0) 425 (9.2)  
  38.00-38.99 1,069 (20.0) 2,903 (18.6) 2,127 (18.6) 1,156 (25.1) 792 (19.5)  
  39.00-39.99 2,109 (39.5) 6,184 (39.6) 4,278 (37.4) 1,799 (33.5) 1,238 (37.7)  
  40.00-40.99 1,169 (21.9) 3,922 (25.1) 2,774 (24.3) 1,286 (23.9) 808 (22.4)  
  41.00-41.99 384 (7.2) 1,386 (8.9) 1,239 (10.8) 595 (11.1) 350 (9.7)  
Birth weight (g)* 3,195 3,345 3,424 3,440 3,440 < .001 
Notes. Abbreviations Chi squared for significance. Continuous variables (*), median reported, Kruskal Wallis test for 
significance. Abbreviations. Cat, category; y, year; m, meters; g, grams.  
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Table 9 
Bivariate Analysis for System Characteristics and BMI 
System Characteristics Normal (n = 5,339) 
Overweight 
(n = 15,599) 
Obese Cat 1 
(n =11,435) 
Obese Cat 2  
(n = 5,373) 
Obese Cat 3 
 (n = 3,613) 
P value 
Hospital type       < .001 
  University 2,932 (54.9) 8,010 (51.3) 5,801 (50.7) 2,727 (50.8) 1,841 (51.0)  
  Community, Teaching  1,817 (34.0) 5,751 (36.9) 4,411 (38.6) 2,126 (39.6) 1,473 (40.8)  
  Community, Non-teaching 590 (11.1) 1,838 (11.8) 1,223 (10.7) 520 (9.7) 299 (8.3)  
Obstetric care level      < .001 
  Secondary  723 (13.5) 2,315 (14.8) 1,661 (14.5) 758 (14.1) 470 (13.0)  
  Tertiary 4,616 (86.5) 13,284 (82.5) 9,774 (85.5) 4,615 (85.9) 3,143 (85.7)  
NICU level      < .001 
  No NICU 212 (4.0) 688 (4.3) 443 (3.9) 175 (3.3) 108 (3.0)  
  Level 2 542 (10.2) 1,793 (11.5) 1,365 (11.9) 681 (12.7) 446 (12.3)  
  Level 3 4,584 (85.9) 13,138 (84.2) 9,627 (84.2) 4,517 (84.1) 3,059 (84.7)  
Notes. Abbreviations: Cat, category; NICU, neonatal intensive care unit; Level 2 (specialty); Level 3 (subspecialty). Chi 
square for significance 
 
Table 10 
Bivariate Analysis of Type of Birth by BMI category for all Women being Induced n = 41,359  
Type of birth 
Normal weight 
(n = 5,339) 
Overweight 
(n = 15,599) 
Obese Cat 1 
(n = 11,435) 
Obese Cat 2 
(n = 1,348) 
Obese Cat 3 
(n = 1,149) 
Total  
(n = 41,359) 
p-value 
Vaginal 4,831 (90.5) 13,296 (85.2) 9,236 (80.8) 4,025 (74.9) 2,414 (66.8) 33,802 (81.7) < .001 
Cesarean 508 (9.5) 2,303 (14.8) 2,199 (19.2) 1,348 (25.1) 1,199 (33.2) 7,557 (18.3)  
Notes. Chi squared for significance 
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While bivariate analyzes were performed for the variables of cervical status and 
gestational age, these variables were not included as predictors in analysis of the aims 
due to several factors. First the sample was selected based on women with induction of 
labor, so all of the women in the sample had an initial cervical exam of less than 6 cm, 
which is the cut off for active labor. This cut point was chosen because a cervical exam of 
less than 6 cm indicates a woman is not yet in active labor, and there is a clinical 
indication for induction of labor. Additionally, the variable cervical dilation at time of 
admission had a large amount of missing data (17%). Lastly, cervical status tends to a 
collinear relationship with BMI. Gestational age was not included as a predictor for the 
use of cervical ripening for induction of labor due to the sample selection criteria, the 
whole sample selected has a term gestational age based on sample inclusion and 
exclusion criteria.   
Analysis of Aims 
The following bivariate and multivariate analyses are reported findings that either 
support or do not support the individual hypotheses of study. All data were analyzed 
using the Statistical Package for the Social Sciences (SPSS) version 25.0. Prior to 
addressing the hypotheses, data were examined for normality, outliers, and missing data. 
Aim One 
Aim 1 states “Interventions: Describe the effectiveness of labor induction methods 
(misoprostol, PGE2, and mechanical means) in women undergoing labor induction 
requiring cervical ripening by BMI category”.  
Aim 1 Hypothesis 1: The odds of requiring intervention to initiate labor will be higher 
by each BMI category compared with normal weight women.  
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Analysis.  
Binary logistic regression assumptions and requirements. A binary logistic 
regression predicts the probability that an observation falls into one of two categories 
(Meyers, Gamst, & Guarino, 2017). Basic assumptions for logistic regression are 
adequate sample size, absence of multicollinearity, independence of errors, and absence 
of outliers (Meyers et al., 2017; Stoltzfus, 2011). Logistic regression is based on 
estimation, so the assumptions for this test are less restrictive than the assumptions in a 
linear model. The data were assessed for independence of observations, outliers, and 
multicollinearity. Multicollinear variables were BMI and height, hospital type, obstetric 
care level, and NICU level. Height was not included in the models. Obstetric care level 
and NICU level were not included as predictors in the models. Hospital type was 
retrained as a predictor, as the collinear relationship improved with the exclusion of the 
other variables from the models.  
Adequate sample size is generally 10 to 20 events per covariate (Stoltzfus, 2011). The 
sample size within this analysis meets this assumption and is considered an adequate size 
for logistic regression. A binary logistic regression requires a dichotomous dependent 
variable, and two or more independent variables that are measured at the scale interval or 
ratio level (dichotomous dummy variables are also allowed) (Meyers et al., 2017). The 
data meet these assumptions and are adequate for linear regression.  
Unadjusted model. A standard binary logistic regression was used to model the binary 
variable Cervical ripening. Cervical ripening is a newly created variable that describes 
whether or not cervical ripening (misoprostol, other prostaglandin, or mechanical means) 
was used for induction of labor (using ‘no’ (0) as the reference category). The 
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independent or predictor variable in this study was BMI at time of hospital admission. 
Based on classification threshold predictive probability of having used cervical ripening 
as 0.5, results of the logistic regression analysis indicate the single categorical predictor 
of BMI within the model provided a statistically significant prediction of the use of 
cervical ripening (χ2 (4, N= 37,149 = 119.99, p < .001). The Nagelkerke pseudo R2 
indicated the model accounted for approximately .5% of the total variance. Classification 
accuracy for all the cases was based on a classification cut off value of .500 for predicting 
the use of cervical ripening by BMI category was moderately high, with an overall 
correct prediction rate of 83.8%, and correct prediction rates of 100 % in women not 
receiving cervical ripening and 0 % in women receiving cervical ripening, Table 11 
summarizes the unadjusted binary logistic regression reporting the unadjusted odds of 
being induced with one or more of the following misoprostol, PGE2, or mechanical 
means by BMI within the selected sample.  
Table 11 
Unadjusted Odds for Women undergoing Induction of Labor requiring Cervical Ripening 
with one or more of the following Misoprostol, PGE2, or Mechanical Means by BMI 
Variables in the 
Equation 
B S.E. Wald df 
Odds 
ratio 
95% 
CI 
Lower 
95% 
CI 
Upper 
P 
value 
Normal weight   121.86 4 1.00   < .001 
Overweight 0.14 0.05 8.29 1 1.15 1.05 1.26 .004 
Obese Cat 1 0.25 0.05 25.22 1 1.28 1.16 1.41 < .001 
Obese Cat 2 0.42 0.06 57.78 1 1.53 1.37 1.71 < .001 
Obese Cat 3 0.54 0.06 78.13 1 1.71 1.52 1.93 < .001 
Notes. Normal weight used as the referent category. Table abbreviations. df, degrees of 
freedom; CI, confidence interval; cat, category 
 
Adjusted model. A standard binary logistic regression was used to model the binary 
variable aim 1 outcome. Aim 1 outcome describes whether or not cervical ripening 
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methods (misoprostol, other prostaglandin, or mechanical means) were used for induction 
of labor (using ‘no’ (0) as the reference category). The independent or predictor variables 
in this study were maternal age, parity, maternal race, insurance status, hospital type, and 
birth weight (g). Based on classification threshold predictive probability of having used 
cervical ripening as 0.5, results of the 6 categorical variables and 3 continuous variables 
in the logistic regression analysis indicate the predictors within the model provided a 
statistically significant prediction of the use of cervical ripening (χ2 (14, N= 37,149) = 
2097.69, p < .001). The model had a low predictive value, the Nagelkerke pseudo R2 
indicated the model accounted for approximately 9.4% of the total variance. 
Classification accuracy for all the cases was based on a classification cut off value of .500 
for predicting the use of cervical ripening by BMI category was moderately high, with an 
overall correct prediction rate of 83.7%, and correct prediction rates of 99.8 % in women 
not receiving cervical ripening and 0.5 % in women receiving cervical ripening, Table 12 
presents the partial regression coefficients, the odds ratio [Exp (B)], and the confidence 
interval (CI) for the odds ratio for each predictor and the p value. 
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Table 12 
Adjusted Odds Ratios for use of one or more Cervical Ripening Methods for Induction of 
Labor  
Variables in the 
equation 
(n = 37,149) 
B S.E. Wald df OR 
95% 
C.I. 
LB 
95% 
C.I. 
UB 
P value 
Normal weight   131.20 4 1.00   < .001 
Overweight 0.15 0.05 9.71 1 1.17 1.06 1.28 .002 
Obese Cat 1 0.29 0.05 30.80 1 1.33 1.20 1.48 < .001 
Obese Cat 2 0.48 0.06 67.13 1 1.62 1.44 1.82 < .001 
Obese Cat 3 0.59 0.07 83.71 1 1.81 1.59 2.05 < .001 
Maternal age 0.01 0.00 18.26 1 1.01 1.01 1.02 < .001 
Parity  0.86 0.03 694.43 1 2.36 2.21 2.52 < .001 
White Non-
Hispanic 
  30.62 3 1.00   < .001 
Black Non-
Hispanic 
-0.17 0.05 11.40 1 0.84 0.76 0.93 .001 
Hispanic 0.10 0.04 5.82 1 1.11 1.02 1.21 .016 
Other -0.07 0.05 1.66 1 0.93 0.84 1.04 .198 
Insurance-Private   112.40 2 1.00   < .001 
Insurance- Public 0.41 0.04 106.56 1 1.50 1.39 1.62 < .001 
Insurance-Other 0.33 0.05 44.71 1 1.39 1.26 1.53 < .001 
University 
teaching hospital 
  1,084.02 2 1.00   < .001 
Community 
teaching hospital 
1.26 0.04 919.04 1 3.51 3.23 3.80 < .001 
Community non-
teaching hospital 
0.32 0.06 25.76 1 1.38 1.22 1.60 < .001 
Birth weight (g) 0.00 0.00 4.88 1 1.00 1.00 1.00 .027 
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, 
University teaching hospital. Abbreviations. OR odds ratio; CI, confidence interval; LB, 
lower bound; UB, upper bound; cat, category 
 
Model testing. Model testing includes testing outliers, leverage and influence (Field, 
2013; Zhang, 2016). Testing for model outliers displays a pattern with an unusual 
condition (Zhang, 2016). A univariate outlier is not necessarily a regression outlier. A 
regression outlier is a record or case that has an unusual value on the outcome variable 
(Field, 2013). Leverage is defined as a case that has an unusual x value (Zhang, 2016). 
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Whereas, influence refers to the amount of influence a covariate has on the y value 
(Zhang, 2016). Influence is a product of leverage and outliers, that is when an influence is 
dropped from the model there is a significant shift in the coefficient or intercept of the 
model (Zhang, 2016). Cook’s distance is a commonly used measure of influence of 
covariates within a model (Field, 2013). A Cook’s distance of greater than one calls for 
further investigation into individual covariates. If the Cook’s distance is less than one 
“just move ahead” (Field, 2013). Model testing, betas were checked. There were no cases 
of leverage, influence or outliers.  The maximum Cook’s distance was .01017, which is 
less than one, requiring no additional investigation. 
Aim 1 summary. Results of A1H1 analysis show the odds of requiring cervical 
ripening as part of the induction process were higher by each BMI category compared 
with normal weight women. The adjusted model showed BMI was a statistically 
significant predictor of the use of cervical ripening methods for induction of labor. 
Additionally, maternal age, parity, race categories (except other), insurance, hospital 
type, and birth weight were statistically significant predictors for the use of cervical 
ripening for labor induction.  
Aim Two 
Aim 2 [should the #2 be spelled out?] states “Time to birth: Compare the 
effectiveness of cervical ripening methods during labor induction (misoprostol, PGE2, 
and mechanical means) by the time from hospital admission to birth with results 
stratified by BMI category”   
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Aim 2 Hypotheses 
A2H1: Women induced with misoprostol will have a shorter time to birth as 
compared to women induced using other prostaglandins, and this time differential will be 
more pronounced with each successive BMI category.  
A2H2: Women induced with mechanical means will have a shorter time to birth 
as compared to women induced using either prostaglandin (misoprostol or other 
prostaglandins), and this time differential will be more pronounced with each successive 
BMI category. 
Aim 2 Sample  
A new, smaller sample was created for the analysis of Aims 2 and 3. The smaller 
sample is comprised of women undergoing induction of labor requiring cervical ripening 
(n = 6,035). These data are escribed in comparison to the sample of 41,539 women 
undergoing induction of labor. The median maternal age and height were similar to the 
original sample. There were a greater number of nulliparous women in this new smaller 
sample. A greater number of women were non-Hispanic white, with fewer women being 
non-Hispanic black. Insurance type was similar between both samples.  
The cervical dilation differences between the two groups, induction of labor and 
induction of labor with cervical ripening, were difficult to assess as there were a greater 
number of missing data on cervical dilation in the women undergoing cervical ripening 
17% verses 30%, respectively. The gestational age was similar between the two groups of 
women. Birthweight was similar between the groups. Table 13 summarizes the 
descriptive statistics for the use of cervical ripening.
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Table 13  
Sample Characteristics: Cervical Ripening for Induction of Labor 
Individual Characteristics n (%) 
 
Median (IQR) 
 
Maternal age (y)  27 (9) 
Height (m)  1.65 (0.1) 
Parity   
  Nulliparous  3,775 (62.6)  
  Multiparous  2,260 (37.4)  
Maternal race/ethnicity    
  Non-Hispanic white  3,466 (57.4)  
  Non-Hispanic black 827 (13.7)  
  Hispanic  1,224 (20.3)  
  Other/unknown 518 (8.6)  
Insurance type   
  Private  3,202 (53.1)  
  Public 1,775 (29.4)  
  Other/Unknown 1,058 (17.5)  
BMI at hospital admission  30.5 (7.89) 
  Normal weight  669 (11.1)  
  Overweight  2,154 (35.7)  
  Obese Cat 1  1,688 (28.0)  
  Obese Cat 2  889 (14.7)  
  Obese Cat 3  635 (10.5)  
Cervical dilation admission (cm)   
   0-.99 823 (13.6)  
  1.00-1.99 1,811 (30)  
  2.00-2.99 688 (11.4)  
  3.00-3.99 601 (10)  
  4.00-4.99 233 (3.9)  
  5.00-5.99 48 (1.1)  
  Missing data 1,831 (30.3)  
 
(Table 13 Continues) 
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(Table 13 Continued) 
 
Individual Characteristics n (%) 
 
Median (IQR) 
 
Gestational age   
  37.00-37.99 587 (9.6)  
  38.00-38.99 963 (16)  
  39.00-39.99 1,852 (30.7)  
  40.00-40.99 1,160 (27.5)  
  41.00-41.99 982 (16.3)  
Birth weight (g)  3,373 (618) 
Hospital type    
  University Affiliated, Teaching  2,535 (42.0)  
  Community, Teaching  3,028 (50.2)  
  Community, Non-teaching 472 (7.8)  
Hospital level for obstetric care    
  Secondary  472 (1.8)  
  Tertiary 5,563 (90.2)  
Highest level of neonatal care   
  No NICU 172 (2.9)  
  Level 2 (specialty) 535 (9.0)  
  Level 3 (subspecialty) 5,328 (88.3)  
Notes. Abbreviations: years (y); meter (m); centimeters (cm); Body mass index (BMI); 
grams (g); interquartile range, IQR; Grams, (g); Neonatal care unit. NICU.  
 
Descriptive Statistics for Induction of Labor Methods 
Descriptive statistics are provided for cervical ripening methods (misoprostol, 
PGE2, and mechanical means used alone or in combination) and the use of Pitocin or 
amniotomy for induction of labor. Since there are no defined temporal relationships in the 
CSL database, Pitocin and amniotomy will be used as covariates. Table 14 describes the 
use of cervical ripening methods (misoprostol, PGE2, and mechanical means used alone 
or in combination) along with the use Pitocin and amniotomy for induction of labor.  
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Table 14 
Labor Induction Methods including Cervical Ripening Methods (Misoprostol, PGE2 and 
Mechanical Means), Pitocin, and Amniotomy n (%). 
Cervical Ripening Method 
n (%)  
(n = 6,035) 
Pitocin  
(n = 2,930) 
Amniotomy  
(n = 2,841) 
Misoprostol  2,203 (36.5) 203 (6.9) 105 (3.7) 
PGE2  2,100 (34.8) 1,328 (45.3) 1,237 (43.5) 
Mechanical + Miso 908 (15.0) 908 (31.0) 889 (31.6) 
Mechanical  504 (8.4) 215 (7.3) 340 (12.0) 
Mechanical + PGE2  173 (2.9) 146 (5.0) 145 (5.1) 
Miso+ PGE2  113 (1.9) 96 (3.3) 84 (3.0) 
Mechanical +Miso +PGE2  34 (0.6) 34 (1.2) 31 (1.1) 
Notes. PGE2 Prostaglandin analogue 2; miso, misoprostol 
Bivariate Analysis 
Bivariate analysis of induction of labor methods requiring cervical ripening by 
BMI category showed most women requiring cervical ripening were induced with 
misoprostol, other prostaglandins, mechanical means, or mechanical means with 
misoprostol. Misoprostol alone was used 36.5% of the time, other prostaglandins were 
used with 34.8%, mechanical means were used with 8.4%, and mechanical means with 
miso were used with 15% of inductions requiring cervical ripening.  The other methods 
(Miso+ PGE2, Mechanical + PGE2, and Mechanical +Miso +PGE2) were rarely used 
and were not included in hypothesis testing for Aim 2. Table 15 summarizes the bivariate 
analysis of cervical ripening method by BMI category with chi squared for significance. 
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Table 15 
Cervical Ripening Induction Methods by BMI Category using Chi-square for Significance  
Induction Method 
 
Normal 
weight 
(n = 669) 
Overweight 
(n = 2,154) 
Obese Cat 
1 
(n = 1,688) 
Obese Cat 
2 
(n = 889) 
Obese Cat 
3 
(n = 635) 
Total 
(n = 6,035) 
P 
value 
Cervical ripening       < .001 
Misoprostol 229 (34.2) 765 (35.5) 645 (38.2) 340 (38.2) 224 (35.3) 
2,203 
(36.5) 
 
PGE2 279 (41.7) 812 (37.7) 552 (32.7) 256 (28.8) 201 (31.7) 
2,100 
(34.8) 
 
  Mechanical 39 (5.8) 150 (7.0) 148 (8.8) 86 (9.7) 81 (12.8) 504 (8.4)  
  Mechanical + Miso 85 (12.7) 335 (15.6) 259 (15.3) 143 (16.1) 86 (13.5) 908 (15.0)  
  Miso+ PGE2 12 (1.8) 26 (1.2) 32 (1.9) 25 (2.8) 18 (2.8) 113 (1.9)  
  Mechanical + PGE2 20 (3.0) 56 (2.6) 40 (2.4) 36(4.0) 21 (3.3) 173 (2.9)  
  Mechanical +M+P 5 (0.7) 10 (0.5) 12 (0.7) 3 (0.3) 4 (0.1) 34 (0.6)  
Cervical ripening 
(collapsed) 
      < .001 
Misoprostol 241(36.0) 791 (36.7) 677 (40.1) 365 (41.1) 242 (38.1) 
2,316 
(38.4) 
 
PGE2 279 (41.7) 812 (37.7) 552 (32.7) 256 (28.8) 201 (31.7) 
2,100 
(34.8) 
 
Mechanical 149 (22.3) 551 (25.6) 459 (27.7) 268 (30.1) 192 (30.2) 
1,619 
(26.8) 
 
Pitocin 332 (49.6) 
 
1,075 
(49.9) 
 
802 (47.5) 429 (48.3) 292 (46.0) 
2,930 
(48.6) 
.363 
Amniotomy 326 (48.7) 
1.055 
(49.0) 
781 (46.3) 414 (46.6) 265 (41.7) 
2,841 
(47.1) 
.020 
Notes. Miso, misoprostol; PGE2, Prostaglandin analogue 2; M, miso; P, PGE2.
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Kruskal Wallis for significance. A Kruskal Wallis is appropriate if there is 
independence of observations and the outcome variable is ordinal and non-parametric 
(Meyers, Gamst, & Guarino, 2017). Kruskal Wallis is a one-way ANOVA on ranks and 
is an extension of the Mann Whitney U test where there are two groups being compared. 
The Kruskal-Wallis test comparing time from hospital admission to birth in minutes by 
BMI category showed there was a statistically significant difference in time to birth in 
minutes between the different BMI groups, χ2(4) = 193.129, p < .001. This level was 
found to be significant, meaning at least one sample dominates one other sample when 
looking at the time to birth for all BMI groups. The Kruskal- Wallis test does not show 
where the differences in rank occur.  
The Kruskal-Wallis test showed a statistically significant difference in time from 
hospital admission to birth in minutes between the different cervical ripening method 
groups, χ2(6) = 446.285, p < .001 and χ2(3) = 331.533, p < .001 for the cervical ripening 
groups.  These levels were found to be significant, meaning at least one sample 
dominates one other sample when looking at the time to birth for all BMI groups. We are 
unable to determine which sample is dominate with the Kruskal Wallis test. The median 
time to birth can help illustrate the difference in time to birth between groups. Table 16 
summarizes the number of women induced with each cervical ripening method, n (%), 
the median time to birth in minutes, with the interquartile range noted, and finally the 
significance value from the Kruskal Wallis test is included
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Table 16  
Kruskal Wallis, Comparison for Time to Birth (Time from Hospital Admission to Birth in 
Minutes) by Cervical Ripening Method  
Variable N = 6,035 
Median 
(minutes) 
Interquartile range 
P 
value 
BMI    < .001 
  Normal weight 668 (11.1) 831.50 539.00 – 1,203.75  
  Overweight 2,151 (35.7) 929.00 596.00 – 1,327.00  
  Obese Cat 1 1,685 (28.0) 1,058.00 705.50 – 1,449.00  
  Obese Cat 2 884 (14.7) 1,114.00 753.00 -1,477.50  
  Obese Cat 3 634 (10.5) 1,182.00 802.00 -1,708.75  
Cervical ripening     < .001 
  Misoprostol 2,191 (36.5) 1,103.50 785.00 – 1,483.00  
  Other prostaglandins 2,099 (34.8) 753.00 465.00 – 1,343.00  
  Mechanical 504 (8.4) 1,098.50 853.25 – 1,335.75  
  Mechanical + and PGE2 173 (2.9) 1,299.00 1,081.50 – 1,502.50  
  Mechanical and miso 908 (15.0) 1,007.00 663.25 – 1,309.25  
  Miso and PGE2  113 (1.9) 1,670.00 1,020.00 - 2,321.50  
  Mechanical+miso+PGE2 34 (0.6) 1,569.00 1,202.25 – 2,062.00  
Cervical ripening 
(collapsed categories) 
   < .001 
  Misoprostol 2,304 (38.2) 1,103.50 789.00 – 1,524.00  
  Other prostaglandins 2,099 (34.8) 753.00 465.00 – 1,343.00  
  Mechanical 1,619 (26.8) 1,068.00 769.00 – 1,358.00  
Type of Birth    < .001 
  Vaginal 4,314 (71.6) 893.00 589.00 – 1,264.00  
  Cesarean  1,708 (28.4) 1,307.00 949.00 – 1,737.75  
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, 
University teaching hospital. Kruskal-Wallis test for significance; reporting median, 
interquartile range and significance value.  
 
Multivariate Analysis  
Survival analysis. Survival analysis was chosen for the analysis of Aim 2 due to 
the non-normal distribution of the data. Survival analysis is a time to event analysis, often 
reported using lifetables, Kaplan-Meier curves, or the Cox proportional hazard regression 
model (Meyers et al., 2017; Singh & Mukhopadhyay, 2011). Life tables are commonly 
used in epidemiology as they can be used in large samples, whereas the Kaplan Meier 
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survival analysis is more appropriately used in smaller populations (Meyers et al., 2017). 
Neither of these analyses are able to assess the relationships of covariates within a model. 
The cox proportional hazard regression model simply known as the cox regression was 
used to analyze Aim 2 as there is no distributional assumptions required and covariates 
can be used within the model (Meyers et al., 2017). The cox regression method is used to 
predict the occurrence of an event at a particular time and to model the time to a specific 
event (Meyers et al., 2017). In this case, we are modeling the time from hospital 
admission to birth.  
Assumptions for cox regression are that the independent variable or predictor 
variables (covariates) are time constant (Meyers et al., 2017). The cox regression is 
typically represented in terms of a hazard ratio (i.e., the rate per unit time a case will 
experience the event given it survived to that point). A cox regression requires a 
dichotomously coded status variable (in this case the type of birth vaginal or cesarean, 
with data being censored at time of cesarean birth) that serves as the dependent measure, 
a time variable (can be continuous or categorical) that assesses the duration to the event 
defined by the status variable, and covariates that are independent or predictor variables, 
either continuous or categorical. As stated, the status variable is type of birth.  For time, 
the minutes from hospital admission to birth represented the time to birth. The variable 
type of birth is an indicator of censorship, with birth type vaginal birth coded as 0 
(uncensored) and cesarean birth coded as 1 (censored). The null model shows among the 
6,022 cases 4,314 (71.8%) were uncensored because they were able to have a vaginal 
birth, with 1,708 (28.3%) cases censored for cesarean birth. Figure 4 summarizes the time 
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from hospital admission to birth for all women needing cervical ripening for labor 
induction. 
 
 
Figure 5. Time from Hospital Admission to Birth for Women needing Cervical Ripening 
for Labor Induction  
Building on the previous model, adding BMI as a covariate, type of birth is an 
indicator of censorship, with birth type vaginal birth coded as 0 (uncensored) and 
cesarean birth coded as 1 (censored). The model shows among the 6,022 cases 4,314 
(71.8%) were uncensored because they were able to have a vaginal birth, with 1,708 
(28.3%) cases censored for cesarean birth. After adjusting for the covariates, there was a 
statistically significant effect on time to birth 2 (4, N = 6,022), = 288.40, p = < .001. 
Cumulative survival rates for time from hospital admission to birth by BMI category for 
women requiring cervical ripening for labor induction are displayed in Figure 6.  
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Figure 6. Minutes from Admission to Birth by BMI Category 
Table 17 summarizes the hazard ratios for time from hospital admission to birth 
by BMI category. 
Table 17 
Hazard Ratios for Time from Hospital Admission to Birth by BMI Category 
BMI 
category 
B SE Wald df 
Hazard 
ratio 
95.0% 
CI LB 
95% CI 
UB 
P 
value 
Normal 
weight   279.19 4 1.00   < .001 
Overweight -0.21 0.05 18.75 1 0.81 0.74 0.89 < .001 
Obese Cat 1  -0.50 0.05 92.81 1 0.61 0.55 0.67 < .001 
Obese Cat 2 -0.64 0.06 112.79 1 0.53 0.47 0.60 < .001 
Obese Cat 3 -0.91 0.07 181.51 1 0.40 0.35 0.46 < .001 
Notes. Normal weight used as reference category. 
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Survival analysis by BMI category. Aim 2 is a comparison of the time from 
hospital admission to the time to birth for women using different cervical ripening 
methods for induction of labor by BMI category. In order to test the hypotheses within 
Aim 2, a survival analysis was run for each BMI category. Using the type of birth as an 
indicator of censorship and the variable Cervical ripening collapsed as a covariate on step 
one of the models. Step 2 has the additional covariates of maternal age, parity, race, 
insurance status, hospital type, Pitocin, amniotomy and birth weight(g). Table 18 
summarizes the Omnibus Tests of Model Coefficients as well as significance levels of the 
side by side models using chi square for significance  
 Table 18 
Omnibus Tests of Model Coefficients for Covariates entered into the Survival Analyses 
that were run Side by Side to Reports Stratified Results by BMI Category  
BMI Category Chi-square df P value 
Normal weight 328.82 14 < .001 
Overweight 1,150.05 14 < .001 
Obese Cat 1 841.21 14 < .001 
Obese Cat 2 520.69 14 < .001 
Obese Cat 3 320.17 14 < .001 
Notes. Model scores for significance in overall models.  Abbreviations Body mass index, 
BMI; degrees of freedom, DF; category, cat. 
 
 Normal Weight. Among the 665 cases of normal weight women 562 (84 %) 
were uncensored for vaginal birth, with 103 (15.4%) cases censored for cesarean birth. 
After adjusting for the covariates, there was a statistically significant effect on time to 
birth at step 1 2(2, N = 665), = 39.35, p < .001, and step 2 2(12, N = 665), = 267.50, p < 
.001. Cumulative survival rates for time to birth are displayed in Figure 4.  
Overweight. Among the 2,147 cases of overweight women 1,655 (76.8%) cases 
were uncensored for vaginal birth, with 492 (22.8%) cases censored for cesarean birth. 
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After adjusting for the covariates, there was a statistically significant effect on time to 
birth at step 1 2(2, N = 2,147), = 157.58 p < .001, and step 2 2(12, N = 2,147),  
= 992.21, p < .001. Cumulative survival rates for time to birth are displayed in Figure 5.  
Obese cat 1. Among the 1,676 cases 1,165 in obese cat 1 (69 %) were event cases 
for vaginal birth, with 511 (30.3 %) cases censored for cesarean birth. After adjusting for 
the covariates, there was a non-statistically significant effect on time to birth at step 1 
2(2, N = 1,676), = 58.63, p < .001 at step 2 2(12, n= 1676), 775.56, p < .001.  
Cumulative rates for time to birth for obese cat 1 are displayed in Figure 6.  
Obese cat 2. Among the 880 cases in obese cat 2 559 (62.9%) were uncensored 
because they were able to have a vaginal birth, with 321 (36.1 %) cases censored for 
cesarean birth. After adjusting for the covariates, there was a non-statistically significant 
effect on time to birth step 1 2(2, N = 880), = 39.33, p < .001 at step 2 2(12, N = 880), 
= 486.60, p < .001. Cumulative survival rates for time to birth for obese cat 2 are 
displayed in Figure 7.  
Obese cat 3. Among the 629 cases 357 (56.2%) were uncensored for vaginal 
birth, with 272 (42.8%) cases censored for cesarean birth. After adjusting for the 
covariates, there was a statistically significant effect on time to birth at step 1 2(2,  
N = 629), = 17.74, p < .001, at step 2 2(12, N = 629), = 301.90, p < .001. Cumulative 
survival rates for time to birth for obese cat 3 are displayed in Figure 8.  
These survival analyses were run as side by side by each BMI category. Table 19 
describes the unadjusted hazard ratios on step 1 and the adjusted Hazard ratios on step 2 
for cervical ripening methods used for induction of labor by BMI category. The adjusted 
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hazard ratios include the following covariates age, parity, race, insurance, hospital type, 
birth weight, Pitocin and amniotomy by BMI category. 
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Table 19 
Hazard Ratios for Induction Methods and Covariates by BMI Category 
BMI 
category 
Step 
entered 
Variable in the 
equation 
B SE Wald df 
Hazard 
ratio 
95.0% CI 
LB 
95.0% 
CI UB 
p value 
Normal 
weight 
Step 1 Misoprostol   39.15 2 1.00 - - < .001 
  Other 
prostaglandins 
0.61 0.10 38.43 1 1.84 1.52 2.22 < .001 
  Mechanical 0.27 0.12 5.39 1 1.31 1.04 1.65 .020 
 Step 2 Misoprostol   32.04 2 1.00 - - < .001 
  Other 
prostaglandins 0.24 0.12 4.05 1 1.27 1.01 1.61 .044 
  Mechanical -0.47 0.15 9.45 1 0.63 .47 .84 .002 
  Maternal age -0.05 0.01 26.84 1 0.96 .94 .97 < .001 
  Parity -1.04 0.10 109.16 1 0.35 .29 .43 < .001 
  Race-white   5.36 3 1.00 - - .148 
  Race-non-Hispanic 
black 
-0.44 0.19 5.30 1 0.65 .45 .94 .021 
  Race-Hispanic -0.11 0.14 .60 1 0.90 .69 1.18 .438 
  Race-other 
unknown 
-0.03 0.15 .03 1 0.98 .73 1.30 .860 
  Insurance-Private   40.22 2 1.00 - - < .001 
  Insurance Public -0.52 0.13 15.66 1 0.59 .46 .77 < .001 
  Insurance-other 
unknown 
0.52 0.19 7.66 1 1.67 1.16 2.41 .006 
  University teaching   26.82 2 1.00 - - < .001 
 
(Table 19 Continues) 
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(Table 19 Continued) 
 
BMI 
category 
Step 
entered 
Variable in the 
equation 
B SE Wald df 
Hazard 
ratio 
95.0% CI 
LB 
95.0% 
CI UB 
p value 
  
Community 
teaching 
0.76 0.16 23.29 1 2.14 1.57 2.92 < .001 
  Community non-
teaching 
0.41 0.24 2.79 1 1.50 .93 2.42 .095 
  Pitocin 0.11 0.14 .58 1 1.11 .85 1.47 .446 
  Amniotomy -0.72 0.15 24.18 1 0.49 .37 .65 < .001 
  Birth weight (g) 0.00 0.00 .05 1 1.00 1.00 1.00 .820 
Overweight Step 1 Misoprostol   152.91 2 1.00 - - < .001 
  Other 
prostaglandins 
0.73 0.06 152.61 1 2.07 1.85 2.33 < .001 
  Mechanical 0.45 0.06 47.93 1 1.56 1.38 1.77 < .001 
 Step 2 Misoprostol   134.93 2 1.00 - - <.001 
  Other 
prostaglandins 
0.18 0.07 5.98 1 1.19 1.04 1.38 .014 
  Mechanical -0.63 0.09 47.87 1 0.54 .45 .64 <.001 
  Maternal age -0.03 0.01 32.36 1 0.97 .96 .98 <.001 
  Parity -.1.14 0.06 432.04 2 0.32 .29 .36 <.001 
  Race-white   23.84 3 1.00 - - <.001 
  Race-non-Hispanic 
black 
-0.20 0.10 3.85 1 0.82 .67 1.00 .050 
  Race-Hispanic -0.31 0.08 16.32 1 0.73 .63 .85 <.001 
  Race- other 
unknown 
-0.35 0.10 11.98 1 0.71 .58 .86 .001 
  Insurance-Private   174.86 2 1.00 - - <.001 
 
(Table 19 Continues)  
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BMI 
category 
Step 
entered 
Variable in the 
equation 
B SE Wald df 
Hazard 
ratio 
95.0% CI 
LB 
95.0% 
CI UB 
p value 
  Insurance Public -0.28 0.07 15.50 1 0.75 .65 .867 <.001 
  Insurance-other 
unknown 
1.07 .011 97.25 1 2.90 2.35 3.59 <.001 
  University teaching   185.21 2 1.00 - - <.001 
  Community 
teaching 
1.28 0.10 183.35 1 3.60 2.99 4.33 <.001 
  Community non-
teaching 
1.12 0.14 66.00 1 3.05 2.33 3.99 <.001 
  Pitocin -0.22 0.08 7.61 1 0.80 .68 .94 .006 
  Amniotomy -0.47 0.09 29.56 1 0.63 .53 .74 <.001 
  Birth weight (g) 0.00 0.00 .53 1 1.00 1.00 1.00 .469 
Obese Cat 1 Step 1 Misoprostol   56.21 2 1.00 - - < .001 
  Other 
prostaglandins 
0.46 0.07 43.27 1 1.59 1.39 1.83 < .001 
  Mechanical 0.47 0.07 40.00 1 1.60 1.38 1.84 < .001 
 Step 2 Misoprostol   48.93 2 1.00 - - < .001 
  Other 
prostaglandins 
0.08 0.09 .82 1 1.08 0.91 1.29 .365 
  Mechanical -0.48 0.11 21.70 1 0.61 0.49 0.75 < .001 
  Maternal age -0.02 0.01 17.19 1 0.98 0.97 0.99 < .001 
  Parity -1.19 0.07 341.64 1 0.30 0.27 0.34 < .001 
  Race-white   12.46 3 1.00 - - .006 
 
(Table 19 Continues) 
 
  
102 
 
(Table 19 Continued) 
 
BMI 
category 
Step 
entered 
Variable in the 
equation 
B SE Wald df 
Hazard 
ratio 
95.0% CI 
LB 
95.0% 
CI UB 
p value 
  
Race-non-Hispanic 
black 
-0.35 0.11 10.40 1 0.70 0.57 0.87 .001 
  Race-Hispanic -0.19 0.09 4.78 1 0.83 0.70 0.98 .029 
  Race- other 
unknown 
-0.20 0.11 2.97 1 0.82 0.66 1.03 .085 
  Insurance-private   137.89 2 1.00 - - < .001 
  Insurance public -0.37 0.08 19.47 1 0.69 0.59 0.82 < .001 
  Insurance-other 
unknown 
1.06 0.13 71.88 1 2.89 2.27 3.70 < .001 
  University teaching   127.84 2 1.00 - - < .001 
  Community 
teaching 
1.29 0.12 126.93 1 3.65 2.91 4.57 < .001 
  Community non-
teaching 
1.32 0.16 71.99 1 3.75 2.76 5.09 < .001 
  Pitocin -0.01 0.09 .02 1 0.99 0.83 1.18 .900 
  Amniotomy -0.50 0.10 25.31 1 0.61 0.50 0.74 < .001 
  Birth weight (g) 0.00 0.00 .02 1 1.00 1.00 1.00 .902 
Obese Cat 2 Step 1 Misoprostol   39.16 2 1.00 - - < .001 
  Other 
prostaglandins 
0.64 0.10 39.10 1 1.90 1.55 2.32 < .001 
  Mechanical 0.35 0.11 11.13 1 1.42 1.16 1.75 .001 
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(Table 19 Continued) 
 
BMI 
category 
Step 
entered 
Variable in the 
equation 
B SE Wald df 
Hazard 
ratio 
95.0% CI 
LB 
95.0% 
CI UB 
p value 
 Step 2 Misoprostol   50.33 2 1.00 - - < .001 
  Other 
prostaglandins 
0.50 0.13 14.95 1 1.64 1.28 2.11 < .001 
  Mechanical -0.33 0.15 4.72 1 0.72 0.54 0.97 .030 
  Maternal age -0.03 0.01 10.90 1 0.97 0.96 0.99 .001 
  Parity -1.57 0.10 249.41 1 0.21 0.17 0.25 < .001 
  Race-white   11.98 3 1.00 - - .007 
  Race-non-Hispanic 
black 
-0.23 0.15 2.19 1 0.80 0.59 1.08 .139 
  Race-Hispanic -0.46 0.13 11.89 1 0.63 0.49 0.82 .001 
  Race- other 
unknown 
-0.17 0.19 .85 1 0.84 0.59 1.21 .356 
  Insurance-private   105.72 2 1.00 - - < .001 
  Insurance public -0.08 0.12 .42 1 0.93 0.73 1.17 .520 
  Insurance-other 
unknown 
1.64 0.19 75.92 1 5.14 3.55 7.42 < .001 
  University teaching   111.50 2 1.00 - - < .001 
  Community 
teaching 
1.55 0.15 107.35 1 4.69 3.50 6.29 < .001 
  Community non-
teaching 
1.17 0.22 29.32 1 3.21 2.10 4.89 < .001 
  Pitocin 0.08 0.13 .41 1 1.09 0.85 1.39 .520 
  Amniotomy -0.57 0.14 17.61 1 0.57 0.44 0.74 < .001 
  Birth weight (g) 0.00 0.00 4.15 1 1.00 1.00 1.00 .042 
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(Table 19 Continued) 
 
BMI 
category 
Step 
entered 
Variable in the 
equation 
B SE Wald df 
Hazard 
ratio 
95.0% CI 
LB 
95.0% 
CI UB 
p value 
Obese Cat 3 Step 1 Misoprostol   17.53 2 1.00 - - .000 
  Other 
prostaglandins 
0.31 0.13 5.72 1 1.37 1.06 1.77 .017 
  Mechanical 0.55 0.13 17.40 1 1.73 1.34 2.24 < .001 
 Step 2 Misoprostol   18.52 2 1.00 - - < .001 
  Other 
prostaglandins 
0.48 0.15 10.20 1 1.62 1.20 2.17 .001 
  Mechanical -0.09 0.17 .28 1 0.91 0.65 1.28 .600 
  Maternal age -0.04 0.01 12.66 1 0.97 0.95 0.98 < .001 
  Other 
prostaglandins 
0.50 0.13 14.95 1 1.64 1.28 2.11 <.001 
  Mechanical -0.33 0.15 4.72 1 0.72 0.54 0.97 0.030 
  Maternal age -0.03 0.01 10.90 1 0.97 0.96 0.99 .001 
  Parity -1.57 .10 249.41 1 0.21 0.17 0.25 <.001 
  Race-white   11.98 3 1.00 - - .007 
  Race-non-Hispanic 
black 
-0.23 0.15 2.19 1 0.80 0.59 1.08 .139 
  Race-Hispanic -0.46 0.13 11.89 1 0.63 0.49 0.82 .001 
  Race-other 
unknown 
-0.17 0.19 .85 1 .84 0.59 1.21 .356 
  Insurance-private   105.72 2 1.00 - - <.001 
  Insurance public -0.08 0.12 .42 1 0.93 0.73 1.17 .520 
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(Table 19 Continued) 
 
BMI 
category 
Step 
entered 
Variable in the 
equation 
B SE Wald df 
Hazard 
ratio 
95.0% CI 
LB 
95.0% 
CI UB 
p value 
  Insurance-other 
unknown 
1.64 0.19 75.92 1 5.14 3.55 7.42 <.001 
  University teaching   111.50 2 1.00 - - <.001 
  Community 
teaching 
1.55 0.15 107.35 1 4.69 3.50 6.29 <.001 
  Community non-
teaching 
1.17 0.22 29.32 1 3.21 2.10 4.89 <.001 
  Pitocin 0.08 0.13 .41 1 1.09 0.85 1.39 .520 
  Amniotomy -0.57 0.14 17.61 1 0.57 0.44 0.74 <.001 
  Birth weight (g) 0.00 0.00 4.15 1 1.00 1.00 1.00 .042 
Obese Cat 3 Step 1 Misoprostol   17.53 2 1.00 - - .000 
  Other prostaglandin 0.31 0.13 5.72 1 1.37 1.06 1.77 .017 
  Mechanical 0.55 0.13 17.40 1 1.73 1.34 2.24 <.001 
 Step 2 Misoprostol   18.52 2 1.00 - - <.001 
  Other prostaglandin 0.48 0.15 10.20 1 1.62 1.20 2.17 .001 
  Mechanical -0.09 0.17 .28 1 0.91 0.65 1.28 .600 
  Maternal age -0.04 0.01 12.66 1 0.97 0.95 0.98 <.001 
Notes Referent categories: Misoprostol, Non-Hispanic white, Private insurance, University teaching hospital. Abbreviations. 
BMI, body mass index; CI, confidence interval; LB, lower bound; UB, upper bound; cat, category 
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Figures for cumulative survival rates. These figures represent the time from 
hospital admission to birth (in minutes) for each BMI category. Cumulative survival rates 
for time to birth for cases in the normal weight category are displayed in Figure 7. 
Cumulative survival rates for time to birth for cases in the overweight category are 
displayed in Figure 8. Cumulative survival rates for time to birth with cases in the obese 
cat 1 category are displayed in Figure 9. Cumulative survival rates for time to birth with 
cases in the obese cat 2 category are displayed in Figure 10. Cumulative survival rates for 
time to birth with cases in the obese cat 3 category are displayed in Figure 11.  
 
Figure 7. Cumulative Survival Rates for Time to Birth for Normal Weight Women  
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Figure 8. Cumulative Survival Rates for Time to Birth for Overweight Women 
 
 
Figure 9. Cumulative Survival Rates for Time to Birth for Obese Category 1 Women 
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Figure 10. Cumulative Survival Rates for Time to Birth for Obese Category 2 Women  
 
 
Figure 11. Cumulative Survival Rates for Time to Birth for Obese Category 3 Women  
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A2H1 Analysis. Women induced with misoprostol will have a shorter time to 
birth as compared to women induced using Other prostaglandins, and this time 
differential will be more pronounced with each successive BMI category.  
To test this hypothesis the use of misoprostol (referent group) was compared to 
the use of other prostaglandins as a single method for induction of labor requiring 
cervical ripening.  The adjusted hazard ratios for the use of other prostaglandins were 
stratified by BMI category finding normal weight, (aHR 1.27 [CI 1.001 - 1.61], p = .044); 
overweight, (aHR 1.19, [CI 1.04 – 1.38], p = 0.014); obese cat 1, (aHR 1.08, [CI .91 – 
1.29], p = .365); obese cat 2, (aHR 1.64, [CI 1.28 – 2.11], p < .001); and obese cat 3 
(aHR 1.62, [CI 1.20 – 2.17], p = .001). Obese cat 2 and 3 had statistically significant 
relationships with time from hospital admission to birth after using other prostaglandins 
for labor induction requiring cervical ripening by BMI category when compared to using 
misoprostol. The time from hospital admission to birth was shorter in each BMI category 
for women using misoprostol as compared to the use of other prostaglandins. However, 
the difference in Hazard ratios was not successively greater by each increase in BMI 
category.  
A2H2 Analysis. The time to birth will be shorter with the use mechanical 
methods than the use of either prostaglandin (misoprostol or other prostaglandins). The 
difference will be more pronounced by each increase in BMI category. 
 To test hypothesis two the use of mechanical means was compared to the use of 
other prostaglandins. Misoprostol was the referent group in this analysis, so the use of 
misoprostol is equal to one. For normal weight women the time from hospital admission 
to birth was shorter with the use of mechanical means (aHR 0.62, [CI .47-.84], p = .002) 
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than with the use of prostaglandins (aHR 1.27, [CI 1.00-1.61] p = .044).  For overweight 
women the use of mechanical means (aHR 0.53, [CI .44 -.64] p < .001) as compared to 
the use of prostaglandins (aHR 1.19, [CI 1.04 – 1.38], p = .014). For women with obese 
cat 1, the time from hospital admission to birth was shorter with the use of mechanical 
means (aHR 0.61, [CI .49-.75], p <.001) than with the use of prostaglandins (aHR 1.08, 
[CI .91 – 1.29], p = .365).  For women with obese cat 2 the time to birth was shorter with 
the use of mechanical means (aHR 0.72, [CI .54 – .97], p = .030) than with the use of 
prostaglandins (aHR 1.64, [CI 1.28 – 2.11], p < .001). For women with obesity cat 3 the 
time to birth was shorter with the use of mechanical means (aHR 0.91, [CI .65-1.28] p = 
.600) than than with the use of prostaglandins (aHR 1.62, [CI 1.20 – 2.17], p = .001). 
Relationships in the adjusted model show the use of mechanical means for 
induction of labor requiring cervical ripening have a shorter time from hospital admission 
to birth than the use of either prostaglandin (misoprostol or other prostaglandins). The 
results of this study were statistically significant within all groups except for the use other 
prostaglandins in obese cat 1 and use of mechanical means in obese cat 3 women. Table 
20 summarizes the adjusted hazard ratios for the time from hospital admission to birth in 
women requiring cervical ripening (misoprostol, other prostaglandins, or mechanical 
means) as part of labor induction.  
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Table 20  
Unadjusted and Adjusted Hazard Ratios for the time from Hospital Admission to Birth in Women requiring Cervical Ripening as part 
of Labor Induction 
BMI 
Category 
Cervical Ripening 
Method HR 
95.0% CI 
LB 
95.0% CI 
UB 
P value aHR 
95.0% 
CI LB 
95.0% 
CI UB 
P value 
Normal 
weight 
Misoprostol 1.00   < .001 1.00   < .001 
 Other prostaglandins 1.84 1.52 2.22 < .001 1.27 1.01 1.61 .044 
 Mechanical  1.31 1.04 1.65 .283 0.63 0.47 0.84 .002 
Overweight Misoprostol 1.00   < .001 1.00   < .001 
 Other prostaglandins 2.07 1.85 2.33 < .001 1.19 1.04 1.38 .014 
 Mechanical  1.56 1.38 1.77 < .001 0.54 0.45 0.64 < .001 
Obese Cat 1 Misoprostol 1.00   < .001 1.00   < .001 
 Other prostaglandins 1.59 1.39 1.83 < .001 1.08 0.91 1.29 .365 
 Mechanical  1.60 1.38 1.84 < .001 0.61 0.49 0.75 < .001 
Obese Cat 2 Misoprostol 1.00   < .001 1.00   < .001 
 Other prostaglandins 1.90 1.55 2.32 < .001 1.64 1.28 2.11 < .001 
 Mechanical  1.42 1.16 1.75 .001 0.72 0.54 0.97 .030 
Obese Cat 3 Misoprostol 1.00   .000 1.00   < .001 
 Other prostaglandins 1.37 1.06 1.77 .017 1.62 1.20 2.17 .001 
 Mechanical  1.73 1.34 2.24 < .001 0.91 0.65 1.28 .600 
Notes. General table notes. Misoprostol used a referent group. Adjusted for age, parity, insurance, race, hospital type, birthweight, 
Pitocin and amniotomy. 
Abbreviations. BMI, body mass index; HR hazard ratio; aHR, adjusted hazard ratio; CI, confidence interval; LB, lower bound; UB, 
upper bound; cat, category 
P value .05 for significance 
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Predictors. Predictor variables included in the model were maternal age, parity, 
race, insurance type, hospital type, birth weight, Pitocin use and amniotomy. Maternal 
age and parity had statically significant relationships with the time from hospital 
admission to birth in all BMI categories. Race had somewhat mixed results as a predictor 
for time to birth, with a statistically significant relationship among all variable categories 
noted only for the overweight category. Insurance type was statistically significant for all 
BMI categories with the exceptions of obese cat 1 and obese cat 3. Hospital type was 
statistically significant predictor among all BMI categories except normal weight women. 
Birth weight was not a statistically significant predictor for time to birth, except for in the 
overweight category. Pitocin was statistically significant for overweight weight, and 
obese category 3 women, but not for other groups.  Amniotomy was a statistically 
significant predictor of time to birth in all BMI categories. Age, parity, and amniotomy 
were statistically significant predictors across all BMI categories within the models.   
Aim 2 Summary  
The analysis of Aim 2 included two hypothesis found statistically significant 
associations between the time from hospital admission to the time to birth in minutes and 
BMI category. Bivariate analysis revealed a longer time to birth in minutes with each 
successive BMI category. Hypothesis testing for A2H1 compared the use of misoprostol 
to the use of other prostaglandins for cervical ripening finding a longer time from hospital 
admission to birth after using other prostaglandins for labor induction requiring cervical 
ripening in each BMI category when compared to using misoprostol.  This relationship 
remained statically significant in all categories for the use of misoprostol however the 
relationship was not statistically significant for the use of other prostaglandins. 
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Hypothesis testing A2H2 compared the use of prostaglandins with the use of mechanical 
means for cervical ripening finding the relationships in the adjusted model show the use 
of mechanical means alone or mechanical means with misoprostol for induction of labor 
requiring cervical ripening have a shorter time from hospital admission to birth than the 
use of either prostaglandin (misoprostol, or other prostaglandin). The results of this study 
found a statistically significant relationship for all cervical ripening methods except other 
prostaglandins. Predictors with the models that remained statistically significant across 
all BMI categories were maternal age, parity, insurance status, hospital type, and the use 
of amniotomy. 
Aim Three 
Aim 3 states “Cesarean birth: Examine the risk of cesarean birth after labor 
induction involving cervical ripening among women by BMI category.”  
Hypotheses-Aim 3. Aim three has three hypotheses; listed below.  
A3H1: Compared to women with normal range BMI, the odds of cesarean birth 
following labor induction requiring cervical ripening will be higher with each increase in 
body mass index category.  
A3H2. The odds of cesarean birth in women induced with misoprostol will be lower 
compared to the odds in similar women induced using other prostaglandins.  
A3H3. Women with obesity (in any obesity category) who are induced using 
mechanical means will have lower odds of cesarean birth than women with obesity (in 
any obesity category) induced with prostaglandins (misoprostol or other prostaglandins) 
when compared to normal weight women.  
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Bivariate analysis. Bivariate analysis was conducted by using the crosstabs function 
is SPSS. The results of the chi squared test showed a significant association between type 
of birth and BMI category. The selected sample had a overall cesarean birth rate of 
28.4%. Table 21 summarizes the bivariate analysis (crosstabs) of Type of Birth by BMI 
and the variable Induct_method_Cervical by BMI Category.  
Table 21 
Bivariate Analysis of type of Birth by BMI Category for needing Cervical Ripening for 
Labor Induction n = 6,035  
Variable 
Vaginal birth 
4,321 (71.6) 
Cesarean birth 
1,714 (28.4) 
Total 
6,035 
P value 
Cervical ripening method    < .001 
  Miso 1,346 (61.1) 857 (38.9) 2,203  
  PGE2 1,664 (79.2) 436 (20.8) 2,100  
  Mechanical + Miso 759 (83.6) 149 (16.4) 908  
  Mechanical 365 (72.4) 139 (27.6) 504  
  Mechanical+PGE2 105 (60.7) 68 (39.3) 173  
  Miso+PGE2 60 (53.1) 53 (46.9) 113  
  Mechanical+PGE2+Miso 22 (64.7) 12 (35.3) 34  
BMI category    < .001 
  Normal weight 566 (84.6) 103 (15.4) 669  
  Overweight 1,661 (77.1) 493 (22.9) 2,154  
  Obese Cat 1 1,171 (69.4) 517 (30.6) 1,688  
  Obese Cat 2  562 (63.2) 327 (36.6) 889  
  Obese Cat 3 361 (56.9) 274 (43.1) 635  
Notes. Chi squared for significance. Abbreviations. Miso, Misoprostol; PGE2, 
prostaglandin analogue 2; cat, category 
 
A3H1: Compared to women with normal range BMI, the odds of cesarean birth 
following labor induction requiring cervical ripening will be higher with each increase in 
body mass index category.  
Multivariate Analysis A3H1.   
Unadjusted model. A standard binary logistic regression was used to model the binary 
variable type of birth (using 0 ‘vaginal’ as the reference category). The predictor variable 
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in this study was the variable BMI at time of hospital admission. Based on classification 
threshold predictive probability of having used cervical ripening as 0.5, results of the 
logistic regression analysis indicate the single categorical predictor of BMI within the 
model provided a statistically significant prediction of the use of cervical ripening (χ2 (4, 
N = 6,035) = 192.33, p < .001). The Nagelkerke pseudo R2 indicated the model 
accounted for approximately 4.5 % of the total variance. Classification accuracy for all 
the cases was based on a classification cut off value of 0.50 for predicting vaginal birth 
by BMI category was moderately high, with an overall correct prediction rate of 71.6%, 
and correct prediction rates of 100 % in women having a vaginal birth and 0% in women 
having a cesarean birth. Table 22 summarizes the logistic regression model by displaying 
the unadjusted odds of having a cesarean birth after labor induction requiring cervical 
ripening with misoprostol, PGE2 or mechanical means by BMI category.  
Table 22 
Unadjusted Odds of having a Cesarean Birth after Labor Induction requiring Cervical 
Ripening with Misoprostol, PGE2 or Mechanical Means by BMI Category  
Variables in the 
Equation 
B S.E. Wald df OR 
95% 
C.I. 
LB 
95% 
C.I. 
UB 
P 
value 
Normal weight   183.55 4 1.00   < .001 
Overweight 0.49 0.12 16.97 1 1.63 1.29 2.06 < .001 
Obese Cat 1 0.89 0.12 55.07 1 2.43 1.92 3.06 < .001 
Obese Cat 2  1.16 0.13 82.82 1 3.20 2.49 4.10 < .001 
Obese Cat 3 1.43 0.13 183.55 4 4.17 3.20 5.42 < .001 
Notes. Normal weight used as reference group. Abbreviations. OR odds ratio; CI, 
Confidence interval; LB, lower bound; UB Upper bound; cat, category.   
 
Adjusted model. A standard binary logistic regression was used to model the 
binary variable type of birth (using 0 ‘vaginal birth’ as the reference category). The 
predictor variables in this study were BMI at time of hospital admission, maternal age, 
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parity, insurance status, race, hospital type, birth weight, Pitocin and amniotomy. Based 
on classification threshold predictive probability of having used cervical ripening as 0.5, 
results of the logistic regression analysis indicate the seven categorical variables and two 
continuous variables as predictors within the model provided a statistically significant 
prediction of type of birth (χ2 (16, N = 6,035) = 2257.49, p < .001). The Nagelkerke 
pseudo R2 indicated the model accounted for approximately 44.9 % of the total variance. 
Classification accuracy for all the cases was based on a classification cut off value of 0.50 
for predicting the type of birth was moderately high, with an overall correct prediction 
rate of 81.8%, and correct prediction rates of 92.2% in women having a vaginal birth and 
55.5% of women having a cesarean birth. BMI at time of hospital admission, maternal 
age, parity, insurance types (private, public and unknown), maternal race, and hospital 
type all remained statistically significant predictors within the model. Table 23 
summarizes the logistic regression model by displaying the adjusted odds ratio for 
cesarean birth following induction of labor
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Table 23  
Adjusted Odds Ratio for Cesarean Birth following Induction of Labor 
Variables in the 
Equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% 
C.I 
UB 
P 
value 
Normal weight   131.81 4 1.00   < .001 
Overweight 0.54 0.14 14.65 1 1.72 1.30 2.27 < .001 
Obese Cat 1 0.99 0.15 46.52 1 2.68 2.02 3.56 < .001 
Obese Cat 2  1.29 0.16 68.42 1 3.62 2.60 4.92 < .001 
Obese Cat 3 1.50 0.16 83.00 1 4.47 3.24 6.17 < .001 
Maternal age 0.09 0.01 171.27 1 1.09 1.08 1.11 < .001 
Parity 2.40 0.10 568.85 1 11.04 9.06 13.447 < .001 
White-non-
Hispanic  
  25.56 3    < .001 
Black non-
Hispanic 
0.29 0.12 5.82 1 1.33 1.06 1.68 .016 
Hispanic 0.44 0.11 17.91 1 1.56 1.27 1.91 < .001 
Race-
other/unknown 
0.45 0.13 12.80 1 1.57 1.23 2.00 < .001 
Private insurance   602.54 2 1.00   < .001 
Public insurance 0.66 0.09 48.89 1 1.93 1.60 2.32 < .001 
Other insurance -2.56 0.14 357.63 1 0.08 0.06 0.11 < .001 
University 
teaching  
  241.54 2 1.00   < .001 
Community 
teaching 
-1.67 0.11 238.58 1 0.19 0.15 0.23 < .001 
Community non-
teaching 
-1.17 0.15 58.37 1 0.31 0.23 0.42 < .001 
Pitocin 0.48 0.10 21.34 1 1.61 1.32 1.98 < .001 
Amniotomy  -0.08 0.11 0.54 1 0.92 0.75 1.14 .462 
Birth weight (g) 0.00 0.00 17.59 1 1.00 1.00 1.00 < .001 
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, 
University teaching hospital. Abbreviations. aOR, adjusted odds ratio; CI, Confidence 
interval; LB, lower bound; UB Upper bound; cat, category.   
 
A3H1 summary. As compared to women with normal range BMI, the odds of 
cesarean birth following labor induction involving cervical ripening will be higher with 
each increase in body mass index category was supported with this analysis.  
Hypothesis A3H1 was tested using a binary logistic regression analysis of the type of 
birth and BMI at time of hospital admission. The findings showed increased odds of 
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having a cesarean birth which increased with each successive increase in BMI category 
for women requiring cervical ripening for induction of labor. After adjusting for maternal 
age, parity insurance, race, hospital type, birth weight, Pitocin and amniotomy, all 
relationships remained statistically significant except the use of amniotomy. This 
hypothesis is was supported.  
A3H2 and A3H3 Analysis  
A3H2. The odds of cesarean birth in women induced with misoprostol will be lower 
compared to the odds in similar women induced using Other prostaglandins.  
Hypothesis. Women with obesity (in any obesity category) who are induced using 
mechanical means will have lower odds of cesarean birth than women with obesity (in 
any obesity category) induced with prostaglandins (misoprostol or other prostaglandins) 
when compared to normal weight women.   
Bivariate analysis. Bivariate analysis showing cross tabs with chi-square for 
significance for BMI category and method of cervical ripening used for induction 
misoprostol, other prostaglandins, mechanical, or mechanical with any prostaglandin 
(miso, other prostaglandin or both). A new variable was created from the previous 
induction method for cervical ripening with the collapsed categories. The misoprostol 
category has cases of misoprostol alone as well as cases who used both miso and other 
prostaglandins together (n = 113). The other prostaglandin category has cases where 
other prostaglandins were used alone.  The mechanical category has cases when 
mechanical means were used alone or in combination with misoprostol, other 
prostaglandins or both.  Table 24 summarizes the bivariate analysis using the cross tabs 
function for type of birth and method used for cervical ripening. 
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Table 24 
Bivariate Analysis using Crosstabs for BMI Category and Cervical Ripening Method 
used for Induction of Labor 
Induction Method Cervical Ripening 
Collapsed Categories 
Vaginal Birth 
Cesarean 
Birth 
Total 
P 
value 
Misoprostol  1,406 (60.7) 910 (39.3) 2,316  
Other prostaglandins 1,664 (79.2) 436 (20.8) 2,100  
Mechanical 1.251 (77.3) 368 (22.7) 1,619  
Total 4,321 (71.6) 1,714 (28.4) 6,035 < .001 
Notes. Using chi-square test for significance. 0.05 used for significance.  
Multivariate Analysis  
Unadjusted binary logistic regression. A standard binary logistic regression was used 
to model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of 
treatment groups where women were induced with misoprostol, other prostaglandins or 
mechanical means were run in a side by side fashion.  The single predictor variable in 
these unadjusted studies was BMI at time of hospital admission. Based on classification 
threshold predictive probability of having a cesarean birth as 0.5, results of the logistic 
regression analyses are reported for each treatment group.   
Misoprostol. With the use of misoprostol, the single variable model provided a 
statistically significant prediction of type of birth (χ2 (4, N = 2,316) = 61.65, p < .001). 
The Nagelkerke pseudo R2 indicated the model accounted for approximately 5.5% of the 
total variance. Classification accuracy for all the cases was based on a classification cut 
off value of 0.50 for predicting the type of birth was moderately high, with an overall 
correct prediction rate of 61.0%, and correct prediction rates of 91.6% in women having a 
vaginal birth and 13.6% of women having a cesarean birth. 
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Other prostaglandins. With the use of other prostaglandins, the single variable 
model provided a statistically significant prediction of the type of birth (χ2 (4, N = 2,100) 
= 81.96, p < .001). The Nagelkerke pseudo R2 indicated the model accounted for 
approximately 6.0% of the total variance. Classification accuracy for all the cases was 
based on a classification cut off value of 0.5 for predicting the type of birth was 
moderately high, with an overall correct prediction rate of 79.2%, and correct prediction 
rates of 100% in women having a vaginal birth and 0% of women having a cesarean 
birth. 
Mechanical means. With the use of mechanical means, the single variable model 
provided a statistically significant prediction of the type of birth (χ2 (4, N = 1,619)  
= 60.34 p < .001). The Nagelkerke pseudo R2 indicated the model accounted for 
approximately 5.5% of the total variance. Classification accuracy for all the cases was 
based on a classification cut off value of 0.5 for predicting the type of birth was 
moderately high, with an overall correct prediction rate of 77.3%, and correct prediction 
rates of 100% in women having a vaginal birth and 0% of women having a cesarean 
birth.  
The three regression models arre summarized together. Table 25 summarizes the 
unadjusted binary logistic regression models for cesarean birth after using cervical 
ripening methods for induction of labor with results stratified by BMI category.
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Table 25 
Unadjusted Logistic Regression for Cesarean Birth following the use of Cervical 
Ripening for Induction of Labor 
Cervical 
ripening 
method 
Variables in 
the equation 
B S.E. Wald df 
Odds 
ratio 
95% 
C.I. 
LB 
95% 
C.I. 
UB 
P value 
Miso Normal weight   58.68 4 1.00   < .001 
 Overweight 0.54 0.17 10.31 1 1.72 1.24 2.40 < .001 
 Obese Cat 1 0.80 0.17 21.90 1 2.22 1.59 3.10 < .001 
 Obese Cat 2  1.12 0.18 37.12 1 3.07 2.14 4.41 < .001 
 Obese Cat 3 1.22 0.20 37.76 1 3.39 2.30 5.01 < .001 
PGE2 Normal weight   77.17 4 1.00   < .001 
 Overweight 0.70 0.23 9.19 1 2.01 1.28 3.15 .002 
 Obese Cat 1 1.21 0.23 27.30 1 3.35 2.13 5.28 < .001 
 Obese Cat 2  1.14 0.26 19.60 1 3.11 1.88 5.14 < .001 
 Obese Cat 3 1.91 0.25 56.07 1 6.72 4.08 11.06 < .001 
Mech Normal weight   58.78 4 1.00   < .001 
 Overweight 0.09 0.26 0.12 1 1.10 0.65 1.84 .727 
 Obese Cat 1 0.58 0.26 4.95 1 1.79 1.07 2.98 .026 
 Obese Cat 2  1.11 0.27 17.01 1 3.03 1.79 5.13 < .001 
 Obese Cat 3 1.25 0.28 20.12 1 3.50 2.02 6.04 < .001 
Notes. Normal weight used as referent category.  
Abbreviations: df, degrees of freedom. CI confidence interval. LB, Lower bound. UB, 
upper bound. Cat, category. Miso, Misoprostol (used alone or with PGE2). PGE2 
prostaglandin analogue 2 (used alone), mech, mechanical means used alone or with either 
prostaglandins.  
Significance 0.05  
 
Adjusted binary logistic regression. A standard binary logistic regression was used to 
model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of 
treatment groups where women were induced with misoprostol, other prostaglandins, 
mechanical, or mechanical with prostaglandins were run as side by side models.  The 
predictor variable in these studies were BMI at time of hospital admission, maternal age, 
parity, race, insurance, hospital type, birthweight, Pitocin and amniotomy. Based on 
classification threshold predictive probability of having a cesarean birth as 0.5, results of 
the nine variable logistic regression analysis are given below.  
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Misoprostol. With the use of misoprostol, the nine variable model provided a 
statistically significant prediction of the type of birth (χ2 (15, N = 2,305) = 1431.34, p < 
.001). The Nagelkerke pseudo R2 indicated the model accounted for approximately 
64.5% of the total variance. Classification accuracy for all the cases was based on a 
classification cut off value of 0.5 for predicting the type of birth was moderately high, 
with an overall correct prediction rate of 85.8%, and correct prediction rates of 90.1% in 
women having a vaginal birth and 79.1% of women having a cesarean birth. 
Other prostaglandins. With the use of other prostaglandins, the nine variable model 
provided a statistically significant prediction of the type of birth (χ15 (4, N = 2,090) = 
556.50, p < .001). The Nagelkerke pseudo R2 indicated the model accounted for 
approximately 41.1% of the total variance. Classification accuracy for all the cases was 
based on a classification cut off value of 0.5 for predicting the type of birth was 
moderately high, with an overall correct prediction rate of 84%, and correct prediction 
rates of 94.6% in women having a vaginal birth and 43.4% of women having a cesarean 
birth. 
Mechanical means. With the use of mechanical means, the nine variable model 
provided a statistically significant prediction of the type of birth after being induced with 
PGE2 (χ2 (15 N = 503) = 102.688, p < .001). The Nagelkerke pseudo R2 indicated the 
model accounted for approximately 32.7% of the total variance. Classification accuracy 
for all the cases was based on a classification cut off value of 0.5 for predicting the type 
of birth was moderately high, with an overall correct prediction rate of 75.7%, and 
correct prediction rates of 90.4% in women having a vaginal birth and 37.4% of women 
having a cesarean birth.  
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The three logistic regression models for cervical ripening with predictors follow.  
Table 26 summarizes the adjusted the odds ratios for cesarean birth after using cervical 
ripening method misoprostol for induction of labor. Table 27 summarizes the adjusted the 
odds ratios for cesarean birth after using cervical ripening method other prostaglandins 
for induction of labor. Table 28 summarizes the adjusted the odds ratios for cesarean 
birth after using cervical ripening method mechanical methods alone or in combination 
with prostaglandins (misoprostol and/ or other prostaglandin) for induction of labor. All 
models include BMI, age, parity, race, insurance, hospital type, birth weight, Pitocin and 
amniotomy as predictors.  
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Table 26 
Adjusted Odds Ratios for Cesarean Birth following the use of Misoprostol for Cervical Ripening for Induction of Labor 
Variables in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Normal weight    35.89 4 1.00   < .001 
Overweight 0.45 0.24 3.58 1 1.57 0.98 2.51 .059 
Obese Cat 1 0.79 0.25 10.16 1 2.19 1.35 3.56 .001 
Obese Cat 2  1.29 0.27 22.94 1 3.62 2.14 6.12 < .001 
Obese Cat 3 1.24 0.29 18.15 1 3.44 1.95 6.07 < .001 
Maternal age 0.09 0.01 56.90 1 1.09 1.07 1.11 < .001 
Parity  2.27 0.17 178.68 1 9.71 6.96 13.55 < .001 
White non-
Hispanic white 
  5.47 3 1.00   .141 
Black non-
Hispanic  
0.34 0.2 2.76 1 1.40 0.94 2.08 .097 
Hispanic 0.36 0.18 4.18 1 1.43 1.02 2.02 .041 
Race-
other/unknown 0.36 0.23 2.53 1 1.43 0.92 2.23 .112 
Private 
insurance 
  599.82 2 1.00   < .001 
Public insurance 1.45 0.18 63.44 1 4.24 2.97 6.05 < .001 
Other insurance -3.08 0.20 250.21 1 0.05 0.03 0.07 < .001 
White non-
Hispanic white 
  5.47 3 1.00   .141 
Black non-
Hispanic  
0.34 0.2 2.76 1 1.40 0.94 2.08 .097 
 
(Table 26 Continues) 
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(Table 26 Continued) 
Variables in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Hispanic 0.36 0.18 4.18 1 1.43 1.02 2.02 .041 
Race-
other/unknown 
0.36 0.23 2.53 1 1.43 0.92 2.23 .112 
Private 
insurance 
  599.82 2 1.00   < .001 
Public insurance 1.45 0.18 63.44 1 4.24 2.97 6.05 < .001 
Other insurance -3.08 0.20 250.21 1 0.05 0.03 0.07 < .001 
University 
teaching  
  76.25 2 1.00   < .001 
Community 
teaching 
-1.75 0.20 73.52 1 0.17 0.12 0.26 < .001 
Community non-
teaching 
-1.46 0.29 25.96 1 0.23 0.13 0.41 < .001 
Birth weight  0.00 0.00 5.92 1 1.00 1.00 1.00 .015 
Pitocin 0.74 0.20 13.97 1 2.10 1.42 3.00 < .001 
Amniotomy  0.14 0.22 0.44 1 1.15 0.76 1.76 .509 
Table notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital.  
Abbreviations. aOR, adjusted odds ratio; CI, Confidence interval; LB, Lower Bound; UB Upper Bound; cat, category.   
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Table 27 
Adjusted Odds Ratios for Cesarean Birth Following the use of Other Prostaglandins (PGE2) for Cervical Ripening for 
Induction of Labor 
Variables in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Normal weight    55.82 4    < .001 
Overweight 0.84 0.25 11.15 1 2.32 1.42 3.79 .001 
Obese Cat 1 1.35 0.26 27.23 1 3.84 2.32 6.37 < .001 
Obese Cat 2  1.32 0.29 20.74 1 3.74 2.12 6.60 < .001 
Obese Cat 3 1.95 0.29 44.96 1 7.03 3.98 12.43 < .001 
Maternal age 0.08 0.01 41.51 1 1.08 1.06 1.11 < .001 
Parity  2.49 0.18 188.65 1 12.06 8.45 17.21 < .001 
Race-non-
Hispanic white 
  6.22 3 1.00   .101 
Race-non-
Hispanic black 
0.26 0.21 1.56 1 1.30 0.86 1.94 .212 
Race-Hispanic -0.13 0.23 0.32 1 0.88 0.56 1.38 .574 
Race-
other/unknown 
0.46 0.23 4.07 1 1.58 1.01 2.46 .044 
Private 
insurance 
  10.26 2 1.00   .006 
Public insurance 0.07 0.16 0.17 1 1.07 0.78 1.46 .681 
Other insurance -0.78 0.26 9.11 1 0.46 0.28 0.76 .003 
University 
teaching    
64.50 2 1.00   < .001 
 
(Table 27 Continued) 
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(Table 27 Continues) 
 
Variables in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Community 
teaching 
-1.33 0.17 64.48 1 0.27 0.19 0.37 < .001 
Community non-
teaching 
-0.74 0.37 4.03 1 0.48 0.23 0.98 .045 
Birth weight    3.28 1 1.00 1.00 1.00 .070 
Pitocin 0.18 0.22 0.66 1 1.20 0.78 1.85 .416 
Amniotomy  -0.18 0.23 0.62 1 0.84 0.54 1.31 .432 
Table notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital.  
Abbreviations. aOR, adjusted odds ratio; CI, Confidence interval; LB, Lower Bound; UB Upper Bound; cat, category. 
 
 Table 28 
Adjusted Odds Ratios for Cesarean Birth Following the Use of Mechanical Means for Cervical Ripening for Induction of 
Labor 
Variables in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Normal weight    45.89 4 1.00   < .001 
Overweight 0.13 0.28 0.23 1 1.14 0.66 1.97 .629 
Obese Cat 1 0.71 0.28 6.65 1 2.04 1.19 3.51 .010 
Obese Cat 2  1.06 0.29 13.59 1 2.88 1.64 5.05 < .001 
Obese Cat 3 1.31 0.30 18.66 1 3.69 2.04 6.68 < .001 
Maternal age 0.06 0.01 18.54 1 1.06 1.03 1.09 < .001 
Parity  2.40 0.21 125.96 1 11.04 7.26 16.78 < .001 
Race-non-
Hispanic white   
8.83 3 1.00   .032 
 
(Table 28 Continues) 
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(Table 28 Continued) 
 
Variables in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Race-non-
Hispanic black 0.37 0.27 1.92 1 1.45 0.86 2.46 .166 
Race-Hispanic 0.57 0.22 6.6 1 1.77 1.14 2.72 .010 
Race-
other/unknown 
0.34 0.23 2.16 1 1.41 0.89 2.21 .141 
Private 
insurance   2.99 2 1.00   .225 
Public insurance 0.27 0.18 2.31 1 1.31 0.93 1.84 .129 
Other insurance 0.81 0.78 1.08 1 2.25 0.49 10.36 .298 
University 
teaching    
17.09 2 1.00   .000 
Community 
teaching 
-1.08 0.38 8.24 1 0.34 0.16 0.71 .004 
Community non-
teaching 
-0.57 0.41 1.96 1 0.57 0.26 1.26 .162 
Birthweight 0.00 0.00 8.54 1 1.00 1.00 1.00 .003 
Pitocin 0.56 0.18 9.12 1 1.74 1.22 2.50 .003 
Amniotomy 0.00 0.26 0.00 1 1.00 0.61 1.65 .995 
Table notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital.  
Abbreviations. aOR, adjusted odds ratio; CI, Confidence interval; LB, Lower Bound; UB Upper Bound; cat, category. 
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Model fitting. The model was evaluated for cases of leverage, influence, or outliers. 
here were 23 missing cases noted. Leverage was checked, using the variable Lev_4, 
created when running a logistic regression model. A max value of .01498 and a minimum 
of .00006.  DBetas were checked within the model, no model outliers were identified. 
The Cook distance was run, with a maximum value of .04335 and a minimum of .00000. 
The model is a good fit for the data.  
Predictors. Three regression models were run side by side for type of birth 
following induction methods used for cervical ripening. The predictors in the model were 
BMI at time of hospital admission, maternal age, parity, race, insurance, type of hospital, 
birth weight, Pitocin and amniotomy. The BMI at time of hospital admission variable was 
statistically significant in most of the BMI categories. For BMI with use of misoprostol 
or other prostaglandins all BMI categories remained significant expect the overweight 
category with the use of misoprostol and the use of mechanical meas.  Overall, BMI had 
a statistically significant relationship with all induction methods. 
Maternal age was a statistically significant predictor for all induction methods. 
Maternal race was statistically significant in a few of the categories but overall was not a 
statistically significant predictor within the models.  Insurance had a statically significant 
relationship with the use of misoprostol and other prostaglandins but not with mechanical 
means for cervical ripening. Hospital type was a statistically significant predictor for type 
of birth after using misoprostol, and prostaglandin but not mechanical means for cervical 
ripening. relationships identified; birthweight was statistically significant predictor within 
the model but may have little clinical relevance due to the odds ratio of 1. Pitocin was 
statistically significantly predictor of birth outcomes after using misoprostol or 
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mechanical means but not after using other prostaglandins for cervical ripening. 
Amniotomy was not statistically significantly predictor of type of birth within the 
models.  BMI at time of hospital admission, maternal age, parity, and birthweight were 
found to be predictive within the models.  
A3H2 hypothesis testing. To test A3H2 which compared the odds of cesarean 
birth in women induced with misoprostol to the odds in similar women induced using 
other prostaglandins. The comparison of the adjusted odds ratios showed higher odds of 
cesarean birth following the use of other prostaglandins for cervical ripening. All of the 
relationships within the model were statically significant except for the use of 
misoprostol in the overweight category. Additionally, there were increased odds of 
cesarean birth with each successive increase in BMI category. This hypothesis is 
supported.  See Table 29 summarizing the odds ratios for misoprostol use and other 
prostaglandin use for cervical ripening as part of induction of labor.  
Table 29 
Adjusted Odds Ratios for Cesarean Birth Following Incursion of Labor with Cervical 
Ripening Method of Misoprostol or other Prostaglandins 
Cervical 
ripening 
method 
BMI 
category 
aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Misoprostol Normal 
weight  
1.00   < .001 
 Overweight 1.57 0.98 2.51 .059 
 Obese Cat 1 2.19 1.35 3.56 .001 
 Obese Cat 2  3.62 2.14 6.12 < .001 
 Obese Cat 3 3.44 1.95 6.07 < .001 
 
(Table 29 Continues)  
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Cervical 
ripening 
method 
BMI 
category 
aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Other 
prostaglandins 
Normal 
weight  
1.00   < .001 
 Overweight 2.32 1.42 3.79 .001 
 Obese Cat 1 3.84 2.32 6.37 < .001 
 Obese Cat 2  3.74 2.12 6.60 < .001 
 Obese Cat 3 7.03 3.98 12.43 < .001 
Notes. Normal weight used as referent group. Abbreviations. Body mass index, BMI. 
Adjusted odds ratio, aOR. Confidence interval, CI. Lower bound, LB. Upper bound, UB. 
Category, cat. 
 
A3H2 summary.  The results showed higher odds of cesarean birth following the use 
of other prostaglandins for cervical ripening as compared with misoprostol. Additionally, 
there was a greater risk of cesarean birth with each increase in BMI category. This 
hypothesis was supported.  
A3H3 Hypothesis testing- To test the hypothesis for A3H3 a binary logistic regression 
was run with side by side models cervical ripening methods of prostaglandins (either 
prostaglandin) and mechanical means (mechanical means alone or mechanical with the 
use of prostaglandins). The results for cesarean birth following the use of cervical 
ripening methods are listed below.  
Unadjusted binary logistic regression. A standard binary logistic regression was used 
to model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of 
cervical ripening (either prostaglandin or mechanical means with or without the use of 
prostaglandins) were run as side by side models. BMI was the singe predictor included in 
the model.  
Either prostaglandin. Based on classification threshold predictive probability of 
having a cesarean birth as 0.5, results of the logistic regression analyses for the single 
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variable model provided a statistically significant prediction of the type of birth (χ2 (4, N 
= 4,416) = 146.69, p < .001). The Nagelkerke pseudo R2 indicated the model accounted 
for approximately 4.6% of the total variance. Classification accuracy for all the cases was 
based on a classification cut off value of 0.5 for predicting the type of birth was 
moderately high, with an overall correct prediction rate of 68.5%, and correct prediction 
rates of 100% in women having a vaginal birth and 0% of women having a cesarean 
birth. 
Mechanical means. Based on classification threshold predictive probability of 
having a cesarean birth as 0.5, results of the logistic regression analyses for the single 
variable model provided a statistically significant prediction of the type of birth (χ2 (4, N 
= 1,619) = 60.33 p < .001). The Nagelkerke pseudo R2 indicated the model accounted for 
approximately 5.6% of the total variance. Classification accuracy for all the cases was 
based on a classification cut off value of 0.50 for predicting the type of birth was 
moderately high, with an overall correct prediction rate of 77.2% and correct prediction 
rates of 100% in women having a vaginal birth and 0% of women having a cesarean 
birth. Table 30 summarizes the adjusted logistic regression for birth outcome after being 
induced by prostaglandins (misoprostol or other prostaglandins) or mechanical methods 
(alone or with prostaglandins).  
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Table 30 
Unadjusted Odds Ratios for Cesarean Birth after using Prostaglandins or Mechanical Means for Cervical Ripening 
Cervical ripening method BMI category B S.E. Wald df OR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Either prostaglandins Normal weight    137.61 4 1.00   < .001 
 Overweight 0.60 0.13 20.29 1 1.82 1.40 2.37 < .001 
 Obese Cat 1 0.98 0.14 53.16 1 2.67 2.05 3.48 < .001 
 Obese Cat 2  1.19 0.15 66.26 1 3.28 2.47 4.37 < .001 
 Obese Cat 3 1.51 0.15 96.67 1 4.54 3.36 6.14 < .001 
Mechanical Normal weight    59.04 4 1.00   < .001 
 Overweight 0.09 0.26 0.12 1 1.10 0.65 1.84 .727 
 Obese Cat 1 0.58 0.26 5.00 1 1.79 1.08 2.98 .025 
 Obese Cat 2  1.11 0.27 17.18 1 3.05 1.80 5.16 < .001 
 Obese Cat 3 1.25 0.28 20.12 1 3.50 2.02 6.04 < .001 
Notes. Referent category Normal weight. Abbreviations. BMI, Body mass index; OR, odds ratio; CI, Confidence interval; LB, 
lower bound; UB Upper bound; cat, category.  
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Adjusted binary logistic regression. A standard binary logistic regression was used to 
model the binary variable- type of birth (0 ‘vaginal’ 1 ‘cesarean’). A comparison of 
cervical ripening methods where women were induced with either prostaglandins, or the 
use of mechanical means were run as side by side models.  The predictor variable in these 
models were BMI at time of hospital admission, maternal age, parity, race, insurance, 
hospital type, birthweight, Pitocin and amniotomy.  
Either prostaglandin. Based on classification threshold predictive probability of 
having a cesarean birth as 0.5, results of the logistic regression analyses for the nine 
variable model provided a statistically significant prediction of the type of birth (χ2 (16, 
N = 4,416) = 1965.34, p < .001). The Nagelkerke pseudo R2 indicated the model 
accounted for approximately 51% of the total variance. Classification accuracy for all the 
cases was based on a classification cut off value of 0.50 for predicting the type of birth 
was moderately high, with an overall correct prediction rate of 82.5%, and correct 
prediction rates of 90.5% in women having a vaginal birth and 64.2% of women having a 
cesarean birth. 
Mechanical means. Based on classification threshold predictive probability of 
having a cesarean birth as 0.5, results of the logistic regression analyses for the nine 
variable model provided a statistically significant prediction of the type of birth (χ2 (16, 
N = 1,619) = 300.50 p < .001). The Nagelkerke pseudo R2 indicated the model accounted 
for approximately 25.8% of the total variance. Classification accuracy for all the cases 
was based on a classification cut off value of 0.50 for predicting the type of birth was 
moderately high, with an overall correct prediction rate of 79.3% and correct prediction 
135 
 
rates of 95.2% in women having a vaginal birth and 25.0% of women having a cesarean 
birth. Table 31 summarizes the adjusted logistic regression for birth outcome after being 
induced by prostaglandins (misoprostol or other prostaglandins).  Table 32 summarizes 
the adjusted logistic regression for birth outcome after being induced by mechanical 
methods (alone or with prostaglandins).   
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Table 31 
Table Description Odds Ratios for Cesarean after using Prostaglandins (Misoprostol or Other Prostaglandins Alone or in 
Combination) Cervical Ripening by BMI Category 
Variable in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Normal weight   84.45 4 1.00   < .001 
Normal weight    84.45 4 1.00   < .001 
Obese Cat 1 1.08 0.17 40.32 1 2.94 2.11 4.11 < .001 
Obese Cat 2  1.32 0.19 49.78 1 3.73 2.59 5.38 < .001 
Obese Cat 3 1.53 0.20 60.25 1 4.61 3.14 6.79 < .001 
Maternal age 0.10 0.01 152.54 1 1.10 1.09 1.12 < .001 
Parity  2.41 0.12 425.67 1 11.11 8.84 13.96 < .001 
Race-non-
Hispanic white 
  16.49 3 1.00   .001 
Race-non-
Hispanic black 
0.28 0.14 4.11 1 1.32 1.01 1.72 .043 
Race-Hispanic 0.39 0.12 10.18 1 1.48 1.16 1.88 .001 
Race-
other/unknown 
0.50 0.15 10.38 1 1.63 1.21 2.20 .001 
Private 
insurance 
  596.22 2  - - < .001 
 
(Table 31 Continues) 
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(Table 31 Continued) 
Variable in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Public insurance 0.83 0.11 53.70 1 2.28 1.83 2.85 < .001 
Other insurance -2.60 0.14 324.10 1 0.08 0.06 0.10 < .001 
University 
teaching  
  185.69 2    < .001 
Community 
teaching 
-1.68 0.12 183.41 1 0.19 0.15 0.24 < .001 
Community 
non-teaching 
-1.27 0.22 34.79 1 0.28 0.19 0.43 < .001 
Birth weight  0.00 0.00 9.11 1 1.00 1.00 1.00 .003 
Pitocin 0.49 0.13 13.29 1 1.63 1.25 2.12 < .001 
Amniotomy  -0.02 0.14 0.02 1 0.98 0.75 1.28 .886 
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital 
Abbreviations. OR odds ratio; CI, Confidence interval; LB, lower bound; UB Upper bound; cat, category.   
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Table 32 
Table Description Odds Ratios for Cesarean after using Mechanical Means (with or without the use of Prostaglandins) for 
Cervical Ripening by BMI Category 
Variable in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
Normal weight    45.89 4 1.00   .000 
Overweight 0.13 0.28 0.23 1 1.14 0.66 1.97 .629 
Obese Cat 1 0.71 0.28 6.65 1 2.04 1.19 3.51 .010 
Obese Cat 2  1.06 0.29 13.59 1 2.88 1.64 5.05 < .001 
Obese Cat 3 1.31 0.30 18.66 1 3.69 2.04 6.68 < .001 
Maternal age 0.06 0.01 18.54 1 1.06 1.03 1.09 < .001 
Parity  2.40 0.21 125.96 1 11.04 7.26 16.78 < .001 
Race-non-
Hispanic white 
  
8.83 3 1.00   .032 
Race-non-
Hispanic black 
0.37 0.27 1.92 1 1.45 0.86 2.46 .166 
Race-Hispanic 0.57 0.22 6.60 1 1.77 1.14 2.72 .010 
Race-
other/unknown 
0.34 0.23 2.16 1 1.41 0.89 2.21 .141 
Private 
insurance 
  2.99 2 1.00   .225 
Public insurance 0.27 0.18 2.31 1 1.31 0.93 1.84 .129 
Other insurance 0.81 0.78 1.08 1 2.25 0.49 10.36 .298 
 
(Table 32 Continues) 
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(Table 32 Continued) 
Variable in the 
equation 
B S.E. Wald df aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P value 
University 
teaching  
  
17.09 2 1.00   < .001 
Community 
teaching 
-1.08 0.38 8.24 1 0.34 0.16 0.71 .004 
Community 
non-teaching 
-0.57 0.41 1.96 1 0.57 0.26 1.26 .162 
Birth weight  0.00 0.00 8.54 1 1.00 1.00 1.00 .003 
Pitocin 0.56 0.18 9.12 1 1.74 1.22 2.50 .003 
Amniotomy  0.00 0.26 0.00 1 1.00 0.61 1.65 .995 
Notes. Referent categories: Normal weight, Non-Hispanic white, Private insurance, University teaching hospital 
Abbreviations. OR odds ratio; CI, Confidence interval; LB, lower bound; UB Upper bound; cat, category.   
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Predictors. Two regression models were run side by side for type of birth 
following induction requiring cervical ripening. The predictors in the model were BMI at 
time of hospital admission, maternal age, parity, race, insurance, type of hospital, birth 
weight, Pitocin and amniotomy. The BMI at time of hospital admission was statistically 
significant in all BMI categories, except in overweight women after using machinal 
means for cervical ripening. Overall, BMI had a statistically significant relationship with 
the use of prostaglandins and mechanical means for cervical ripening.  
Maternal age and parity were statistically significant predictors for all both 
cervical ripening methods.  Maternal race and insurance remined statistically significant 
with the use of prostaglandins for cervical ripening but not with the use of mechanical 
means. Hospital type was a statistically significant predictor for type of birth after using 
prostaglandins and mechanical means for cervical ripening with all hospital types except 
in community nonteaching hospital after the use of mechanical means for cervical 
ripening. Birth weight was statistically significant within the models but was not 
clinically related to type of birth. The use of Pitocin was a statistically significantly 
predictor of higher cesarean births which may be related to a difference in labor initiation 
and processes. Amniotomy was not a statistically significant predictor of type of birth 
within the models.  BMI at time of hospital admission, maternal age, parity, birthweight, 
and the use of Pitocin for induction were found to be predictive of within the models. 
Table 33 summarizes the adjusted odds ratios for cesarean after cervical ripening with 
either type of prostaglandin or mechanical means alone or with prostaglandin
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Table 33  
Adjusted Odds Ratios for Cesarean after Cervical Ripening with either type of 
Prostaglandin or Mechanical Means alone or with Prostaglandins 
Cervical ripening 
method 
BMI category aOR 
95% C.I. 
LB 
95% C.I. 
UB 
P 
value 
Either prostaglandin Normal weight  1.00 - - < .001 
 Overweight 1.98 1.43 2.73 < .001 
 Obese Cat 1 2.94 2.11 4.11 < .001 
 Obese Cat 2  3.73 2.59 5.38 < .001 
 Obese Cat 3 4.61 3.14 6.79 < .001 
Mechanical Normal weight  1.00 - - .000 
 Overweight 1.14 0.66 1.97 .629 
 Obese Cat 1 2.04 1.19 3.51 .010 
 Obese Cat 2  2.88 1.64 5.05 < .001 
 Obese Cat 3 3.69 2.04 6.68 < .001 
Notes. Normal weight used as referent group. Abbreviations. BMI, Body mass index; 
aOR, adjusted odds ratio; CI, Confidence interval; LB, lower bound; UB, Upper bound; 
cat, category.   
 
Aim 3 summary. A3H1 hypothesis was supported, as there were higher odds of 
having a cesarean birth after labor induction requiring cervical ripening with each 
increase in BMI category when compared to normal weight women. A3H2 hypothesis for 
was supported, as there were lower odds of cesarean birth after receiving misoprostol for 
induction as compared to receiving other prostaglandins. A3H3 hypothesis for was 
supported, as women had lower odds of cesarean birth in any obesity category after using 
mechanical means for induction method as compared to women induced with either 
prostaglandin. This hypothesis is supported.   
Chapter Summary 
This chapter presents the results of this retrospective cohort study on the 
influences of maternal obesity on induction of labor processes and outcomes. The sample 
selection was described. A description of the sample characteristics for the entire sample 
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was given. The demographic variables as well as other variables used in individual and 
system characteristics were described. The findings from the statistical analysis and the 
results of hypothesis testing were reported for the three aims of this study.   
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
This study was designed to examine induction of labor requiring cervical ripening 
processes and outcomes and the influences of maternal BMI among a cohort of women 
with low-risk pregnancy. Obesity continues to be an epidemic in the US, and this obesity 
epidemic includes childbearing women.  It is important to understand if there are 
differences in labor induction processes and outcomes for women of differing BMI 
categories when cervical ripening is required. Chapter five presents a discussion of the 
study results and conclusions regarding the research aims and hypotheses. This chapter 
concludes with a discussion of the study strengths and limitations, implications for 
practice, theory development, and model testing, and future research.  
This study adds to the limited body of knowledge regarding the influences of BMI 
on labor induction processes and outcomes. This study focused on the different cervical 
ripening methods used for induction of labor including misoprostol, PGE2, and 
mechanical means. This study was not the first to focus on labor induction methods while 
stratifying results by BMI category, but this study is the first to use a large existing 
national database that was gathered to study contemporary labor patterns (Zhang et al., 
2010). 
  
144 
 
 
 
Evaluation of the Influences of BMI on the use of  
Cervical Ripening for Labor Induction 
 Overall, this sample of more than 43,000 women with healthy, singleton, 
cephalic, term pregnancies shows that maternal does BMI influence labor induction 
processes and outcomes.  In a smaller sample of 6,035 women requiring cervical 
ripening, the time to birth and type of birth were also influenced by BMI. The following 
discussion is organized by each aim of the study, including a discussion of individual and 
system characteristics, and other confounding variables.   
 Discussion of Aim 1: Use of Cervical Ripening Methods for Induction of 
Labor. Aim 1 explored the methods used for induction of labor requiring cervical 
ripening. Logistic regression was used to determine the odds of using cervical ripening 
(misoprostol, other prostaglandins, or mechanical means) for induction of labor. The 
cervical ripening methods were used either alone or in combination to initiate labor. The 
odds for requiring cervical ripening with labor induction were higher by each BMI 
category when compared with normal weight women. This relationship was found in 
both the unadjusted and adjusted models. The model was adjusted for age, height, parity, 
race, insurance, hospital type, NICU level, and birth weight.  This study found that BMI 
was a statistically significant predictor for the use of cervical ripening methods for 
induction of labor. Additionally, this study found maternal age, maternal height, parity, 
racial categories of Hispanic, and other/unknown, insurance status, hospital type, hospital 
level, NICU level and birth weight were statistically significant predictors for the use of 
cervical ripening for labor induction.  
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 Little is known from previous studies about the differences in use and the 
effectiveness of cervical ripening methods for induction of labor in women belonging to 
BMI categories 1, 2, and 3. In previous studies of induction of labor requiring cervical 
ripening, small sample sizes were used requiring the obesity categories to be collapsed 
into one obese category for analysis (Anabusi, Mei-Dan, Hallak, & Walfisch, 2016; 
Beckwith, Magner, Kritzer, & Warshak, 2016; Melamed, Ben-Haroush, Kremer, Hod, & 
Yogev, 2010; O'Dwyer et al., 2011; Roloff, Peng, Sanchez-Ramos, & Valenzuela, 2015; 
Vinturache, Moledina, McDonald, Slater, & Tough, 2014). Two studies were identified 
where the BMI categories for obesity were not collapsed into lean (< 30 kg/m2) and 
obese (> 30 kg/m2). In the first the categories were instead collapsed into 30 - 39 kg/m2, 
and > 40kg/m2  (Lassiter et al., 2016; Pevzner, Powers, Rayburn, Rumney, & Wing, 
2009). The second study used BMI categories of normal weight (20 - 25 kg/m2), 
moderate obesity (30 - 35 kg/m2), severe obesity (35 - 40 kg/m2) and morbid obesity (> 
40 kg/m2) (Gauthier et al., 2012).  
 When looking for comparable rates of cervical ripening from the literature Only 
one of these studies reported the rate of use of cervical ripening in women with a higher 
BMI.  One study reported a lower rate of PGE2 cervical ripening use among obese 
women as compared to normal weight women (Gauthier, 2012). The women in the lean 
group had a higher mean age so there is a chance the increase in cervical ripening need 
among this group of lean women could be due to another factor outside of BMI. One 
study included only women needing cervical ripening for induction of labor (Lassiter et 
al., 2016), having a 100% use rate for cervical ripening  
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This study offers a look into contemporary labor induction requiring cervical 
ripening in a nationally representative sample. The data for this sample were collected 
from 2006 to 2012. This retrospective observational study describes the use of cervical 
ripening for labor induction in modern women with results stratified by standardized BMI 
categories. This study shows a statistically significant relationship between BMI and the 
use of cervical ripening methods to initiate labor. 
Discussion of Aim 2: Time to Birth.  Aim 2 explores the time to birth (time from 
hospital admission to birth, in minutes) after using differing cervical ripening methods 
with the results stratified by BMI category.  Bivariate analysis shows a longer time to 
birth with each successive BMI category. Survival analysis was used for hypothesis 
testing. This study compared the hazard ratios for the use of misoprostol to the use of 
other prostaglandins for cervical ripening, finding an increased time to birth after using 
other prostaglandins for labor induction requiring cervical ripening as compared to 
misoprostol. While these findings were not statistically significant in all BMI categories, 
there may be clinical significance. For example, bivariate analysis showed there was a 
351-minute time to birth difference between normal weight women and obese cat 3 
women. This time difference makes a difference in the clinical setting where the time in 
the hospital is longer, nursing staff is needed at the bedside for a longer period of time, all 
resulting in higher cost for the hospital and the woman being induced. This study 
supported women needing a longer time to birth with an increase in BMI, despite the lack 
of statistical significance. The increased hazard ratios did not have a successive increase 
with each increase in BMI. category.  
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The time difference seen in this study is similar to what is seen in previous 
research. One previous study found a 5-hour difference in the time from induction to 
birth in obese women as compared to normal weight women (Gauthier, 2012). Another 
found a 5-hour difference in women with a BMI  30 kg/m2 compared to women with a 
BMI  40 kg/m2 (Lasstier, 2016). 
This study also compared the use of prostaglandins with the use of mechanical 
means for cervical ripening.  The time to birth after the use of mechanical means alone or 
mechanical means with misoprostol for induction of labor requiring cervical ripening 
were shorter when compared to the use of either prostaglandin (misoprostol or other 
prostaglandins). Predictors within the models remaining statistically significant across all 
BMI categories were maternal age, parity, insurance status, hospital type, NICU level, 
and the use of Amniotomy. This study showed that mechanical means were more 
effective than either prostaglandin for cervical ripening for women in all BMI categories. 
Little is known about differences in the time to birth for differing cervical 
ripening methods by BMI category from previous research. Previous studies have shown 
misoprostol seems to be more effective than dinoprostone (PGE2/other prostaglandins) 
for cervical ripening in women with obesity (Gauthier et al., 2012; Kunzier, Park, Cioffi, 
Calixte, & Vintzileos, 2016; Suidan, Rondon, Apuzzio, & Williams, 2015). One previous 
study reported a shorter time to birth after the use of misoprostol for induction of labor 
versus the use of other prostaglandins, resulting in an overall shorter hospital stay.  
(Kunzier et al., 2016). This study suggests misoprostol is more effective than other 
prostaglandins for cervical ripening among women in any BMI category and especially 
for women with obesity. The results of the previous research support this study which 
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also found the use of misoprostol resulted in a shorter time to birth than the use of other 
prostaglandins, 
Little is known about the time to birth after using mechanical means versus 
prostaglandins for cervical ripening. There were two previous studies with time to birth 
as an outcome after the use of cervical ripening (mechanical means, prostaglandins, or 
both) for induction of labor (Anabusi et al., 2016; Beckwith et al., 2016).  One of the 
studies reported an increased time to birth in women with obesity as compared to normal 
weight women (Anabusi et al., 2016). The other study reported an increased failure of 
cervical ripening with misoprostol; however, the same failure of cervical ripening was 
not seen with mechanical methods. (Beckwith et al., 2016). The findings of these 
previous studies are consistent with the findings from this research study. Based on the 
results of this study, mechanical means appears to be more effective than the use of 
prostaglandins alone for cervical ripening in women of any BMI category.  
Discussion of Aim 3: Type of Birth. Aim 3 explored the type of birth (vaginal or 
cesarean) following the use of cervical ripening methods for induction of labor with 
results stratified by BMI category. Logistic regression was used for analysis. This study 
showed there was a greater risk of cesarean birth with each increase BMI category when 
compared to normal weight women regardless of cervical ripening method used for 
induction of labor. Previous studies have shown a higher cesarean birth rate in women 
with obesity compared to normal weight women (Anabusi et al., 2016; Beckwith et al., 
2016; O'Dwyer et al., 2011; Pevzner et al., 2009). The risk of cesarean birth increases 
with each increase in BMI category. 
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This study showed there were higher odds of cesarean birth following the use of 
other prostaglandins for cervical ripening than with the use of misoprostol, meaning 
misoprostol is more effective for inducing labor.  Previous studies have shown obese 
patients who underwent induction using misoprostol (PO or PV) had a lower cesarean 
birth rate than those induced with other prostaglandins (dinoprostone) (39.1 vs. 51.3%; 
OR, 0.61; 95% CI, 0.44-0.85; p. 0.003)  (Suidan et al., 2015). The use of misoprostol for 
cervical ripening seems to result in fewer cesarean births that the use of Other 
prostaglandins for cervical ripening.  
This study showed there were lower odds of cesarean birth in any obesity 
category after using mechanical means for cervical ripening method for induction of 
labor than women induced with either prostaglandin. Two previous studies looked at the 
outcome of cesarean birth following induction with either prostaglandins and/or 
mechanical means (Anabusi et al., 2016; Beckwith et al., 2016). Both studies were 
conducted with a relatively small sample of women (n = 181) and (n = 709), respectively. 
The small sample size required researchers to collapse the BMI categories for analysis to 
less than 30 mg/kg2 and greater than 30 mg/kg2,, so the results were not stratified by BMI 
category. One study reports a higher number of cesarean births in women with obesity 
compared to normal weight women (17.6% vs. 25.3%) (Anabusi et al., 2016). The 
researchers in the other study found a higher number of cesarean births in women with 
obesity after being induced with misoprostol as compared to normal weight women 
(Beckwith et al., 2016).  The same relationship was not seen in women with obesity who 
were induced with mechanical means as compared to normal weight women (Beckwith  
150 
 
 
 
et al., 2016). Mechanical means seem to be more effective than prostaglandins 
(misoprostol) for inducing women with higher BMI’s and women with obesity. 
Strengths of the Study 
This study had several strengths. First, it used a multi-site, national sample of 
women undergoing induction of labor, also allowing for a larger sample size than 
previously used. When comparing the demographic characteristic of this study to national 
birth data from 2006 to 2008 we see similar characteristic within the study (Martin, 
2010). The median age of women in this study is similar to the median age in the Birth 
data for 2008 (27 years, 27.4 years, respectively). The make up the maternal racial and 
ethnic groups is the same for Non-Hispanic white women between this study national 
data (53.3%). The rates of Non-Hispanic black women were higher in this study when 
compared to national birth data (19.3%, 14.6%, respectively). The rates of Hispanic 
women were lower in this study as compared to national birth data (18.4%, 24.5%, 
respectively). 
Second, this study was the first to use a large sample size to better evaluate 
induction by BMI category. Third, no other study to date has evaluated mechanical 
cervical ripening alone or in conjunction with the use of prostaglandins in a sample as 
large as the sample in this study. By evaluating a larger group of women, it is easier to 
see the impact of BMI category on induction of labor. While the hazard ratios for the 
time to birth were not statistically significant after being induced with prostaglandins, the 
cesarean birth rates did show a statically significant increase with each increase in BMI 
category.  Finally, this study adds to the body of knowledge on the influences of BMI on 
induction of labor processes and outcomes. 
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Limitations of the Study 
The study findings must be considered in the context of some limitations. One of 
the study limitations is the representativeness of the sample. While this study utilized a 
large sample, it may not be representative of all women undergoing induction of labor. 
Most of the birth occurred in large urban medical centers. When comparing these study 
findings (cesarean birth and induction of labor) to national birth data for the years of birth 
in this sample 2006-2008 (Martin, 2010) we see some difference in the outcomes. The 
cesarean birth rate in this study was lower than cesarean birth rates in national data for 
2008 (32.3% of all births) (Martin, 2010). This study found 18.3% of women undergoing 
induction of labor had a cesarean birth, and 28.4% of women undergoing induction of 
labor with cervical ripening had a cesarean birth. These differences could be due to 
differences in provider practices or regional differences in practice. This study had an 
18% induction of labor rate which is lower induction of labor rates national data where 
22.9% of women were induced (Martin, 2010). This difference is likely due to the 
inclusion of low-risk pregnancies the study where national data included all women 
undergoing induction of labor.  
A second limitation is inconsistencies in data collection. The data were collected 
from multiple sites, and the collection of data and data reporting varied between sites. For 
example, one site did not collect or report the induction type (n = 4,210). However, we 
cannot assume there were no inductions at this site. While the site was included in the 
sample to better describe women undergoing induction of labor, the data were deleted for 
analysis. Sites may have collected other information inconsistently such as the first 
cervical exam was not always documented in the medical record.  
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A third limitation is the missingness of the data. On the variables for BMI, 30% of 
the data were missing and thus were deleted for missingness. A sensitivity analysis 
should be run on Aim 1-3 of this study to see if there are differences in the median time 
to birth or the odds ratios for cesarean birth in the women with missing data compared to 
the included women.  The sensitivity analysis would help verify the outcomes by 
assessing the impact of the missing data.  
A fourth limitation is the sample size. Many statistically significant findings may 
be due to the extremely large sample size, and not represent clinically significant 
findings. A fourth limitation relates to the statistical analysis. The data could be analyzed 
using other techniques to go beyond the correlational analyses that were planned for this 
study. By using logistic regression to analyze the sample as a whole the nuances of 
individual sites were not accounted for in the modeling process. This multisite database 
included twelve different sites; hierarchical modeling could have been used to represent 
the site differences.  A fifth limitation is the use of survival analysis for time to birth. By 
using survival analysis, a unique set of women were created, who were able to have a 
vaginal birth. More obese women required cesarean birth, so it is likely the two groups 
vary in a significant way.  
These study limitations are in part due to the study design and the use of 
secondary data. These limitations may impact the generalizability of the study findings. 
These study limitations warrant closer inspection. 
Implications for Practice 
Clinicians should account for maternal BMI when considering induction of labor 
and or cervical ripening. As shown with this research, women with obesity are more 
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likely to experience a longer time to birth and end labor induction with a cesarean birth. 
This study found women with obesity had longer labors of approximately 3.78 hours 
longer, and in the highest category of obesity, there were an additional 5.85 hours in labor 
when compared to normal weight women. The number of cesarean births within this 
sample were higher for women with cervical ripening compared to women undergoing 
induction of labor without cervical ripening (28.4% versus 18.3%).  Among women 
induced using cervical ripening methods, women with obesity were twice as likely to end 
labor with cesarean birth as compared to normal weight women. Among women in the 
highest obesity category, there was a 4-fold increase in cesarean birth as compared to 
normal weight women. Therefore, clinicians should use careful consideration before 
recommending or counseling on elective induction of labor.  
There were different associations of time to birth and cesarean birth with the use 
of differing cervical ripening methods. When using mechanical means for induction of 
labor women had a shorter time to birth to birth in all BMI categories as compared to 
using misoprostol. The odds of cesarean birth were four times higher in women induced 
with misoprostol or PGE2, and three times higher in women induced with mechanical 
means compared to normal weight women induced with any cervical ripening method. 
These associations suggest mechanical means may be more effective for cervical ripening 
in women with a high BMI or obesity.  
Maternal BMI calculated at the time of hospital admission or close to birth should 
help clinics determine the best method(s) for cervical ripening. Although pre-pregnancy 
BMI may be helpful for guiding antenatal care, maternal BMI at the end of pregnancy 
better reflects a woman’s metabolic condition near labor. Clinicians should expect 
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induction will take longer in women with obesity. This should be reflected in their 
counseling. Clinicians should prepare the clinical team, support person and possibly the 
women for the longer time frame to induce labor in women with a higher BMI or women 
with obesity.   
Maternal obesity and labor induction are “the new normal” in contemporary 
childbearing.  Clinicians need better information on preparing women with higher BMI’s 
for induction of labor. This study adds to the body of knowledge for clinical use in the 
timing of labor induction and the choice of method for women with a high BMI or 
women with obesity. This research supports the need for new labor induction protocols 
that are individualized by the degree of maternal obesity both in the timing and choice of 
induction methods. With patience and time, many more women with obesity might 
achieve normal labor outcomes following safe and effective labor induction.  
Implications for Theory Building and Model Testing 
Theory Building  
There is a theoretical concept that labor initiation is different for women with 
obesity than it is for women with a normal BMI. These differences are thought to be 
related to physiologic differences that exist among the different BMI groups, where 
women with obesity have difficulty initiating labor at term when compared with normal 
weight women (Harper et al., 2012; Hermesch, Allshouse, & Heyborne, 2016; Stirrat et 
al., 2014). This study supports this theory, a higher number of women with a high BMI 
were induced compared to normal weight women.   
While one potential explanation for a longer time for labor initiation in women 
with obesity is increased leptin levels which appear to increase placental PGE2 release 
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(Wendremaire et al., 2013) however we did not measure or have access to raw data with 
leptin or prostaglandin levels in this study. It is thought that women with obesity have 
higher levels of endogenous prostaglandins (PGE2).  Knowing PGE2 is increased would 
suggest that inducing women with a high BMI with prostaglandins and especially PGE2 
would likely be ineffective. The findings from this study support this theory by finding a 
longer time from induction to birth and higher cesarean section rates in obese women 
being induced with prostaglandins and especially PGE2. 
Other alternative explanations may exist for these study findings. Since this is was 
not a prospective study, we can’t know if other factors could be explaining the observed 
associations.  For example, women with higher BMI could have been more at risk for 
cesarean birth because their babies were more likely to have fetal heart rate abnormalities 
following dinoprostone vs. misoprostol.  Another alternative explanation for these 
findings could be that clinicians dosed the prostaglandins differently by maternal BMI 
and this difference in dosing was the problem causing women’s higher risk for cesarean 
birth and longer labor course.  Since we cannot tell temporal relationships in the use of 
cervical ripening or other IOL methods, we cannot rule this out. 
Model Testing  
Based on these study findings the Quality Health Outcome Model (Mitchell & 
Lang, 2004) adapted for this study is useful in explaining the influences of maternal BMI 
on the labor induction processes and outcomes with a few changes as noted. Future 
model testing could include post hoc analysis of BMI as a mediator or moderator as wells 
using BMI as a continuous variable rather than categorical within the model.  
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Individual Characteristics. The individual characteristics of maternal age, BMI, 
parity and cervical status were included in the proposed model. The sample as a whole 
was selected based on having an unfavorable cervical status, therefore this researcher 
would move cervical status out of the proposed model as an individual factor contributing 
to interventions and outcomes of labor induction. Additionally, the characteristics of 
height, race, and insurance status were found to be individual predictors of the study 
outcomes, the effectiveness of induction method, time to birth, and the type of birth. 
Therefore height, race, and insurance status should be added as individual characteristics 
to the model.  
Systems Characteristics. The system characteristics of hospital type, size, and 
geographic location were included in the proposed model. The characteristics of hospital 
type (university, community teaching, and community non-teaching) were included as 
system variables and found to be a significant predictor within most models in this study. 
Additionally, hospital level (obstetric level), and NICU level were found to be 
independent predictors of the study outcomes, the effectiveness of induction methods, the 
time to birth and the type of birth. These system characteristics account for some of the 
variances within the models. The system characteristics are site-specific (there were 12 
hospital systems included) and could be used/may be better represented by higher level 
statistical modeling. The system characteristics should be included as covariates in future 
multilevel or hierarchical modeling.  
Interventions/Outcomes. The interventions in the model were the specific 
methods for induction of labor misoprostol, PGE2, and mechanical means. All of the 
women in the sample were induced, effectively creating a group that was induced with 
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oxytocin alone or in combination with amniotomy or one or more of the previously listed 
induction methods. Outcomes of time to birth and type of birth were given for each 
induction method included in the study. Outcomes were found to be increased time to 
birth for women with a higher BMI and increased odds ratio for cesarean birth among 
women with a higher BMI. A multidirectional arrow could be added between 
intervention and outcomes since they seem to have a well-defined relationship.  
Model Summary. This modified Quality Health Outcomes Model is appropriate 
for explaining the observed relationships among the study variables. A few minor 
changes are needed in the proposed model. Variables need to be added to the individual 
characteristics as to better reflect the variables used for analysis within this study. 
Overall, the QHOM explains the relationships between the observed client 
characteristics, system characteristics, interventions and outcomes. This study showed 
cervical ripening methods were used more frequently among women with obesity as 
compared to normal weight women. The time to birth was increased among women using 
PGE2 for cervical ripening and decreased for women using mechanical means as 
compared to the use of misoprostol. Cesarean births were more common among women 
with obesity as compared to normal weight women. Cesarean births were more common 
after using PGE2 for cervical ripening than misoprostol. Cesarean births were less 
common after using mechanical means for cervical ripening than the use of either 
prostaglandin in women with obesity as compared to normal weight women.  
Implications for Future Research 
This study contained a cohort of women with healthy low-risk pregnancies. 
Future research should include all women being induced, both high-risk and low-risk to 
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see if the influences of BMI are similar in both groups of women. Many women with 
high-risk pregnancies are induced for medical reasons, making this group just as 
important to study. One way to do this would be to include all women in the sample and 
look at all women being induced after 24 weeks (Suidan, Apuzzio, & Williams, 2012). 
Maternal and fetal outcomes should be included along with gestational age for 
comparison to the limited research available.  
Additional secondary analysis is needed on the influences of race and insurance 
status in relation to outcomes of induction methods used, time to birth and cesarean birth 
rates. Additional analyses of the larger sample including high-risk women would give 
researchers insight into induction of labor processes and outcomes for all women 
including those needing pre-term and post-term induction of labor. This additional 
research could potentially increase the effectiveness of labor induction for medical 
indications. This study reported the use of private or public insurance whereas national 
data report the number of births to married or unmarried women.  Future research in the 
data set should focus on using comparable variables to national outcomes. Closer 
inspection of BMI and the difference between pregnancy BMI and  BMI at the time of 
hospital admission are warranted. Additionally, there are national data on pregnancy 
weight gain which could be used for comparisons.  
Multilevel modeling. Future analysis of this dataset using a multi-level model to 
account for differences between the sites. Additional areas for secondary analysis could 
include the racial disparities seen in cesarean section rates. It is important to understand if 
minority women are being induced differently than the general population. The outcomes 
for vulnerable women such as outcomes for ethnic and racial minority women and 
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women who are using public health insurance due to disadvantaged socio-economic 
status are also important to explore. If cesarean section rates are higher it could be 
important for insurers, policy makers and other stake holders to understand the 
differences in these cesarean birth rates.  
Prospective studies are needed using standardized BMI categories, standardized 
labor induction protocols, and a consistent definition of active labor. Women should be 
included from all BMI categories to further our knowledge of timing and choice of 
induction method on the processes and outcomes of labor induction. Future research is 
needed on the effectiveness of individual methods as well as those used in combination.  
Individualized labor induction plans or protocols should be created by the degree 
of maternal obesity and the choice and timing of labor induction methods. An increased 
understanding of labor initiation and outcomes among women with obesity could lead to 
more effective individualized care for women in general and especially for women with 
obesity.   
Finally, additional bench research is needed to increase our understanding of the 
metabolic shifts in women with obesity in general and especially at the time of birth. We 
have an idea that the protein levels of leptin are altered at the time of birth and 
prostaglandins levels are increased. It would be useful to develop a point of care test for 
these altered levels to determine the most effective way to induce low-risk women with 
obesity.  
Conclusions 
This study adds to the body of literature regarding the influences of BMI on 
induction of labor in a cohort of healthy low-risk women. A combination of individual 
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and system characteristics influence induction of labor requiring cervical ripening. These 
study findings emphasize that maternal BMI influences both labor induction processes 
and outcomes. Clinicians should take the responsibility to individualize care for women 
with obesity and explain the altered physiology, longer time for labor induction in terms 
that women and their labor support person can understand.  
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